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ABSTRACT 
 
Extracellular vesicles (EVs) represent an alternative and recently discovered way by which 
diverse cell phenotype can deliver complex messages through released vesicles and their 
cargoes to neighbor or distant targets. EVs mediate fundamental physiological and 
pathological processes in biological systems. 
In particular, we focused on neuron-glia communication mediated by microvesicles (MVs), 
a subpopulation of EVs that directly originate by outward budding of cellular plasma 
membrane, which are mostly released under specific stimuli. Given the nanosized dimension 
and origin of MVs, we tested the ability of carbon-based nanomaterial (small graphene oxide 
nanoflakes, s-GO), which are demonstrated to interface cells and interact with their 
physiology at the level of their plasma membrane, to affect the mechanisms governing 
vesicles release. We first investigated whether s-GO affected the ability of astrocytes to 
release synaptic-like MVs in pure glial cultures. Our results describe the potential of GO 
nanosheets to alter different modes of interneuronal communication systems in the central 
nervous system (CNS). We further tested the reactivity of microglia, a sub-population of 
neuroglia that acts as the first active immune response, when challenged by chronic s-GO 
delivery at high doses. We investigated the tissue reactivity in 3D tissue models by using 
organotypic spinal cord cultures, ideally suited for studying long-term interference with cues 
delivered at controlled times and concentrations and in isolated neuroglia cultures. In the 
latter condition, we further tested the role of microglial micro-vesicle release in mediating 
cell responses to s-GO. Finally, starting from the observation that small graphene oxide 
flakes (s-GO) are able to boost MVs basal release in cortical glial cells of rodents after a sub-
chronic treatment of 6-8 days, we compared through the use of highly sensitive and resolutive 
nanotechnological tools, MVs obtained under s-GO exposure with MVs obtained by 
stimulation with the purinergic agonist bzATP, known to induce such release in glial cells. 
The structural and macromolecular similarities found, suggested a comparable nature of s-
GO-derived MVs with the bzATP-derived ones, despite the unusual induction of release. We 
finally investigated the acute effects of those populations of vesicles exerted on single 
cortical neurons by focusing on their synaptic activity. We found that both the MVs types 
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induced an increase in spontaneous post synaptic currents (PSCs) on neurons, after 15 
minutes from MVs administration. 
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INTRODUCTION 
 
1. EXTRACELLULAR VESICLES (EVs) 
Communication among cells is an imperative and basic task of any multicellular organisms 
and it is accomplished by adopting diverse strategies. Traditionally, the known pathways of 
intercellular communication included the expression of signaling molecules on the cellular 
plasma membrane and the secretion of soluble ligands (the so called secretome) (Gundacker 
et al., 2009; Makridakis and Vlahou, 2010), and various cell-cell contact interactions, like 
gap junctions or tunneling nanotubes that allow metabolic and electrical pairing (Mendoza-
Naranjo et al., 2011; Valiunas et al., 2005). However, recent studies enlarged this scenario 
with an additional signaling modality, once restricted only to specialized blood cells, that 
involves the release of small membrane vesicles in the extracellular environment able to 
affect target cells (Hess et al., 1999; Holme et al., 1994; Maas et al., 2017; Raposo and 
Stoorvogel, 2013).  
The first report describing the existence of extracellular vesicles (EVs) dated back in 1946. 
Chargaff and West, investigating the coagulation factors involved in the clotting process, 
found that human plasma exposed to a strong centrifugal field (30000g) forms sediments that 
they identified as “pro-coagulant platelet-derived particles” (Chargaff and West, 1946). Few 
years later another study by Wolf and colleagues described the presence of lipid-rich 
particles, they referred to them as “platelets dust” attributing no active role in the coagulation 
process (Wolf, 1967). An increasing interest and more focused research during the 1980s 
conducted by independent research groups showed that such particles could be found in 
different biological fluids, like serum, seminal plasma and prostatic fluid (Benz and Moses, 
1974; Ronquist et al., 2009). A significant boost in these studies was brought about by the 
development of techniques that allow investigating this “dust” at the nano-scale. In 1983 
Harding and colleagues while describing the maturation of reticulocytes, found that these 
cells also secretes nano-sized vesicle characterized by freeze-fracture electron microscopy 
(Harding et al., 1983). These vesicles were called exosomes and were hypothesized to be 
used in removing unneeded molecules, in particular proteins, from cells (Johnstone et al., 
1987). It took almost two decades to demonstrate their importance in intercellular 
communication, starting from their capacity of antigen presentation in B lymphocytes of 
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immune system (Raposo et al., 1996; Théry et al., 2009), spreading to increasing numbers of 
specialized biological systems (Pant et al., 2012; Record et al., 2011; Simons and Raposo, 
2009). The production and release of EVs has been shown in all eukaryotes, ranging from 
extremely simple organisms up to mammals and this alternative way of cellular signaling 
was shown to be conserved throughout the evolution, although it is still unknown how it may 
have actually evolved. For example, protists like Dictyostelium discoideum and 
Trypanosoma cruzi are able to exchange genetic material via EVs, indicating that these 
vehicles may effectively exchange genetic material between parasites (Regev-Rudzki et al., 
2013), and between parasites and host cells (Bayer-Santos et al., 2013; Lavialle et al., 2009). 
The same observations were reported for fungi and plants, extending the pool of 
macromolecules transferred to lipids and polysaccharides by the same mechanisms of release 
and uptake. Interestingly in some fungi the EVs signaling is also a way to spread fungal 
virulence, demonstrating an involvement of this communication pathway not only in 
physiological but also in pathological conditions (Regente et al., 2012; Rodrigues et al., 
2011). Moving to the animal kingdom, as expected, also invertebrates use EVs as a parallel 
way to exchange information, mainly during their development, for instance in the 
Drosophila melanogaster and Caenorhabditis elegans. In the first example the 
Wnt/Wingless signaling is mediated also by exosome-like vesicles containing the Wnt-
binding protein Evenness Interrupted/Wntless/Sprinter (Beckett et al., 2013; Gross et al., 
2012; Korkut et al., 2009) while in the second case a specific sector of C. elegans called V0 
is able to secrete Hedgehog-related peptides through a multivesicular compartment capable 
of release exosomes (Liégeois et al., 2006). Given the increasing evidence and heterogeneity 
of EVs involvement in cell biology, I decided to introduce here a classification of this form 
of extracellular signaling system.  
 
1.1 Classification 
The generic term “extracellular vesicles” is currently used to refer to all the secreted 
membrane vesicles with a 30 and 1000 nm vast size range. This highly heterogeneous 
population can be broadly divided based on their biogenesis into two main categories: 
exosomes and microvesicles or ectosomes (Fig. 1).  
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Figure 1  
Schematic representation of the extracellular vesicles. Major populations include exosomes, 
microvesicles and apoptotic bodies (György et al., 2011).  
 
The denomination exosome was used for the first time to refer to small membrane vesicles 
released by reticulocytes during their differentiation (Johnstone et al., 1987). Basically, 
exosomes are membrane vesicles of diameter comprised between 30 and 100 nm originating 
by the inward budding of endosomal membrane during the maturation of multivesicular 
endosomes (MVEs), intermediates of the endosomal pathway and they are secreted upon 
fusion of MVEs with the inner part of the plasma membrane of the cell (Simons and Raposo, 
2009). The second category is represented by the microvesicles (MVs), firstly identified as 
subcellular product originating from platelets both in normal plasma and serum and formerly 
called “platelet dust” (Wolf, 1967). Differently from exosomes, MVs originates through 
direct outward budding and fission of the plasma membrane following different states of cell 
activation or during early stages of apoptosis (Tricarico et al., 2017). Even though MVs in 
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the past have been studied mainly for their role in blood coagulation (Satta et al., 1994; Sims 
et al., 1988), more recently they were reported to have a role in cell–cell communication 
comparable to that of exosomes, in several cell types, including cancer cells, where they are 
generally called oncosomes (Antonyak and Cerione, 2014). MVs are larger and more 
heterogeneous in size compared to exosomes, ranging from 50 to 1000 nm (Antonyak and 
Cerione, 2014; Raposo and Stoorvogel, 2013; van Niel et al., 2018) but they can be even 
larger, reaching a diameter of 10 μm in the case of oncosomes (Antonyak and Cerione, 2014; 
Minciacchi et al., 2015). This dimension-based identification is weaken by a clear 
overlapping of the size between exosomes and MVs, thus the mechanism of biogenesis is 
primarily used to distinguish MVs and exosomes (Akers et al., 2013; Antonyak and Cerione, 
2014; György et al., 2011). In fact, the formation and release of MVs result from a dynamic 
process of phospholipid redistribution and cytoskeletal protein breakdown, in contrast with 
the more regulated biogenesis mechanism of exosomes. 
There is also a third class of EVs that is not involved in the cellular crosstalk: the apoptotic 
bodies (ABs). ABs are the largest EVs, even larger than MVs, with a size range between 1 
and 5 μm and are produced by nucleated cells undergoing programmed cell death. An 
apoptotic cell passes through several stages, beginning with condensation of the nuclear 
chromatin, followed by membrane blebbing, progressing to disintegration of the cellular 
content into the ABs (Akers et al., 2013).  
 
1.2 EVs Biogenesis 
The mechanisms involved in the biogenesis of exosomes and MVs are the main 
discriminating factor to distinguish these two classes of EVs (Fig. 2). Exosomes are firstly 
generated as intraluminal vesicles (ILVs) inside the lumen of endosomes, requiring a very 
precise molecular machine dedicated to sorting vesicles and their cargo, called endosomal 
sorting complex required for transport (ESCRT) (Hurley, 2008). This complex drives the 
assembling of exosomes by mediating the accumulation of distinct proteins, nucleic acids 
and bioactive lipids in the proximity of microdomains at the cytosolic side of the endosomes. 
The vesicles are successively generated by the inward budding of these microdomains with 
the formation of ILV (Colombo et al., 2014). 
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On the other hand, the biogenesis of MVs is still poorly understood compared to that of 
exosomes. The assembly of MVs takes place at the cytosolic side of specialized plasma 
membrane microdomains and requires the collection of macromolecules that will constitute 
their future cargo, which is slightly different from that of exosomes. Differently from the 
ILVs, the generation of MVs is the result of outward budding and shedding of these 
microdomains distributed across multiple and large plasma membrane areas. This 
mechanisms is probably mediated by the rearrangement of the asymmetric membrane 
phospholipid composition, induced by Ca2+ enzymes called flippase and floppase that cause 
a curvature of the plasma membrane promoting the budding and shedding of the vesicles 
(Akers et al., 2013; Cocucci and Meldolesi, 2015; Colombo et al., 2014). Other factors like 
the small GTPase Arf6, which mediates the vesicular trafficking and GTPase of Rho family 
are also involved in in this process (Antonyak et al., 2012; Muralidharan-Chari et al., 2009). 
 
 
Figure 2  
(left) Different pathways of EVs biogenesis. Exosomes form via the endocytic pathway by budding 
inwardly into the lumen of the endosome, generating the multivesicular bodies (MVBs). MVBs then 
fuse with the plasma membrane, releasing exosomes into the extracellular space. In contrast to 
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exosomes, microvesicles form by the outward budding of the plasma membrane surface. (right) Cell 
undergoing apoptosis sheds apoptotic bodies, which bud off from the plasma membrane (Budnik et 
al., 2016). 
 
1.3 EVs Release and Uptake 
Exosomes and MVs are released by parent cells into the extracellular environment usually 
triggered by specific internal or external stimuli, although a constitutive release in resting 
conditions has been proposed (Cocucci et al., 2009; Raposo and Stoorvogel, 2013; van Niel 
et al., 2018). Upon release, both types of EVs start navigating to reach their target cells. The 
release of exosomes, both at rest and under specific stimulations, may be variously delayed 
upon the biogenesis of intraluminal vesicles (ILVs) generated inside the MVBs, which, in 
many cells represents a store that prolong the release of this signal.  
Conversely, prior to MVs generation the releasing cells accumulate specific molecules at 
their plasma membrane microdomains where the vesicles will be produced by the outward 
budding and consecutive shedding of plasma membrane (Akers et al., 2013; Cocucci and 
Meldolesi, 2015; Colombo et al., 2012) that is mostly induced. For example, in several cell 
types like macrophages and glial cells, the production of MVs in stimulated by the activation 
of the purinergic receptor-channel P2X7 (Bianco et al., 2005; Wilson et al., 2004). In other 
cell types like the PC12 and platelets is the purinergic receptor P2Y coupled with Gq protein 
(Kahner et al., 2008) that mediate the their release. Dependently to the type of stimulus 
applied, the shedding of MVs begins with some delay, ranging from few tens of second to 2 
minutes(Antonyak and Cerione, 2014; Pilzer et al., 2005; Pizzirani et al., 2007). 
An additional difference between the two EVs types may emerge from their kinetic of 
release. In the case of exosomes, upon appropriate stimuli MVBs translate from the 
perinuclear area (MVBs intracellular location) to the plasma to directly fuse with it by a 
process of exocytosis (Lopez-Verrilli and Court, 2013; Raposo and Stoorvogel, 2013). MVs 
release, if compared with exosomes, is much faster and this is probably due to the additional 
steps that the biogenesis and release of exosomes require. 
However, the mechanisms involved in the formation of both exosomes and MVs require a 
dynamic remodeling of the membranes, for this reason the parental cell has to take important 
measures to preserve the equilibrium of the plasma membrane after the loss of its surface 
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necessary for the building of the EVs (Morris and Homann, 2001). If the shedding is slow, 
like in the case of exosomes, it is compensated by the trafficking of endosomes that are 
maintained in the equilibrium at the surface but in the case of MVs the rate of shedding is 
much higher and can rapidly affect cell volume, leading to a reduction of the plasma 
membrane area (Cocucci et al., 2009; Shifrin et al., 2013). This shrinkage is progressively 
compensated by exocytosis and subsequent fusion of intracellular vesicles called 
enlargeosome with the inner side of plasma membrane (Cocucci et al., 2007). 
While the biogenesis and release of EVs is well regulated, once they are released in the 
extracellular space begin an unregulated navigation. As a consequence, a variable fraction of 
the released vesicle remains intact for a short period before the membrane breaks down. 
When this happens, their cargo, that is mostly composed by bioactive macromolecules like 
proteins, lipid and nucleic acids, becomes available for binding directly to their receptors on 
nearby cells inducing specific responses (Proia et al., 2008; Schiera et al., 2007). However 
most of released EVs  are resistant enough to persist in the extracellular environment for long 
periods, such a resistance enable EVs to reach major body fluids such as blood serum or 
lymph and cerebrospinal fluid (Yoon et al., 2014) . 
The most interesting part is how EVs can recognize specific cell phenotypes. The first 
evidence of this mechanisms were observed in platelets (Lösche et al., 2004). Losche and 
colleagues demonstrated how MVs released by these cells were able to bind selectively 
monocytes and not neutrophils. More recently, additional observations supported this notion, 
for example exosomes from cortical neurons are able to bind other cortical neurons, but not 
glial cells (Chivet et al., 2014) and exosomes released by oligodendrocytes are able to bind 
microglia, excluding other types of brain cells (Fitzner et al., 2011). 
Once EVs identified their targets, they firstly interact with the cell surface to secondly fuse 
with the plasma membrane (Mulcahy et al., 2014) allowing the discharge of luminal cargoes 
into the cytosol (Fig. 3). However, there are some cases in which EVs can deliver their signal 
upon the bind and activation of surface receptors of the target cell (Gabrielli et al., 2015).  
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Figure 3 
Schematic representation of EVs uptake by target cell. Extracellular vesicles can be regarded as 
signalosomes for several biological processes. They can be involved in antigen presentation and in 
the transfer of both major histocompatibility complex (MHC) molecules and antigens, thereby 
participating in immune regulation. Extracellular vesicles can directly activate cell surface receptors 
via protein and bioactive lipid ligands, transfer cell surface receptors or deliver effectors including 
transcription factors, oncogenes and infectious particles into recipient cells5. In addition, various 
RNA species including mRNAs and small regulatory RNAs (for example, microRNAs (miRNAs) and 
non-coding RNAs) are contained in extracellular vesicles and functionally delivered to recipient cells 
(EL Andaloussi et al., 2013). 
 
1.4 Macromolecular Composition 
Focusing on EVs composition, recent literature has highlighted that the two classes of EVs 
share some characteristics while differ in many others, in terms of molecular profile. 
Exosome lipid bilayer consists of a high concentration of cholesterol and sphingomyelin plus 
ceramide and its products, which have a leading role in ILVs biogenesis. (Cocucci and 
Meldolesi, 2015; Raposo and Stoorvogel, 2013). Because of their endosomal origin, 
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membrane proteins are mostly represented by classes of proteins involved in membrane 
transport and fusion, like tretraspanins and integrins which also participate in cargo loading 
processes, biogenesis and release and have been conserved during evolution (Perez-
Hernandez et al., 2013; Simons and Raposo, 2009; Urbanelli et al., 2013). Their cargo is 
mainly constituted by cystoskeletal and associated protein such as actin, chaperones, kinases 
and receptor. Together with proteins, exosomes transport also genetic material, mostly 
RNAs, such as miRNAs and mRNAs and in smaller quantity DNA (Gibbings et al., 2009; 
McKelvey et al., 2015) (Fig.4). 
 
 
Figure 4 
Structure and composition of exosomes and microvesicles (also known as ectosomes). In exosomes 
(yellow fill), the membranes are rich in tetraspanins, small transmembrane proteins important for 
membrane and luminal protein anchoring. In ectosomes (pale blue fill), the membrane contains 
many additional proteins like some receptors, glycoproteins and metalloproteinases. In orange are 
represented nucleic acids and in purple the proteins which constitutes EVs cargoes (Meldolesi, 
2018). 
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MVs have a similar lipid membrane composition, with high levels of cholesterol, 
sphingomyelin and ceramide, but since they originate from the plasma membrane, their 
structure mostly depend on the lipid composition of parental cell. Ca2+-dependent enzymes 
are able to perturbate the plasma membrane inducing a reorganization of phospholipid 
bilayer by translocating phosphatidylserine from the inner to the outer leaflet and these 
changes are also accompanied by changes in membrane proteins profile (Cocucci and 
Meldolesi, 2015; Tricarico et al., 2017). MVs cargoes differ from those of exosomes for the 
proteins, in fact MVs transport matrix metalloproteinase, glycoprotein receptors and other 
cytosolic proteins like those constituting the cytoskeleton in addition to centrosomal, 
ribosomal and mitochondrial proteins. As in exosomes, RNAs are also abundant within MVs 
consisting mostly of miRNAs but also mRNAs and non-coding RNAs.  
A recent study suggested that, in line with the molecular species that the two classes of EVs 
transport, they exert different biological functionalities, in fact exosomes are mostly involved 
in signaling, antigen presentation and in the transfer of major histocompatibility complex 
while MVs are implicated in protein translation (Chang et al., 2013; Keerthikumar et al., 
2015).  
Even if a fraction of the cargoes-macromolecules is conserved throughout the evolution, the 
nature of EVs cargoes is strictly dependent on the donor cell-type and cargoes are often 
influenced by the cell physiological or pathological state, the stimuli that modulate their 
production and release and the molecular mechanisms that lead to their biogenesis (Kalra et 
al., 2016; Minciacchi et al., 2015). 
 
1.5 EVs in Central Nervous System (CNS) 
EVs as mediators of intercellular communication have been conserved throughout the 
evolution and for this reason virtually any cell is able to produce and release them (Akers et 
al., 2013; Maas et al., 2017; Minciacchi et al., 2015; Raposo and Stoorvogel, 2013). Even in 
the central nervous system (CNS), that is a relatively recent structure, EVs were shown to 
play an active role in cellular crosstalk and can be either taken up by neighbor cell or released 
into the cerebrospinal fluid (CSF) (Bianco et al., 2005; Colombo et al., 2012; Lugli et al., 
2015). EVs released by neural cells share the same common features with all other EVs but 
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exert different functional effects on their targets and on the biological system they belong to, 
depending on the signals they deliver and then on the composition of their cargo. The 
functional role of EVs in the CNS has been shown in several aspects of neural biology, 
ranging from development to neurodegeneration (Fig. 5). 
 
 
Figure 5 
(top) Gradient of EVs can work as directional guide to axonal growth in the development of 
nervous system. (middle) EVs released from presynaptic nerve terminals and taken up by their 
postsynaptic partners can modulate synaptic activity. (bottom) Regeneration of peripheral nerves is 
enhanced by the transfer of ribosomes and mRNA mediated by EVs released from surrounding 
Schwann cells into the injured nerve to promote protein synthesis (Lai and Breakefield, 2012). 
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Development 
EVs capacity to horizontally transfer various cargoes, especially genetic material and 
proteins, might significantly impact signaling during CNS development. Marzesco and 
colleagues in 2005 reported the presence of both exosomes and MVs in the luminal fluid of 
the neural tube of mice embryos (Marzesco et al., 2005). In cultured cortical neurons from 
mice embryos, EVs are released after the depolarization of immature neurons, apparently 
regulating synaptic activity via transported proteins like the L1 cell adhesion molecule (L1-
CAM), the glycosylphosphatidyl-inositol–anchored (GPI-anchored) prion protein and the 
glutamate receptor subunit GluR1/3 (Fauré et al., 2006). Another and more recent study 
identified a pool of nanovesicles in embryonic cerebrospinal fluid (eCFS) of both rodents 
and humans, carrying protein and miRNA components of the insulin-like growth factor (IGF) 
signaling pathway which if isolated from eCFS and added to a mixed culture of embryonic 
neural stem cells (eNSC) were able to activate mTORC1 pathway enhancing the proliferation 
rate of these stem cells (Feliciano et al., 2014). 
EVs generation in CNS is not limited to neurons or neural progenitors but involves virtually 
all kind of cell, comprising glial cell. In fact, another important role for EVs is the regulation 
of myelinogenesis, a complex and highly controlled process that takes place during 
development and regeneration. During CNS development the signals necessary to 
differentiate oligodendrocytes and those leading to the formation of myelin-membrane 
enwrapping axons are  negatively regulated by EVs released by oligodendrocytes 
themselves. The release of this EVs and the resulting downregulation is dramatically 
inhibited at some point by neurons via the release of positive signals, thus initiating the 
maturation of oligodendrocytes and the following axonal myelinization (Bakhti et al., 2011). 
Astrocyte-derived EVs instead exhibited different effects on neurons during brain 
development, promoting neurite outgrowth and their survival, by delivering molecules like 
synapsin I and mediating neuronal differentiation (Wang et al., 2011). Another evidence of 
the strictly conserved nature of EVs is the identification of main cell-fate proteins, such as 
Wnt, TGF-β, EGF and FGF within EVs cargoes of both Drosophila and humans (Kalra et 
al., 2012).  
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Synaptic Communication 
EVs may indeed modulate synapses and can be released in response to cortical neurons 
depolarization (Fauré et al., 2006; Lachenal et al., 2011). These neuron-derived exosomes 
can carry the GluR2 subunit of the glutamate receptor, suggesting EVs participation in 
regulating the amount of postsynaptic AMPA and NMDA receptors, modulating synaptic 
plasticity. EVs release after neuronal depolarization were also found to alter miRNA 
composition at both target-cellular and subcellular levels. They down-regulate and up-
regulate the expression of brain-specific miRNA resulting in rapid changes in translation of 
mRNAs relevant to synaptic activity in postsynaptic region (Goldie et al., 2014).  
EVs are exchanged not only among neurons but also between neurons and glial cells. 
Interestingly, neuronal synaptic activity and glutamate release appear to be necessary 
conditions to induce oligodendrocytes’ EVs release, in fact the administration of calcium 
chelators like EDTA before exposure to glutamate completely abolishes exosomes release, 
indicating that entry of extracellular Ca2+ through ionotropic glutamate channels is essential 
to trigger exosome release in oligodendrocytes. A possible explanation is that mature 
oligodendrocytes express on their surface ligand-operated Ca2+ channels, such as NMDA 
receptors and their activation by glutamate released from depolarized neurons may stimulate 
the production of EVs in a calcium dependent way. This hypothesis is supported by the fact 
that pharmacological inhibition of NMDA receptors affected EVs release as EDTA did 
(Frühbeis et al., 2013a). This crosstalk between oligodendrocytes and neurons is not only 
necessary for the myelinogenesis during CNS development but is also thought to be crucial 
in maintaining axonal integrity in mature neurons. 
Potentially all neuroglia cells might communicated with neurons via EVs. Antonucci and 
colleagues demonstrated in 2012 that MVs released by microglia interact with neurons, 
enhancing the miniature excitatory postsynaptic current (mEPSC) frequency without 
affecting the mEPSC amplitude (Antonucci et al., 2012). These authors  investigated the 
effect of microglia-derived MVs in vivo by injecting them into the rat visual cortex and 
observed an acute increase in the amplitude of field potentials evoked by visual stimuli. The 
proposed mechanism underlying these effects on neurons is the capacity of MVs of 
regulating sphingolipid metabolism. Indeed, MVs promote ceramide and sphingosine 
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production in neurons which has been demonstrated to increase the probability of 
neurotransmitter release (Davletov and Montecucco, 2010). 
Finally, astrocytes are known to scavenge extracellular glutamate, known to be neurotoxic 
when present at high concentrations, through excitatory amino acid transporters (EAAT-1 
and EAAT-2), also crucial to regulate neurotransmission. Both these transporters have been 
identified in EVs released by astrocytes suggesting their role in synaptic transmission 
(Gosselin et al., 2013).  
Axonal Regeneration 
The ability to regenerate injured nerves is a peculiarity of peripheral nervous system (PNS) 
and axonal regeneration in adult PNS is finely regulated by a synergy of cellular and 
molecular processes that are mostly led by Schwann cells (SCs) (Bosse, 2012). A recent 
work demonstrated that exosomes produced by SCs are able to selectively target and be 
internalized by axons, both in dorsal root ganglia (DRG) cultures and in an in vivo model for 
sciatic nerve. SCs-derived exosomes have the capability to increase the regeneration rate of 
DRG neurons in both the models. The observed pro-regenerative effect depends either on 
proteins expressed on exosomal membrane that mediate the internalization by the targeted 
cell and on the cargo delivered (Lopez-Verrilli et al., 2013). 
 
1.5.1 EVs in CNS diseases 
EVs have a strong impact not only on physiological processes but contribute also to the 
development and spreading of cancer, neurodegeneration and neuroinflammation. 
Neurodegenerative diseases include: Alzheimer’s disease (AD), Parkinson’s disease (PD) 
and Prion diseases, which all share the common feature of protein accumulation and 
deposition in specific brain regions, called amyloid (Table 1).  
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Table 1 
Current knowledge of possible EVs roles in brain diseases. 
Abbreviations: MVBs - Multivesicular bodies; PrPc - cellular prion protein; PrPsc - scrapie prion 
protein; Aβ peptides - amyloid-beta peptides; APP - amyloid precursor protein; NFT - neurofibrillary 
tangles; α-syn - α-synuclein; LRRK2 - Leucine-rich repeat Kinase-2; mutant htt - mutant huntingtin 
protein; SOD1 - Cu/Zn superoxide dismutase 1; TDP43 - TAR DNA-binding protein 43; RTK - 
receptor tyrosine kinase; PI3K - phosphatidylinositol 3 kinase; RB - retinoblastoma protein; EGFR 
- epidermal growth factor receptor; EPHA2 - ephrin type-A receptor 2; IDH1 - isocitrate 
dehydrogenase 1. (Rufino-Ramos et al., 2017) 
 
Interestingly, there are evidences that EVs play a dual role in neurodegeneration: on one 
hand they promote the formation and spreading of these aggregates while on the other healthy 
cells use EVs to remove toxic proteins and amyloid aggregates from their cytoplasm. For 
example, it has been demonstrated that EVs released by neurons in a model of AD are able 
either to mediate aggregation and degradation of amyloid-beta (Aβ) and tau proteins (Asai 
et al., 2015; Rajendran et al., 2006). 
The accumulation and transmission among cells of cytotoxic misfolded proteins like in AD 
is also the key mechanism of some prion diseases and it has been reported the presence of 
EVs carrying prion proteins, both the normal form (PrPc) and scrapie form (PrPsc) in 
biological fluids such as blood and CSF (Fevrier et al., 2004; Klöhn et al., 2013). In the case 
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of both PD and amyotrophic lateral sclerosis (ALS), the accumulation of α-synuclein and 
SOD1 respectively within EVs is a potential mechanism disease propagation, yet a causality 
has not been demonstrated (Basso et al., 2013; Danzer et al., 2012). Given the capacity of 
EVs to present antigens in the context of immune responses (Raposo et al., 1996; Théry et 
al., 2009), they are also able to carry tumor antigens promoting the oncogenesis and 
metastasis formation. By this mechanism, such EVs, known as oncosomes, may suppress the 
anti-cancer immune response (Czernek and Düchler, 2017). The most studied brain tumor in 
relation to EVs is the Glioblastoma (GBM), an extremely heterogeneous cancer, and several 
studies have demonstrated that GBM-derived EVs have a pivotal role in inducing malignant 
cell proliferation, angiogenesis, healthy tissue invasion and suppression of antitumor 
immune responses (Graner et al., 2009; van der Vos et al., 2011). 
 
2. GLIA 
The CNS is composed of two kinds of cells: neurons and neuroglia. Inthe human brain 1011 
cells out of 1012 are neurons, while the remaining 9 1011 are glia.  
The name glia was coined by Virchow at the end of 1850s when he described it as a 
“connective substance formed in the brain, in the spinal cord, and in the higher sensory 
nerves, a sort of putty in which the nervous elements are embedded ” (Somjen, 1988). The 
name itself comes from the ancient Greek word “glia” meaning “glue”.  Since their 
discovery, glial cells were unfairly thought to only passively support neurons but we 
currently know that are more than just a glue keeping neurons stuck together. In fact glia 
actively participates to neurotransmission by modulating and responding to it and guides the 
development, maintenance and recovery of synapses (Fields and Stevens-Graham, 2002).  
 
2.1 Classification and Functions 
Glial cells are represented by several cell phenotypes that share the sole feature of not being 
neurons ultimately, being non-excitable cells. Neuroglia cells belong to four major 
phenotypes: astrocytes, oligodendrocytes, Schwann cells and microglia. These 4 cell types 
can be grouped, based on their origin, in  macroglia and microglia (Fig. 6). 
Macroglia includes astrocytes and oligodendrocytes (in the CNS) which arise from the 
neuroepithelium of embryonic neural tube and forebrain (Rowitch and Kriegstein, 2010) and 
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Schwann cells (in the PNS) which originate from the neural crest (Jacob, 2015). In contrast 
to macroglia, microglia has a mesodermal origin and is generated by the yolk sac during 
embryogenesis (Ginhoux and Prinz, 2015). As a first step hematopoietic stem cells generates 
primitive macrophages, which migrate in the developing CNS to be transformed into 
microglia.  
Astrocytes most essential function in the CNS is related to neuronal survival, since these 
cells usually take up nutrients from the blood, thanks to their dual interaction with neurons 
and blood vessels of the blood brain barrier (BBB) (Pellerin et al., 2007). In response to 
neurotransmitter release by active neurons, they can also increase the blood flow to those 
brain regions where the metabolic needs are higher (Attwell et al., 2010). More recent 
evidences demonstrated the participation of astrocytes in synaptic maintenance, in addition 
to the already known capacity of scavenging neurotransmitter from the synaptic cleft and 
buffering extracellular potassium, they are able to control the formation, strength and 
turnover of synapses (Clarke and Barres, 2013). Lastly, astrocytes participate in the removal 
of exceeding synapses during CNS development where weak synapses were “pruned” and 
the strong ones kept (Allen, 2014). 
Oligodendrocytes and Schwann cells are instead involved in myelinization of axons in CNS 
and PNS, respectively. Differentiating oligodendrocytes undergo complex morphological 
changes to generate numerous long processes that enwrap different axons forming the myelin 
sheaths (Snaidero and Simons, 2014). In PNS this job is carried out by Schwann cells, which 
constitute about the 80% of all cells in the peripheral nerves. In contrast to oligodendrocytes 
every Schwann cell surround only one axon and the myelin sheath is often thicker than CNS 
myelin (Salzer, 2015). Finally, as astrocytes participate in the removal of exceeding synapses 
in CNS, Schwann cells as well eliminate excess axons and synapses in the developing PNS 
by phagocytosis (Schuldiner and Yaron, 2015). 
Microglia are the tissue-resident macrophages in the CNS and like macrophages, their role 
is to defend the nervous system against potential injuries. Resting microglia cells usually 
have a very ramified morphology, or surveillant state, to screen the environment in order to 
detect signs of injury. When needed, microglia rapidly migrate toward the lesion site and 
switch from the resting state to the activated one which is defined by an amoeboid 
morphology and production of cytokines and chemokines released in the injured site, 
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triggering a state of inflammation and cell apoptosis (Nimmerjahn et al., 2005). Also 
microglia, together with astrocytes and peripheral glia, is involved in synapse pruning in 
developing brain and this process, as for astrocytes, is strongly dependent on neuronal 
activity as demonstrated by the lack of synapse removal when action potential generation is 
pharmacologically blocked (Schafer and Stevens, 2015). 
 
 
Figure 6 
On the left are represented glial cells of the central nervous system including oligodendrocytes, 
astrocytes, ependymal cells, and microglial cells. Oligodendrocytes form the myelin sheath around 
axons. Astrocytes provide nutrients to neurons, maintain their extracellular environment, and 
provide structural support. Microglia scavenge pathogens and dead cells. Ependymal cells produce 
cerebrospinal fluid that cushions the neurons. On the right are represented glial cells of the  
peripheral nervous system, including Schwann cells, which form the myelin sheath, and satellite cells, 
which provide nutrients and structural support to neurons. 
 
2.2 Glia-derived EVs 
As synthesized in the previous paragraphs, neurons as well as neuroglia secrete EVs and the 
recent literature supports how intercellular communication through EVs has a strong 
functional impact in the nervous system both in physiological and pathological conditions, 
suggesting that the horizontal transfer of biomolecules may be a common mechanism of 
communication in the CNS (Frühbeis et al., 2012). 
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Astrocytes-derived EVs 
EVs released by astrocytes are very heterogeneous in their composition and may have 
beneficial or pathological effects on CNS. For example, vesicles which are involved in 
physiological processes may carry heat-shock proteins like Hsp/Hsc 70 and synapsin I which 
have been suggested to have a neuroprotective function against oxidative stress (Taylor et 
al., 2007). Other molecules packaged inside EVs are factors that modulate angiogenesis, like 
FGF-2, VEGF endostatin and PED (Proia et al., 2008) and metalloproteinases which mediate 
astrocytes motility in physiological and pathological states (Sbai et al., 2010). A relevant role 
of astrocytes within the CNS is the regulation of glutamate homeostasis during synaptic 
transmission (Danbolt, 2001). This job is performed by the transporter EAAT-1 and EAAT-
2 that are expressed on astrocytes plasma membrane, but recent evidences demonstrated that 
also astrocyte-derived EVs contain this class of transporters (Gosselin et al., 2013). EAATs 
use the electrochemical Na+ gradient of the plasma membrane to transport glutamate and 
subsequently convert it to glutamine and their localization on astrocytes-derived EVs suggest 
a functional role in the elimination of exceeding glutamate from the extracellular 
environment (Rose et al., 2009). EVs released by astrocytes may also mediate the 
propagation of pathogenic proteins around the CNS, participating to the development of 
neurodegenerative diseases. Evidences were found in the context of disorders like ALS 
(Basso et al., 2013), AD (Wang et al., 2010, 2012) or HIV-associated neurological disorders 
(Hu et al., 2012).   
Oligodendrocytes-derived EVs 
EVs released by oligodendrocytes, as previously highlighted, are mostly involved in myelin 
formation and in the maintenance of axonal integrity. In fact, the presence of myelin proteins 
such as PLS, CNP, MAG and MOG has been detected as components of exosome cargo, 
essential for myelinogenesis during the early stages of development (Krämer-Albers et al., 
2007). However, EVs have also a trophic function for neurons enwrapped in myelin sheath. 
They use exosomes as vehicle to deliver biomolecules such as metabolites, protective 
proteins, enzymes, mRNA and miRNA to neurons and this supportive action is regulated by 
neurons themselves. Glutamate released by active neurons induces Ca2+ entry through 
oligodendroglial ionotropic glutamate receptors with the consequent increase of intracellular 
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calcium which trigger EVs release (Frühbeis et al., 2013a) (Fig. 7). The same axonal support 
is mediated by Schwann cells in PNS (Lopez-Verrilli and Court, 2012). 
 
Figure 7 
Oligodendrocyte-derived exosomes involved in neuron-glia communication. (1) Electrically active 
axons release glutamate that provokes Ca2+ entry through glutamate receptors present on 
oligodendrocytes surface. (2) Increase of intracellular Ca2+ levels induces exosome release from 
oligodendrocytes. (3) Exosomes internalization by neurons. (Frühbeis et al., 2013b) 
 
Microglia-derived EVs 
EVs released by microglia are mostly MVs and have the peculiarity of having irregular shape 
and size and are composed by high levels of phosphatidylserine and their shedding is induced 
upon activation of purinergic receptor P2X7 by ATP (Bianco et al., 2005). Microglia-derived 
MVs transmit inflammatory signals such as interleukin-1β (IL-1β) to other microglial cells, 
resulting in an upregulation of proinflammatory genes like IL-1β, IL-6, cyclooxygenase-2 
and nitric oxide synthase (Verderio et al., 2012). Given the role of microglia in the 
development of neuroinflammation, it is reasonable to consider also the involvement of MVs 
in this process. In fact, it has been observed how in multiple sclerosis and autoimmune 
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encephalomyelitis (EAE) the number of MVs dramatically increases and studies on rodents 
suggested that MVs enforce inflammation state in neuroinflammatory diseases. For this 
reason they also represent a promising diagnostic marker or therapeutic target (Colombo et 
al., 2012). Finally, experiments in vitro and in vivo demonstrated that microglia-derived 
MVs can stimulate spontaneous and evoked post-synaptic currents in hippocampal neurons 
through the modulation of ceramide metabolism at the pre-synaptic level (Antonucci et al., 
2012). 
 
3. TOOLS FOR INVESTIGATION OF EVs 
At present, the role of EVs as fundamental mediators of intercellular communication is 
supported by an increasing number of studies in a large variety of biological systems, yet, 
their functions have not been fully elucidated. EVs contribution in either physiological or 
pathological processes makes them promising targets for the development of diagnostic and 
therapeutic applications, especially in the field of neuroscience (György et al., 2015).  
However, despite the promise of unveiling critical information of medical interest, working 
with these small particles represents a very tough scientific and technical challenge. 
EVs are relatively new targets for bioassays and have peculiar biological and physical 
features in addition to their high heterogeneity (Yáñez-Mó et al., 2015). Such traits make 
them difficult to define and isolate with conventional analytical tools that possess sensitivity 
and throughput optimized for other biological targets (Witwer et al., 2013). 
All these issues can be faced and partially overcome by using nanotechnological approaches. 
Nanotechnology indeed provides a set of materials, devices and systems whose functions are 
relevant for investigating very small scales of length, ranging from 1 nanometer to 1 micron 
that is the scale window where EVs are located (Whitesides, 2003). 
The research on EVs may be subdivided in two main approaches: physical characterization 
and molecular composition analysis. 
Physical characterization 
Since EV is a generic word to identify a large variety of nanovesicles, heterogeneous in terms 
of origin and signals delivered, a first step in their study is the characterization for size, size 
distribution, concentration and morphology. However, conventional optical microscopies 
due to their diffraction limit, which is very close to that of EVs size, are not the best choice 
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to physically characterize them (van der Pol et al., 2010). High-resolution EV images are 
obtained through electron microscopy (EM) or atomic force microscopy (AFM).  
The most popular EM technique for the study of EVs morphology are the transmission 
electron microscopy (TEM) and the scanning electron microscopy (SEM), with a preference 
for the first (Wu et al., 2015). In both techniques a focused beam of electrons hit the sample, 
but in the first case it is transmitted through the specimen to create a sample image, while in 
the second the beam scans the surface of the sample, interacting with atoms and providing a 
3D surface topography information. There is also a third EM technique, that requires the 
sample to be analyzed at temperature around -100° C after a long fixation and staining, but 
with the advantage of avoiding the effect of dehydration and then the production of artifacts 
(Yuana et al., 2013). 
Another high-resolution imaging technique for the characterization of EVs is AFM. AFM is 
a scanning probe technique  based on the interaction of a very sharp tip directly with the 
sample, mounted on a mechanical cantilever with a laser beam that constantly hit the top of 
the cantilever and then reflected to a four-quadrant photodiode. While the tip passes over the 
sample, the deflection of the cantilever is measured by the displacement of the laser beam 
(Parisse et al., 2017). AFM does not require extensive preparation of the sample and provides 
two kind of information: surface topography and mechanical features (i.e. stiffness) of the 
sample (Sharma et al., 2010). 
To note, these EM techniques do not allow studying the entire pool of EV. To do that there 
are techniques like dynamic light scattering (DLS) and nanoparticle tracking analysis (NTA) 
which are developed to study nanosized particles in suspension and therefore to gain 
information on, for example, an entire sample size distribution. 
DLS measures the interference and intensity fluctuation of light scattered by EVs illuminated 
by a monochromatic light source and subjected to Brownian motion. The fluctuation rate is 
converted into the diffusivity of the vesicles in order to extrapolate the hydrodynamic radius 
(Rh). However the information obtained is intensity-related and proportional to Rh
6, meaning 
that larger objects can prevail over smaller ones, giving an inaccurate picture of EVs 
population (Palmieri et al., 2014). NTA is an optical method that calculates the size 
distribution and concentration of nanoparticles. In this technique the light scattered by 
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suspended EVs is captured by a camera that records their Brownian motion and tracking the 
single vesicle path and successively calculate size and concentration (Soo et al., 2012). 
Molecular composition analysis  
Another important aspect is the molecular composition of EV itself and of their cargo. The 
research over EVs focuses mainly on two macromolecules: proteins and nucleic acids.  
Protein characterization is a fundamental step in the study of EVs not only to reconstruct 
their molecular profile but also for the identification of potential markers to use in biomedical 
research (Pant et al., 2012). A recent survey evidenced that the most widely used technique 
to characterize EVs is western blot (Gardiner et al., 2016), that together with the enzyme-
linked immunoassay (ELISA) belong to the conventional protein assays which allow to 
easily demonstrate the presence of target proteins associated with EVs. However it requires 
a large amount and extensive pre-processing of the sample, which is very inconvenient for 
this kind of studies, especially in biomedical research (Witwer et al., 2013). In order to 
overcome the technical challenge of protein quantification related to low sensitivity of 
conventional techniques, new biosensors that require a smaller amount and minimal 
processing of the biological sample are under development. One of the more promising is 
the small particle flow cytometry, an enhancement of the conventional flow cytometry which 
can discriminate particles of around 100 nm in diameter versus the 500 nm of the classic one 
(Stoner et al., 2016) after they are stained with fluorescent antibodies in order to be 
characterized for their protein markers (Pospichalova et al., 2015). However, up to now other 
new biosensors have many limitations and are not still standardized for the study of EVs. 
In addition to proteins, EVs transport also nucleic acids and RNA represents the major 
nucleic acid of their cargo. As with proteins, the total amount of nucleic acids inside EVs is 
very low and their study requires efficient extractions and very sensitive detection tools 
(Mateescu et al., 2017). The most used are the phenol-chloroform extraction and spin 
columns and both of them are standardized and provide well purified RNA (Enderle et al., 
2015; Skog et al., 2008). Amplification and sequencing of nucleic acids allow to verify 
quality, yield and size but are typically sequence-dependent, meaning that we can amplify 
and detect only known sequences of DNA and RNA by using polymerase chain reaction 
(PCR) or real-time PCR (RT-PCR) (Balaj et al., 2011; Skog et al., 2008), resulting in a low 
throughput. Anyhow, next generation sequencing (NGS) now gives us the opportunity to 
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largely screen and characterize the transcriptome, including known and unknown RNA of 
EVs thanks to the generation of library shared among laboratories worldwide (Huang et al., 
2013). 
 
4. CARBON BASED NANOMATERIALS IN NEUROSCIENCE 
In the last two decades we have witnessed an exponential interest in carbon based materials 
(CBMs) by the scientific community. Their unique physico-chemical properties coupled to 
the nano-size make them promising substrates for the development of biomedical 
applications in many fields of biomedicine, with a particular focus on neurosciences 
(Baldrighi et al., 2016b). The prospects that these materials opened to the scientific research 
range from the delivery to the CNS of molecules that usually cannot cross the blood brain 
barrier (BBB) (Saraiva et al., 2016) to the development of neuro-scaffolds for the 
regeneration of damaged nerves (John et al., 2015; Usmani et al., 2016). 
The discovery of such materials begun in 1985 with fullerenes (Kroto et al., 1985), then with 
carbon nanotubes (Iijima, 1991) and finally with the synthesis of graphene (Novoselov et al., 
2004) which are all composed of carbon atoms only but with different structures. 
Carbon, constitutes the most versatile element of the periodic table, because of the variety of 
its allotropes and structures, given from the ability of the carbon valence orbitals to hybridize 
in sp, sp2 and sp3 configurations. The allotropes of carbon that are naturally produced are 
diamond, amorphous carbon and graphite but there are also carbon allotropes deriving from 
a synthetic process such as graphene, carbon nanotubes, fullerenes and nanodiamonds 
(Dresselhaus, 2012) (Fig. 8).  
 
 
Figure 8 
Hybridization states of carbon-based nanomaterials 
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All CBMs are naturally good electrical conductor with good biocompatibility, which make 
them excellent candidates for the development of electrically conductive scaffolds 
(Supronowicz et al., 2002). Among all kinds of CBMs, carbon nanotubes (CNTs) and 
graphene are the most popular that have been widely studied, since both possess excellent 
mechanical strength, electrical and thermal conductivity, and optical properties coupled with 
biocompatibility that is an imperative for biomedical applications. Lots of the research efforts 
have been focused on exploiting these advantageous properties for various applications 
including electronics, biological engineering, filtration, lightweight/strong composite 
materials, photovoltaic and energy storage (Esawi and Farag, 2007; Sreeprasad et al., 2011; 
Wang et al., 2010). 
 
4.1 Graphene 
Graphene (GR) is the thinnest compound known to man at one atom thick, the lightest 
material known (with 1 square meter coming in at around 0.77 milligrams), the strongest 
compound discovered (between 100-300 times stronger than steel and with a tensile stiffness 
of 150,000,000 psi), the best conductor of heat at room temperature (at (4.84±0.44) × 103 to 
(5.30±0.48) × 103 W×m−1×K−1) and also the best conductor of electricity known (studies 
have shown electron mobility at values of more than 15,000 cm2×V−1×s−1 ) (Bolotin et al., 
2008). The excellent physicochemical properties of graphene combined with its potential 
biocompatibility provide exciting opportunities for new biomedical applications. The 
different applications for which graphene have been proposed, lead to engineering not only 
graphene monolayers, but a wide variety of graphene-based materials (GBMs). The single 
layer graphene, bi-layer graphene, multilayer graphene, graphene oxide (GO), reduced 
graphene oxide (rGO) and chemically modified graphene are the members of the graphene-
based nanomaterial family. GO and rGO are often preferred for biological applications 
because graphene itself is difficult to suspend in water solutions, due to its highly reactive 
surface. Research in neuroscience demonstrated how graphene films have excellent 
biocompatibility for primary culture of mouse hippocampal neurons and are even able to 
promote neurite sprouting and outgrowth, especially during the early stages of development 
(Li et al., 2011). GBMs are also able to preserve the basal physiological level of neuronal 
30 
 
activity as reported by Fabbro and colleagues (Fabbro et al., 2016). They highlighted 
uncommon properties of graphene-based substrates (GBSs) to support neuronal 
development, in terms of neuronal passive properties, spontaneous synaptic activity, 
synaptogenesis, and short-term synaptic plasticity (STP). Another amazing property of 
graphene is to tune the extracellular ions distribution at the interface with hippocampal 
neurons that is a key regulator of neuronal excitability. The interaction between graphene 
and ions are maximized when a single layer graphene is deposited on substrates electrically 
insulated. These biophysical changes caused a significant shift in neuronal firing phenotypes 
(Pampaloni et al., 2018). 
One of the first observation related to the possible use of GR in the brain environment was 
that the biocompatibility and broad-spectrum transparency, flexibility and mass-
producibility of graphene make it an ideal candidate for replacement of ITO in neural 
interfacing devices. Indeed, there are several examples of effective graphene-based electrode 
devices in the recent literature.  A graphene-based, carbon-layered electrode array device 
was implanted in the brain surface in rodents for high-resolution neurophysiological 
recording. Its optical transparency of the device at >90% transmission over the ultraviolet to 
infrared spectrum was characterized and prove its utility through optical interface 
experiments that use this broad spectrum transparency. These experiments included 
optogenetic activation of focal cortical areas directly beneath electrodes, in vivo imaging of 
the cortical vasculature via fluorescence microscopy and 3D optical coherence tomography.  
GR is also being explored as a novel platform for the local delivery of therapeutic molecules 
with encouraging preliminary results. Functionalization of GR and GO can tailor their 
properties and enable their use as carriers of therapeutic molecules (Vincent et al., 2017) 
even because they potentially can deliver molecules that are usually rejected by the BBB. 
In neurology, GR represents a promising tool for neuronal implants or bio-devices, with 
potential applications ranging from neuro-oncology to neuro-regeneration (Bitounis et al., 
2013; Kuzum et al., 2014). It was also reported recently the ability of small graphene 
oxide nanosheets (s-GO) to interfere specifically with neuronal synapses, without 
affecting cell viability. In particular, in cultured neuronal networks, upon chronic s-GO 
exposure, glutamatergic release sites were sized down (Rauti et al., 2016a).  
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Among the different possible implementations of GBMs, building of graphene-based 
scaffolds for cell growth and differentiation is one of the most promising. 3D graphene 
foams (3D-GF) can be obtained using nickel foam template for chemical vapor deposition 
of graphene. Growing neural stem cells on these substrates allows not only a more 
physiological condition but also a substrate that can be electrically stimulated (Li et al., 
2013). Growing neurons on 3D scaffold allows us also to recapitulate two basic properties 
of the complexity of the brain: firstly, the coexistence of local and global electrical activity, 
and secondly, the existence of neuronal assembly with a degree of correlated electrical 
activity varying in space and time (Ulloa Severino et al., 2016). A different strategy recently 
explored by Martìn and colleagues, these authors build hybrid hydrogel with polyacrylamide 
and graphene. Their study demonstrated that graphene improves the biocompatibility of the 
3D scaffold (Martín et al., 2017). 
 
4.1.1 Graphene Interaction with Cell Membrane 
As observed with other nanosized particles, graphene and GBMs are able to interact with 
cell plasma membrane (Zhang et al., 2016). This interaction is the starting point for the 
development of biomedical interfaces between GBMs and mammalian cells but despite the 
recent increasing literature describing these interactions at different levels of living systems, 
there is still an unclear and incomplete picture of the mechanisms underlying (Bitounis et al., 
2013; Kostarelos and Novoselov, 2014). Graphene interaction with cellular plasma 
membrane may be of two types: absorption or internalization (Kostarelos and Novoselov, 
2014), however the nature of interaction depends on the characteristics of both the material 
and the biological system targeted. In fact, the internalization or adsorption of GBMs is 
strictly influenced by material size and surface chemistry. Smaller GO particles, for example, 
are mostly internalized by endocytosis but increasing the size of GO brings to a phagocytic 
way of uptake (Mu et al., 2012). Also its reduction state influences the internalization by 
increasing or decreasing the hydrophobicity of the material and then the capacity to interact 
with cell membrane component (Chatterjee et al., 2014). The type of cell targeted also affects 
the way GBMs can be internalized as demonstrated by Linares and colleagues in three 
different kind of cell treated with GO nanosheets (Linares et al., 2014). The cell uptake of 
graphene may alter the dynamic of plasma membrane and thus inducing biological effects 
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that in case of exposures at high concentrations can lead to neuroinflammatory response, as 
observed in macrophages (Zhou et al., 2012), or even cell death (Liao et al., 2011). It is 
therefore clear that the effects of graphene and its derivatives on cells are still not well 
elucidated and there are several biological processes happening in specific kind of cells or 
tissues which can be influenced by such interactions but have not been investigated yet.  
In this context and considering the capacity of GO to influence plasma membrane 
equilibrium, we decided to investigate the effects that small GO flakes (s-GO) may exert on 
plasma membrane of glial cells, focusing membrane dynamics and  MVs release. Since the 
release of MVs is a phenomenon that involves finely regulated alterations of plasma 
membrane lipids dynamics and given the previous report of the ability of s-GO to affect 
synaptic vesicles release in hippocampal neurons (Rauti et al., 2016a) we perform a sub-
chronical exposure of glial cells to s-GO and measured the response to this stimulus in terms 
of MVs release. As reported in literature, MVs basal release is very low in physiological 
conditions but we demonstrated that a short treatment with s-GO at low concentrations 
boosted this spontaneous release without affecting cell viability. The ability of MVs to easily 
reach inaccessible regions due to the presence of biological barriers, like the blood brain 
barrier (BBB) of the brain might have a decisive role in the development of biomedical tools 
for the delivery of drugs or genetic material in these regions. 
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AIMS 
 
This work is focused on the investigation of intercellular communication between glia and 
neurons of cerebral cortex. It is well established, since years, that glia has a leading role in 
the modulation and maintaining of synaptic connectivity and neuronal survival, starting from 
the early stages of development until the formation of a mature and stable network. The 
highly diversification of glial cell types allows the nervous system to mediate a wide range 
of functions critical for neuronal signaling. In particular, astrocytes represent the majority of 
glia and actively communicate with neurons in terms of survival and modulation of synaptic 
activity. In the context of astrocytes-neurons crosstalk there is a lack of knowledge regarding 
the role of newly discovered way of communication, alternative to the “classic” signaling, 
represented by extracellular vesicles. 
The first aim of this study is to unveil the response of astrocytes to unconventional stimuli, 
understanding how these stimuli can affect the release of extracellular vesicles in rodent 
cerebral cortex. Once verified the capability of cortical astrocytes to release extracellular 
vesicles under pharmacological stimulation with agonists of purinergic receptor P2X7 we 
investigated how the interaction of graphene based materials with glial cells could affect this 
signaling pathway. We focused on graphene and in particular small graphene oxide (s-GO) 
flakes, because of their ability to interact with plasma membranes and its unique physico-
chemical properties which made s-GO extremely promising substrates for the development 
of biomedical application. Given the direct impact of s-GO on plasma membranes, we 
pointed our attention on the class of extracellular vesicles called microvesicles (MVs) due to 
the fact that their biogenesis is directly linked to plasma membrane perturbations. The 
literature about biological effects that MVs exert on neurons in terms of modulation of 
synaptic activity is currently very poor and incomplete, especially if we consider astrocytes-
derive MVs. Some reports demonstrate the capability of extracellular vesicle to affect 
neuronal activity but are mostly focused on microglia-derived vesicles describing the effects 
of a mid-long exposure to them. We developed an efficient strategy to release MVs from 
astrocytes by s-GO exposure and MVs were systematically characterized by nano-
technology based tools, and compared to ATP-released ones. Second aim of this study is to 
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investigate the effects of an acute exposure of cortical neurons to MVs isolated from 
astrocytes cultures, focusing not on the network activity but on the single neuron.  
However, when we work with carbon based nanomaterials we must take in consideration 
also how the treated tissue could react. Tissue reactivity in response to GBMs is strictly 
dependent to many variables like: concentration, functionalization, size and shape of the 
material and with the perspective of a biomedical application it is mandatory to examine in 
depth also this aspect. For this reason, a collateral research was design to verify how the 
resident macrophages on central nervous system, represented by microglia, react to the 
presence of s-GO flakes, at the same concentration and conditions used for the treatment of 
astrocytes in order to evaluate possible long-term neurotoxic effects. 
The results of this Thesis were in part published or submitted and are included as so in the 
following order: 
 
Graphene Oxide Nanosheets Reshape Synaptic Function in Cultured Brain Networks. ACS 
Nano (2016) 
Graphene Oxide Nanosheets and Neural System: from Synaptic Modulation to 
Neuroinflammation. Frontiers in System Neuroscience (2018) (submitted) 
s-GO Nanoflakes Boost Microvesicle Production in Brain Cultured Astrocytes. Nanoletters 
(Manuscript in preparation) 
Carbon Nanomaterials for Brain Interfaces (Review). Carbon (2018) (under revision) 
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△Basque Foundation for Science, Ikerbasque, Bilbao 48013, Spain
*S Supporting Information
ABSTRACT: Graphene oﬀers promising advantages for biomedical applications.
However, adoption of graphene technology in biomedicine also poses important
challenges in terms of understanding cell responses, cellular uptake, or the intracellular
fate of soluble graphene derivatives. In the biological microenvironment, graphene
nanosheets might interact with exposed cellular and subcellular structures, resulting in
unexpected regulation of sophisticated biological signaling. More broadly, biomedical
devices based on the design of these 2D planar nanostructures for interventions in the
central nervous system require an accurate understanding of their interactions with the neuronal milieu. Here, we describe
the ability of graphene oxide nanosheets to down-regulate neuronal signaling without aﬀecting cell viability.
KEYWORDS: nanotechnology, graphene, patch-clamp, synaptic terminals, exocytosis, FMI-43, microvesicles
Graphene is a 2D plate-like material consisting of sp
2-
hybridized carbon atoms organized in a hexagonal
lattice and characterized by, among other properties,
high electron mobility and mechanical ﬂexibility.1−3 In addition
to the successful exploitation of graphene and graphene-based
materials in an increasing number of industrial products,
current applications of graphene hold the potential to
revolutionize speciﬁc areas of medicine.2−6 Biomedical develop-
ments, in general, in neurology, in particular, are focusing on
few-layer graphene sheets to manufacture novel biodevices,
including biosensors, interfaces, tissue scaﬀolds, drug delivery,
and gene therapy vector systems.4 The successful design of
multifunctional graphene-based neurodevices will expose brain
cells and neuronal circuits directly to this material by injection
or implantation.4,7 In this context, the exploration of the
interactions between graphene nano- and microsheets with the
sophisticated signaling machinery of nerve cells, with a
particular focus on potential graphene ﬂake interactions with
the hydrophobic membrane domains, is of great impor-
tance.1,8,9 Such interactions may favor graphene translocation
or adhesion to cell membranes,8,10 potentially interfering with
exquisite membrane activities, such as the exocytic and
endocytic traﬃcking systems, which are crucial to physiological
synaptic transmission.8,11
Here, we explore by patch clamp and ﬂuorescence imaging
the ability of graphene (GR) and graphene oxide (GO)
nanosheets to interfere with synaptic signaling once hippo-
campal cultured neurons are exposed for 1 week to a growth
medium containing thin sheets of such materials at 1 or 10 μg/
mL (concentrations reported not to induce cell death12−14).
We further investigated whether, in the absence of explicit cell
toxicity, such materials aﬀected the ability of astrocytes to
release synaptic-like microvesicles15 (MVs) in pure glial
cultures. Our results describe the potential of GO nanosheets
to alter diﬀerent modes of interneuronal communication
systems in the central nervous system (CNS), hinting at
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opportunities for neuromodulatory applications or highlighting
subtle, but potentially unwanted, subcellular interactions.
RESULTS AND DISCUSSION
To address the issue of prolonged exposure of a functional
brain network to graphene sheets, we used diﬀerent materials.
Graphene oxide sheets of large and small lateral dimensions (l-
GO and s-GO, respectively) were synthesized using a modiﬁed
Hummers method (see Methods). Following the reaction, the
GO gel-like top layer was extracted carefully by using warm
water, resulting in the large GO (l-GO). Final concentrations
ranging between 1 and 2 mg/mL were obtained with a yield of
ca. 10%. l-GO was freeze-dried, reconstituted in water for
injection, sonicated for 5 min, and centrifuged at room
temperature to generate the small GO (s-GO).The lateral
dimension of the GO sheets was controlled by drying and
sonicating the l-GO to obtain the s-GO sheets, which were
always at least 1 order of magnitude smaller, without
introducing any signiﬁcant changes among their surface
properties (see Table S1 in the Supporting Information).
The GO dispersions in aqueous media were homogeneous,
of brownish color, and stable at room temperature for more
than 6 months. The physicochemical characterization of the l-
GO and s-GO dispersions is shown in Figure 1a−f and in the
Supporting Information Figures S1 and S2. The structural
properties (lateral dimension and thickness) were studied by
optical microscopy, transmission electron microscopy (TEM),
and atomic force microscopy (AFM). Optical properties were
studied by UV−vis and ﬂuorescence spectroscopy. Raman
spectroscopy and laser Doppler electrophoresis (measuring ζ-
potential) were used to assess the surface properties of the GO
materials. The Raman spectroscopic analysis revealed D and G
bands at 1319 and 1596 cm−1, respectively, characteristic of
most polyaromatic hydrocarbons. The D to G band intensity
ratio (ID/IG) was calculated to be 1.3, corresponding to the
metric of disorder in the graphitic structure. The surface charge
Figure 1. Characterization of small graphene oxide (s-GO) of biological grade; graphene oxide exposure at high concentration inﬂuences
synaptic function. (a−f) Physicochemical characterization of s-GO: (a) TEM micrograph (scale bar 1 μm), (b) AFM height image (scale bar 1
μm), (c) lateral dimension distribution, and (d) thickness distribution analysis; (e) normalized Raman spectrum and (f) TGA analysis. (g)
Graphene oxide exposure at high concentration inﬂuences synaptic function. Spontaneous synaptic activity recorded from hippocampal
cultures in control, melamine, s-GO, and GR-treated cultures at 1 μg/mL (top traces) and 10 μg/mL (bottom traces) grown for 8−10 days in
vitro. Postsynaptic currents (PSCs) were detected at −56 mV holding potential. Bottom plots represent pooled data and summarize average
PSC amplitude and frequency; note the reduction in s-GO treatment (10 μg/mL, ﬁnal concentration) of PSC frequency (*** = P < 0.001
Student’s t test; data are mean ± SEM).
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measured with a Zetasizer instrument showed an average ζ-
potential of −50 mV, indicating ﬂakes of high negative surface
charge. To elucidate the degree of surface functionalization,
thermogravimetric analysis (TGA) and X-ray photoelectron
spectroscopy (XPS) were performed to quantify the purity of
the GO (>99%) and the C/O ratio. XPS high-resolution C 1s
spectra were recorded to elucidate the contribution of
individual functional groups such as carboxylic, carbonyl,
epoxide, and hydroxyl (Table S2b). All ﬁttings shown were
performed using the CasaXPS software, and the diﬀerent
regions were assigned according to NIST’s XPS and lasurface
databases. Deconvolution XPS spectra and assignment of the
functional groups indicated that hydroxyls were the least
abundant species in the GO material (see Supporting
Information Table S2a).
Aqueous dispersions of graphene ﬂakes were prepared using
ball-milling for the exfoliation of graphite through interaction
with melamine, as previously described16,17 (see Methods).
Due to the GR preparation process, graphene dispersions can
contain traces of melamine. In order to determine the exact
amount of these traces, ﬁnal graphene dispersions (0.09 mg/
mL) were evaluated by elemental analysis, which indicated 0.9
ppm of melamine. Experiments that involved incubation in
neurons also included controls exposed to equal amounts of
melamine alone (see Methods). The physicochemical charac-
terization of GR dispersions is shown in Figure S3. The lateral
size, studied by TEM, was found to range between 500 nm and
3 μm (Figure S3a,b in the Supporting Information). Optical
properties were studied by UV−vis absorption spectroscopy.
Dispersions were diluted, and the respective UV−vis absorption
spectra were recorded (Figure S3). The spectra are featureless
in the vis−NIR region, as expected. The absorbance at 660 nm,
divided by cell length, is plotted against the concentration,
exhibiting Lambert−Beer behavior (Figure S3d). Raman
spectroscopy revealed diﬀerences between the GO and GR.
Graphene exhibits G and 2D modes around 1573 and 2700
cm−1 that satisfy Raman selection rules, while the D peak,
around 1345 cm−1, requires a defect for its activation (Figure
S3e). The D to G band intensity ratio was calculated at
diﬀerent locations, giving a signiﬁcantly low value (0.22) in
comparison with that of GO. TGA was also used to quantify
the functionalization degree of GR. The low weight loss
observed in GR (7%) corroborated the low quantity of oxygen
groups generated by the exfoliation process (Figure S3f).
We used hippocampal neurons isolated and cultured for 8−
10 days in vitro (DIV). Primary neuronal cultures were
incubated for 2 DIV in the presence of GR or s-GO (at 1
and 10 μg/mL; see Methods) and maintained for 6−8 days.
Afterward, visually identiﬁed neurons were patch clamped
under a voltage clamp. Hippocampal neuron maturation and
viability were assessed using single-cell recordings (see
Methods) to measure the cell passive membrane properties
that are accepted indicators of neuronal health18−20 that
allowed comparison among the recorded cells. These
parameters (membrane capacitance and input resistance)
displayed similar values in all treatment conditions (summar-
ized in Table 1).
To investigate synapse formation and activity after in vitro
growth of neurons, we monitored the occurrence of
spontaneous postsynaptic currents (PSCs). The appearance
of PSCs provided clear evidence of functional synapse
formation, and it is a widely accepted index of network
eﬃcacy.21,22
Figure 1g shows representative current tracings of the
recorded electrical activity. In neurons exposed to low (1 μg/
mL) s-GO and GR, spontaneous synaptic activity was not
aﬀected. In fact, measured PSC amplitude and frequency in s-
GO and GR (79 ± 7 pA, 2.5 ± 0.4 Hz, n = 27 and 77 ± 8 pA, 3
± 0.5 Hz, n = 30, respectively) were comparable to the
corresponding control and control−melamine values (87 ± 8
pA and 2.3 ± 0.3 Hz, control, n = 24; 80 ± 15 pA and 2.3 ± 0.5
Hz melamine n = 28; plots in Figure 1g). In all tests, cell
parameters measured in melamine were comparable to those
expressed by control neurons (Figure 1g, bottom plots), thus
the impact on cells of such a contaminant at the estimated
concentration is negligible.
When investigating the impact of higher graphene doses (10
μg/mL), we detected a signiﬁcant diﬀerence (P < 0.001;
Student’s t test) in PSC frequency when comparing control
neurons (2.0 ± 0.1 Hz control, n = 20) with s-GO-treated ones
(0.6 ± 0.1 Hz, n = 18), while in melamine and GR, PSC
frequency values remained unchanged (2.5 ± 0.7 Hz, n = 25 for
melamine and 2.8 ± 1.1 Hz, n = 25 for GR). In all treatments
studied, the amplitude values of the PSCs were never aﬀected
(data are summarized in Figure 1g plots). We further tested
synaptic responses when neurons were treated (1 and 10 μg/
mL) with a commercially available GO provided by an
industrial partner (A-GO; Supporting Information and Figure
S4). Similar reduction in PSC frequency (Figure S5) was
detected that validated the observation that GO nanosheets,
diﬀerently than GR ﬂakes, speciﬁcally interfered with synapses
in cultured neurons, regardless of the starting material.
The impact of 10 μg/mL s-GO on synaptic activity was not
related to a decreased number of surviving neurons in the
presence of s-GO. In fact, we determined the cellular
composition of control and s-GO-treated hippocampal cultures
using immunoﬂuorescence markers23 for astrocytes (GFAP)
and neurons (β-tubulin III). We observed both β-tubulin III
and GFAP immunoreactive cells in all growing conditions
(Figure 2a), and both cell groups were represented in a
comparable proportion in all treatment groups (quantiﬁed by
measuring the cell density in Figure 2a; n = 13 visual ﬁeld per
condition, three diﬀerent culture series). Thus, s-GO at higher
concentrations speciﬁcally altered synapse formation and/or
function without aﬀecting cell survival or the global network
size.
To gain more insight into such processes, we further
investigated s-GO-treated (10 μg/mL) cultures. We speciﬁcally
addressed the distribution of neuronal excitation by measuring
the activity of small clusters of neurons with ﬂuorescence
calcium imaging.23−25 On average, 7 ± 2 ﬂuorescent neurons (n
= 26 ﬁelds), stained with the membrane-permeable Ca2+ dye
Fura-2-AM (see Methods), were simultaneously visualized in
Table 1. Neuronal Passive Membrane Properties upon GR
and s-GO Exposure (1 and 10 μg/mL, Respectively)
capacitance (pF) input resistance (MΩ)
control1 (n = 24) 59 ± 4 976 ± 138
melamine1 (n = 28) 46 ± 5 1036 ± 132
s-GO1 (n = 27) 62 ± 8 876 ± 145
GR1 (n = 30) 50 ± 5 1029 ± 161
control10 (n = 20) 57 ± 7 744 ± 82
melamine10 (n = 25) 72 ± 16 717 ± 106
s-GO10 (n = 18) 67 ± 6 997 ± 156
GR10 (n = 25) 59 ± 18 1223 ± 501
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the recorded ﬁeld (120 × 160 μm2). We compared and
characterized the cell ability to generate repetitive Ca2+
oscillations.23−25 In control conditions, all recorded ﬁelds (n
= 8) displayed active cells, while in s-GO-treated cells, 56% (n =
10 out of 18) of the recorded ﬁelds did not display detectable
cell activity. However, in the remaining s-GO ﬁelds (n = 8), we
found an amount of neurons that were spontaneously
generating repetitive Ca2+ oscillations comparable to that
measured in controls (Figure 2b; 36% in control, 20 out of
56 neurons, n = 8 active ﬁelds and 30% in s-GO-treated, 18 out
of 60 neurons, n = 8 active ﬁelds).
Figure 2b traces represent ﬂuorescence recordings from
active ﬁelds in control and s-GO-treated cultures (two sampled
cells in each ﬁeld). Episodes usually comprised spontaneous
bursts of activity, fully blocked by tetrodotoxin (TTX, a blocker
of voltage-gated, fast Na+ channels) applications (1 μM; n = 8
ﬁelds, control and s-GO-treated; not shown). Control Ca2+
oscillations displayed an interevent interval (IEI) of 36 ± 2 s (n
= 20 cells) that was signiﬁcantly lower (P < 0.001; Student’s t
test) than that measured in s-GO-treated networks (110 ± 6 s,
n = 18 cells, right plot in Figure 2b). When GABAA receptors
were pharmacologically blocked by bicuculline (20 μM, 20
min), an antagonist of inhibitory connections known to
potentiate rhythmic activity patterns,23,26,27 the control IEI
average value was still signiﬁcantly lower (P < 0.001; Student’s t
test) than that measured in s-GO neurons in the presence of
the GABAA receptor antagonist (18 ± 1 s, n = 20 in control
cells vs 92 ± 10 s, n = 18 in s-GO cells; plot in Figure 2b, right).
This indicated a direct reduction in the excitatory activity due
to s-GO exposure.
Figure 2. s-GO exposure at high concentration impaired network activity without changing network size. (a) Immunoﬂuorescence images are
shown to visualize neurons and glial cells in four diﬀerent conditions (anti-β-tubulin III, in red, left panels; anti-GFAP, in green, right panels;
in all, nuclei are visualized by DAPI in blue) (samples are for the 10 μg/mL protocol; scale bar 50 μm). The plots summarize neuronal (left)
and glial (right) densities in all conditions. (b) Repetitive spontaneous Ca2+ (left panel) or bicuculline-induced (right panel) oscillations
recorded in hippocampal cultures at 8−10 DIV (from each ﬁeld sample, recordings of two cells were selected). Histograms summarize the
percentage of spontaneous active cells (middle) and the average values of the interevent interval (IEI; right) in standard saline (Krebs) and in
the presence of bicuculline (*** = P < 0.001 Student’s t test; data are mean ± SEM).
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Next, we recorded single-cell synaptic activity in the presence
of TTX (1 μM, Figure 3a). Under these experimental
conditions, synaptic currents, termed miniature PSCs
(mPSCs), do not depend on action potential generation.
mPSCs are due to the stochastic fusion of neurotransmitter
vesicles at the presynaptic membrane, and their frequency is
proportional to the number of synaptic contacts.28 Despite the
fact that in the recorded hippocampal neurons spontaneous
synaptic activity was manifested as inward currents (in our
recording conditions, see Methods21) made up by a mixed
population of inhibitory (GABAA receptor-mediated) and
excitatory (AMPA glutamate receptor-mediated) PSCs, vir-
tually all mPSCs, as previously reported,22 were identiﬁed as
excitatory by their fast kinetics (decay time constant τ = 4 ± 0.3
ms; see Methods22). Notably, s-GO signiﬁcantly decreased (P <
0.001, Student’s t test; see plots in Figure 3a) the frequency of
mPSCs without aﬀecting their amplitude (0.06 ± 0.02 Hz and
30 ± 0.7 pA, control, n = 15; 0.02 ± 0.001 Hz and 26 ± 0.7 pA,
s-GO-treated, n = 9; summarized in Figure 3a). To ascertain
whether the s-GO interference with synaptic activity was
selective on glutamate-mediated fast synaptic transmission, we
tested the occurrence of evoked inhibitory PSCs by pair
recordings of monosynaptically coupled neurons22 (Methods
and Figure S6a), and we observed that s-GO apparently did not
impair GABAA-mediated connections.
Figure 3. s-GO exposure at high concentration impaired excitatory synapses. (a) Sample tracings of mPSCs recorded in control and s-GO-
treated cultures (left panel). Right panel: plots reporting mPSC amplitude and frequency values. s-GO treatment signiﬁcantly decreased the
frequency of mPSCs (*** = P < 0.001 Student’s t test). (b) Confocal reconstruction of control and s-GO-treated neurons immunolabeled for
the vesicular glutamate transporter 1 (VGLUT1, green) and counterstained for cytoskeletal component β- tubulin III (red; nuclei are
visualized by DAPI in blue; scale bar 10 μm). The plot shows the signiﬁcant decrease of VGLUT1-positive puncta in s-GO-treated cultures
(*** = P < 0.001 Student’s t test). (c) Top: ﬂuorescence images following staining with FM1-43, control, and s-GO-treated. Scale bar 50 μm.
The areas in the boxes are higher magniﬁcations to highlight the diﬀerence in vesicular staining between the two conditions (scale bar 100
μm). The plot (top right) reproduces the representative (control and s-GO) traces of FM1-43 destaining (please note that each trace has been
normalized to the maximum ﬂuorescence detected). Bottom: left plot summarizes the initial raw ﬂuorescent intensities of hippocampal
terminals from control and s-GO-treated cultures (** = P < 0.01 Mann−Whitney test); the right plot summarizes the decay time constant τ of
FM1-43 destaining in the two conditions (*** = P < 0.001, Mann−Whitney test).
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To determine whether changes in excitatory synaptic density
may account for the reduction in fast mPSC frequency detected
in s-GO-treated cultures, neurons were co-immunostained for
β-tubulin III and the vesicular glutamate transporter
(VGLUT1), a transmembrane protein localized at the
glutamatergic presynaptic terminals.29 Antibody to VGLUT1
labeled presynaptic boutons under both conditions (Figure 3b).
Using β-tubulin III labeling to identify neuronal bodies and
dendrites, we quantiﬁed VGLUT1-positive puncta, detecting a
signiﬁcant (P < 0.001; Student’s t test) reduction in their
density in s-GO-treated samples (1.4 × 10−3 ± 0.045 × 10−3, n
= 6 ﬁelds for control and 0.28 × 10−3 ± 0.11 × 10−3, n = 6
ﬁelds for s-GO; plot in Figure 3b). Parallel experiments were
performed to quantify GABAergic synapses, by similar co-
staining but for the vesicular GABA transporter (VGAT) to
localize presynaptic GABAergic terminals.22,30 These studies
indicated that s-GO incubation did not alter the inhibitory
connection density (Supporting Information and Figure S6b).
In the next set of experiments, we measured the kinetics of
synaptic vesicle release by real-time imaging of vesicles labeled
with FM dye to monitor the rate of presynaptic vesicle
recycling from hippocampal neurons treated or untreated with
s-GO. After being stained with the lipophilic dye FM1-43,31−33
clusters of presynaptic terminals were visible as bright
ﬂuorescent spots (Figure 3c). The ﬂuorescence intensity
measured on FM-positive puncta following high KCl (50
mM34) depolarization is proportional to the number of vesicles
endocytosed during synaptic vesicle recycling and thus allows
estimation of the size of the recycling vesicle pool.34 In s-GO-
treated cells, upon a high-K+-loading protocol, we detected a
signiﬁcant (P < 0.01; Mann−Whitney test) reduction in the
raw ﬂuorescence intensity of FM1-43-positive hippocampal
Figure 4. s-GO exposure and microvesicle release in glial cells. (a) Immunolabeling of primary rat astrocytes (3 weeks) in control and s-GO-
treated cells (10 μg/mL, 6−8 days). Both cultures were immunostained for GFAP (green) and nuclei visualized by DAPI (blue; scale bar 100
μm). No statistical signiﬁcance was found between the two conditions (top right). (b) AFM image of ﬁxed MVs, where the diﬀerences in color
are representative of height diﬀerences (brighter means higher). A representative height proﬁle crossing three MVs is reported. The scatter
plot (right) shows MV width versus height distribution and is ﬁtted with a regression line represented by the equation y = 0.046x + 0.218. A
frequency histogram, built upon experimental measurements of both width and height, was plotted over each axis of the scatter graph and
ﬁtted with Gaussian distributions. The frequency histograms revealed the highest number of occurrences to be about 490 and 24 nm for width
and height, respectively. (c) Western blotting of the pellets (bottom row) and cell lysates (top row) for the MV marker ﬂotillin-1. Pellets were
obtained from the medium of glial cultures treated or untreated with s-GO under two diﬀerent conditions: stimulated and not stimulated
(Krebs) by 100 μM bzATP. Note the marked increase of the band for ﬂotillin-1 in s-GO-treated cells. (d) Plots summarizing the decreased
density of hippocampal cells when treated with l-GO (∼10 μm lateral size; 10 μg/mL ﬁnal concentration).
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terminals (11876 ± 1100 arbitrary units (au), n = 7 ﬁelds for
control and 7400 ± 1057 au, n = 6 ﬁelds for s-GO; three
diﬀerent culture series; Figure 3c), suggesting that chronic
incubation with s-GO decreased the recycling vesicle pool.
When analyzing the decay time constant (τ) of the FM1-43
ﬂuorescence destaining proﬁles during vesicle exocytosis, we
observed a signiﬁcant (P < 0.001; Mann−Whitney test)
diﬀerence in the kinetics displayed by control (τ = 5.7 ± 0.5
s, n = 205 terminals) and s-GO-treated (τ = 18 ± 2 s, n = 85
terminals) cells, as summarized in Figure 3c. In reference
experiments, the image series captured on FM1-43-stained cells,
but without the high-K+ destaining stimulus, produced a
baseline reference plot (not shown). Taken together, these
results support the speciﬁc ability of chronic exposure to s-GO
ﬂakes to reduce the amount of excitatory synaptic contacts and
to interfere with presynaptic vesicle recycling.
To test the ability of s-GO to impair cell membrane
dynamics, in general, we investigated whether s-GO (10 μg/
mL) was also reducing exocytosis and recycling of synaptic-like
microvesicles15 from cultured primary glial cells (see Methods).
MVs are released into the extracellular space by direct budding
from the plasma membrane of astrocytes and have been shown
to contribute to intercellular communication.15,35,36 We treated
pure glial cell cultures with s-GO (10 μg/mL) for 6−8 days. In
Figure 4a, immunoﬂuorescence staining of control and s-GO-
treated GFAP-positive cells are shown. s-GO incubation did
not aﬀect astrocyte density (Figure 4a, right histograms; n = 20
ﬁelds for both conditions), excluding any cytotoxic eﬀect. In
glial cultures, MV release was induced by bzATP incubation
(100 μM, 30 min, n = 3 diﬀerent series of cultures37−39), and
MV release was detected and quantiﬁed by immunoblot
analysis of the collected supernatant. In control, bzATP
stimulation induced the appearance of the band corresponding
to ﬂotillin-1 (Figure 4c, bottom blot), a signature of MV
release.40−42 Surprisingly, in s-GO-treated astrocytes, the
bzATP stimulation induced a marked increase in the size of
the ﬂotillin-1 band. This band was also detected in the absence
of stimulation (Figure 4c, bottom blot), suggesting that s-GO
per se induced the MVs’ constitutive release.
AFM micrographs in Figure 4b (left panel) show the
presence of vesicles in the stimulated control supernatant
appearing as circular spots protruding from the ultraﬂat mica
surface. For each of them, width and height were independently
measured from particle crossing height proﬁles, and the
resulting distributions were plotted (Figure 4b, right panel).
Intriguingly, similar experiments with GR (10 μg/mL) did not
induce shedding of MVs in glial cell cultures (Supporting
Information and Figure S7).
We also attempted to investigate the eﬀect of increased
lateral size of GO (l-GO, with a lateral dimension in the few
micromter range; 10 μg/mL ﬁnal concentration) on cultured
hippocampal cells. However, after 6−8 days of incubation, we
measured a signiﬁcant (P < 0.001; Student’s t test; Figure 4d)
reduction in both neuron and glial cell densities (160 ± 10
neurons/mm2 and 96 ± 10 astrocytes/mm2 for control and 96
± 10 neurons/mm2 and 40 ± 7 astrocytes/mm2 for l-GO; n =
10 visual ﬁelds each, three series of cultures; Figure 4d),
indicating cell toxicity that prevented any further functional
measurements. We believe further investigations are warranted
to explore such lateral size-dependent cytotoxic responses.
We report here the ability of s-GO nanosheets to interfere
speciﬁcally with neuronal synapses, without aﬀecting cell
viability. In particular, in cultured neuronal networks, upon
chronic s-GO exposure, glutamatergic release sites were sized
down. This was shown by (i) the reduction in frequency of
spontaneous synaptic activity (PSCs and mPSCs) together with
the marked reduction in VGLUT1-positive labeling,43 (ii) the
reduced probability of ﬁnding active neurons when networks
were explored by Ca2+ imaging,23,44 and (iii) the decreased
recycle vesicle pool quantiﬁed by FM1-43 measurements
together with the altered kinetics of vesicle recycling.34 This
down-regulation of glutamate-mediated synapses was appa-
rently not due to a general cell membrane disruption or to
neuronal cell loss. In fact, we never detected alterations in basic
electrophysiological parameters, reﬂecting neuronal health and
membrane integrity.18−20
In addition, cell densities in treated cultures were comparable
to control ones. The survival of GFAP-positive glial cells was
also not aﬀected by s-GO exposure, both in mixed neuronal and
in pure neuroglial cultures. In the latter condition, MV release
was indirectly monitored by the blot analysis of ﬂotillin-1
protein,40,41 and MV presence was conﬁrmed by direct AFM
measures. In these cultures, exposure to s-GO stimulated the
basal release of shed vesicles and augmented the bzATP-
induced one.37−39 s-GO increase in MV release from neuroglia
cells might be related to a general cell-stress condition15
ultimately due to s-GO glial−membrane interactions or even
internalization, depending on the ﬂakes’ shape, lateral
dimension, and oxidization degree,10 as well as the degree of
protein adsorption from the culturing milieu.45
Based on our experimental evidence, we cannot rule out that
treatment with s-GO down-regulated the synaptic function (in
particular, presynaptic release) via MVs released in mixed
neuronal−glial cultures, thus excluding a direct, membrane
interference of s-GO nanosheets at the presynaptic glutama-
tergic terminals. MVs have long been reported as active
messengers of intercellular communication, rather than mere
inert debris;37 however, to our knowledge, there are no reports
of astrocyte shedding MVs acting as regulators of synaptic
activity. On the contrary, MVs released by microglia have been
reported to aﬀect synaptic activity, mainly acting at the
presynaptic site of the excitatory synapses, but increasing
synaptic activity and release in primary cultures.37 Against this
neuroglial cell-mediated response to s-GO is also the fact that
astrocyte density in mixed cultures is artiﬁcially kept at a low
level by the culturing procedure itself, while the surviving
microglia are even fewer.46
In contrast to s-GO, the inert nature of GR ﬂakes regarding
synaptic activity and MV release by glia is also of interest. This
could be due to diﬀerences in shape and lateral size aﬀecting
ﬂake−membrane interactions.10 It is also interesting to consider
that GR has a much less hydrophilic surface characteristic and
overall poorer dispersibility in cell culture media45 that may
lead to the formation of aggregates potentially unable to
interact with submicroscopic structures (such as the synaptic
clefts).
The apparent selectivity in terms of the presynaptic terminals
targeted by s-GO was also notable, with the inhibitory
GABAergic ones that remained unaﬀected, as evidenced by
pair recordings and the VGAT labeling.22 Given the ability of
graphene ﬂakes to undergo motion and vibration that can lead
to interaction with and possible piercing of lipid bilayers,8 we
propose an alternative mechanistic interpretation of our
synaptic results. s-GO ﬂakes may prevent the synaptic vesicle
endocytotic cycle because their dimensions allow them to
interact with the presynaptic cell membrane at the periphery of
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the synaptic cleft and then be taken up by vesicles. In this
process, the ﬂakes may transiently trap vesicles in an open
mode and prevent their closing and the subsequent
endocytosis. This could aﬀect synaptic release in the short
term, inducing, in the long term, a down-regulation of
glutamatergic release sites and synapses. Note that glutamater-
gic synaptic activity is speciﬁcally, and reversibly, aﬀected also
when neurons are transiently exposed to s-GO, with a short-
term up-regulation of release, turned into a down-regulation
within the ﬁrst 3 days of chronic exposure (Figure S8 in
Supporting Information). This observation further supports the
hypothesis of the ability of s-GO to directly target synapses.
The mechanism of such interaction among s-GO ﬂakes and
vesicles (including extra-synaptic ones) could be similar to what
has been previously described for dispersed single-walled
carbon nanotubes.47 In this context, the unlikeliness of aﬀecting
GABAergic terminals may reside in the diﬀerent dimensions of
the excitatory (16 nm) and inhibitory (10 nm) synaptic clefts.48
The latter are reported to be narrowed to 6 nm at the periphery
of the clefts due to transcleft elements, while docked vesicles
are concentrated at the central cleft domain.48 On the contrary,
docked vesicles in excitatory synapses are distributed evenly
over the synaptic cleft.48 It is tempting to speculate that these
synaptic ultrastructural diﬀerences might explain why gluta-
matergic terminals became ideal targets of s-GO interactions.
This selectivity is supported by the notion that, even when
transiently exposed to s-GO via pressure-ejected brief pulses,
GABAergic synapses are unaﬀected (see Supporting Informa-
tion and Figure S8).
CONCLUSIONS
Regardless of the mechanisms involved, the described ability of
s-GO to alter synapses and induce glial cell reaction has not
been previously documented. This might compromise neuronal
signaling and CNS functions and seems crucially dependent on
the GO sheet dimensions since larger ﬂakes were found
unequivocally cytotoxic. In our experiments, 6 days of exposure
of cultures to equal amounts of dispersed l-GO induced
unequivocal hippocampal cell loss, both neuroglia and neurons,
thus hampering any further evaluation of membrane/ﬂake
interactions.
These observations deserve further studies; in fact, altering
synapses and inducing glia reactivity may raise concerns from a
safety and nanotoxicity point of view.49
Beyond the safe design of nanomaterials, such a subtle
interference aﬀecting exquisite CNS signaling may oﬀer
possibilities in neuropharmacology when speciﬁc targeting of
excitatory synapses is desired.50−52 The use of nanoparticles as
therapeutics is, in fact, fueled by their ability to circumvent
biological barriers,53 and targeting of synapses has created the
basis for theranostics applications.54 Our observations with thin
s-GO ﬂakes illustrate the potential of 2D nanosheet physical
properties to engineer speciﬁc glutamate transmission modu-
lators.
It is also relevant to note that synapse formation and function
in neuronal networks, when interfaced to planar graphene-
based materials, are not aﬀected.55 This strengthens the notion
that when exploring the application of graphene in biology,
studies should be performed with well-characterized types of
materials because the materials’ physical−chemical features,
including geometry, are governing the potential interactions
with speciﬁc biological components.2
METHODS
Synthesis and Characterization of Biological-Grade Thin
Graphene Oxide of Diﬀerent Lateral Size Distribution. For
graphene oxide preparation, graphite ﬂakes (Graﬂake 9580) were
obtained from Nacional Graﬁte Ltd. (Brazil) and used for the
preparation of large and small graphene oxide. Nitric acid 70%, sodium
nitrate, potassium permanganate, sulfuric acid 99.999%, and hydrogen
peroxide 30% were purchased from Sigma-Aldrich. Water for injection
was obtained from Fresenius Kabi.
Graphene oxide sheets were synthesized using the modiﬁed
Hummers method previously described56 and under endotoxin-free
conditions by using a laminar ﬂow hood, water for injection, gloves,
nonpyrogenic plastic containers, and depyrogenated glassware.57
Brieﬂy, 0.8 g of graphite ﬂakes was mixed with 0.4 g of sodium
nitrate in a round-bottom ﬂask, and then 18.4 mL of sulfuric acid
99.999% was added slowly to the mixture. After a homogenized
mixture was obtained, 2.4 g of potassium permanganate was slowly
added and the mixture was maintained for 30 min. Next, 37 mL of
water for injection was added dropwise due to the violent exothermic
reaction, and the temperature was continuously monitored and kept at
98 °C for 30 min. The mixture was further diluted with 112 mL of
water for injection, and 30% hydrogen peroxide was added for the
reduction of the residual potassium permanganate, manganese dioxide,
and manganese heptoxide to soluble manganese sulfate salts. The
resulting mixture was puriﬁed by several centrifugation steps at 9000
rpm for 20 min until a viscous orange/brown layer of pure GO started
to appear on top of the oxidation byproducts at neutral pH.58
This GO gel-like layer was extracted carefully with warm water,
resulting in the large GO. Final concentrations ranging between 1 and
2 mg/mL were obtained with a yield of ca. 10%. l-GO was freeze-dried,
reconstituted in water for injection, sonicated in a bath sonicator
(VWR, 80W) for 5 min, and centrifuged at 13 000 rpm for 5 min at
room temperature to prepare the s-GO. Structural properties such as
lateral dimension and thickness of the GO materials have been studied
by optical microscopy, TEM, and AFM. Optical properties such as
absorbance and ﬂuorescence have been studied by using UV−vis and
ﬂuorescence spectroscopy, respectively. Surface properties have also
been studied by Raman spectroscopy and ζ-potential measurements.
To elucidate the functionalization degree of the GO sheets, TGA was
performed. X-ray photoelectron spectroscopy has been used to
quantify the chemical composition of the GO sheets, C/O ratio, and
the contribution of each individual functional group such as carboxylic,
carbonyl, and epoxides.
Optical Microscopy. Bright-ﬁeld microscopy using a Zeiss
Primovert microscope was used to assess the lateral dimension
distribution of the l-GO and to verify the size reduction of the s-GO.
Transmission Electron Microscopy. TEM was performed using a
FEI Tecnai 12 Biotwin microscope (FEI, The Netherlands) at an
acceleration voltage of 100 kV. Images were taken with Gatan Orius
SC1000 CCD camera (GATAN, UK). One drop of sample was placed
on a Formvar/carbon-coated copper grid. Filter paper was used to
remove the excess material.
Atomic Force Microscopy. A multimode AFM was used on the
tapping-mode with a J-type scanner, Nanoscope V8 controller (Veeco,
Cambridge, UK), and an OTESPA silicon probe (Bruker, UK). Images
were taken in air by depositing 20 μL of 100 μg/mL of GO on a
freshly cleaved mica surface (Agar Scientiﬁc, Essex, UK) coated with
poly-L-lysine 0.01% (Sigma-Aldrich, UK) and allowed to adsorb for 5
min. Excess unbound material was removed by washing with Milli-Q
water and then allowed to dry in air; this step was repeated once.
Lateral dimension and thickness distributions of GO were carried out
using NanoScope Analysis software (version 1.40 Bruker, UK).
UV/Visible Spectroscopy. UV/visible absorbance spectra were
obtained for GO samples from 7.5 to 20 μg/mL using a Varian
Cary winUV 50 Bio spectrophotometer. Dual beam mode and baseline
correction were used throughout the measurements to scan the peak
wavelength and maximum absorbance between 200 and 800 nm.
Fluorescence Spectroscopy. Fluorescence emission spectroscopy
was performed for GO samples from 75 to 200 μg/mL using a LS-50B
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PerkinElmer spectroﬂuorimeter at the excitation wavelength of 525
nm, with both excitation and emission slits set at 20.
Raman Spectroscopy. Raman spectra were recorded for GO (20
μL of 100 μg/mL) on glass slides after complete evaporation of the
water. Measurements were carried out using a 50× objective at 633 nm
laser excitation using a micro-Raman spectrometer (ThermoScientiﬁc,
UK). An average of ﬁve diﬀerent locations within each sample was
measured to calculate the ID/IG ratio.
Zeta-Potential Measurements. Electrophoretic mobility (μ) was
measured by Malvern Zetasizer Nano ZS (UK) after dilution of
samples with water in disposable Zetasizer cuvettes (Malvern
Instruments). Default instrument settings and automatic analysis
were used for all measurements, where the μ was converted
automatically by the equipment software to zeta-potential (ζ) values
as it is directly related to ζ-potential by Henry’s equation. All values for
samples prepared are triplicate measurements, and values were mean ±
SD.
Thermogravimetric Analysis. The weight loss of GO samples was
performed by TGA using a Pyris 6, PerkinElmer Ltd. GO (1−2 mg)
was weighed into a ceramic crucible and analyzed from 100 to 995 °C
at 10 °C/min with a nitrogen ﬂow of 20 mL/min.
X-ray Photoelectron Spectroscopy. The composition of GO
surfaces was studied by XPS at the NEXUS facility (the UK’s National
EPSRC XPS Users’ Service, hosted by nanoLAB in Newcastle-upon-
Tyne). XPS was recorded using a Thermo Theta Probe XPS
spectrometer with a monochromatic Al Kα source of 1486.68 eV.
The survey XPS spectra were acquired with pass energy (PE) of 200
eV, 1 eV step size, 50 ms dwell time, and averaged over ﬁve scans. The
etching was 90 s. High-resolution C 1s XPS spectra were acquired with
PE of 40 eV, 0.1 eV step size, 100 ms dwell time, and averaged over 20
scans. Spectra from insulating samples have been charge-corrected by
shifting all peaks to the adventitious carbon C 1s spectral component
binding energy set to 284.6 eV. CasaXPS software was used to process
the spectra acquired at NEXUS. For the deconvolution of the diﬀerent
components, the CasaXPS software was used and the diﬀerent regions
were assigned according to NIST’s XPS and lasurface databases:
π−π*: 290.9−289.7
O−CO: 288.8−288.0 eV
CO: 287.6−286.6 eV
C−O−C: 286.7−286.3 eV
C−OH: 285.9−285.3 eV
C−C and CC: 284.6 eV
For graphite samples, the CasaXPS software was able to properly ﬁt
the hydroxyl component at 285.6 eV, but for graphene oxide samples,
it was not possible to ﬁt six components where we should expect to
have the epoxide and hydroxyl contributions separately. The amount
of hydroxyls in the graphene oxide samples depends on the degree of
oxidation, with the hydroxyl groups being the least oxidized, followed
by epoxide, carbonyl, and carboxylic groups (the latter being the most
oxidized).
Synthesis and Characterization of Pristine Graphene. The
pristine graphene ﬂakes used in this study were obtained by a
methodology16 that uses mechanochemical activation by ball-milling
to exfoliate graphite through interactions with melamine (2,4,6-
triamine-1,3,5-triazine) in solvent-free conditions. In a typical
experiment, 7.5 mg of graphite (purchased from Bay Carbon, Inc.
SP-1 graphite powder) and 0.16 mmol of melamine were ball-milled in
a Retch PM100 planetary mill at 100 rpm for 30 min in air
atmosphere. The resulting solid mixtures were dispersed in 20 mL of
water to produce stable black suspensions. The as-prepared
dispersions can be ﬁltered and washed in hot water to remove
melamine. Graphene water dispersions were obtained with a ﬁnal
concentration of 0.09 mg/mL in Milli-Q water. Melamine traces in the
dispersions were analyzed by elemental analysis (LECO CHNS-932,
model no. 601-800-500), giving 0.9 ppm of melamine. For TEM
analyses, water dispersions were placed on a copper grid (3.00 mm,
200 mesh, coated with carbon ﬁlm), and samples were investigated by
high-resolution transmission electron microscopy (HRTEM) on a
JEOL 2100. Lateral dimension distribution was carried out using Fiji-
win32. UV−vis−NIR absorbance was performed for GR samples from
2.4 to 14.2 μg/mL using a 1 cm quartz cuvettes on a Cary 5000 UV−
vis−NIR spectrophotometer. For Raman spectroscopy, the water
dispersions are drop-cast onto a silicon surface (Si-Mat silicon wafers,
CZ). Measurements were carried out using a 100× objective at 532
nm laser excitation using a SENTERRA Raman microscope. An
average ID/IG ratio was measured from diﬀerent locations in the
sample. Thermogravimetric analyses were performed with a TGA Q50
(TA Instruments) at 10 °C/min in a nitrogen atmosphere.
Commercially Sourced Graphene Oxide. The graphene oxide
was prepared by stirring powdered carbon ﬁbers (GANF helical-
ribbon carbon nanoﬁbers manufactured by the Grupo Antolin
Ingenieriá, GANF) and sodium nitrate in sulfuric acid at 0 °C.
While vigorous agitation was maintained, potassium permanganate was
added to the suspension. After 30 min, water was slowly stirred into
the paste. Then, the suspension was ﬁltered and rinsed with copious
amounts of water to remove the presence of acids.59 For TEM
analyses, water dispersions were placed on a copper grid (3.00 mm,
200 mesh, coated with carbon ﬁlm). Samples were investigated by
HRTEM on a JEOL 2100. Lateral dimension distribution was carried
out using Fiji-win32. UV−vis−NIR absorbance was performed for GO
samples from 7.5 to 20 μg/mL using a 1 cm quartz cuvettes on a Cary
5000 UV−vis−NIR spectrophotometer. For Raman spectroscopy, the
water dispersions were drop-cast onto a silicon surface (Si-Mat silicon
wafers, CZ). Measurements were carried out using a 100× objective at
532 nm laser excitation using a SENTERRA Raman microscope. An
average ID/IG ratio was measured from diﬀerent locations in the
sample. The thermogravimetric analyses were performed with a TGA
Q50 (TA Instruments) at 10 °C/min in a nitrogen atmosphere.
Preparation of Primary Cultures. Primary hippocampal cultures
were prepared from 2 to 3 days postnatal (P2−P3) rats as previously
reported.21,22,60 All procedures were approved by the local veterinary
authorities and performed in accordance with the Italian law (decree
116/92) and the UE guidelines (86/609/CE, 2007/526/CE, and
2010/63/UE). The animal use was approved by the Italian Ministry of
Health. All eﬀorts were made to minimize suﬀering and to reduce the
number of animals used. All chemicals were purchased by Sigma unless
stated otherwise. Brieﬂy, enzymatically dissociated hippocampal
neurons21,22,60 were plated on poly-L-ornithine-coated glass coverslips
(Kindler, EU) at a density of 200 000 ± 16 000 cells/mL (measure by
sampling n = 4 culture series). Cultures were incubated (37 °C, 5%
CO2) in medium consisting of either 1× MEM (Gibco) or 10× MEM
(Gibco) to compensate the volume of the added GR and GO water
dispersion when treating cells at higher ﬂakes concentrations (i.e., 10
μg/mL). In both cases, the MEM was supplemented to reach 35 mM
glucose, 1 mM Apo-transferrin, 15 mM HEPES, 48 μM insulin, 3 μM
biotin, 1 mM vitamin B12, 500 nM gentamicin, and 10% fetal bovine
serum (FBS; Invitrogen). For experiments involving chronic treat-
ments, cultures were incubated at 2 DIV, with a medium containing 1
or 10 μg/mL of GR, either s-GO and A-GO, or l-GO, and controls
were subjected to the same medium changes with addition of
equivalent volumes of Milli-Q water or melamine alone. Cultures were
used at days 8−10 (after 6−8 days of incubation).
Primary cortical glial cultures were prepared from P2−P3 rats as
described in Calegari et al.61 Brieﬂy, dissociated cells were plated into
plastic 75 cm2 ﬂasks, incubated (37 °C; 5% CO2) in culture medium
consisting of DMEM (Gibco), supplemented with 10% FBS, 100 IU/
mL penicillin, and 10 mg/mL streptomycin. At 21 DIV, GR or s-GO
(10 μg/mL) was added to the culture medium and cultures were used
after 6−8 days of incubation.
Electrophysiological Recordings. Single and paired whole-cell
recordings were obtained at room temperature (RT) with pipettes (5−
7 MΩ) containing (in mM) 120 K gluconate, 20 KCl, 10 HEPES, 10
EGTA, 2 MgCl2, 2 Na2ATP, pH 7.3; osmolarity was adjusted to 300
mOsm. The extracellular solution contained (in mM) 150 NaCl, 4
KCl, 1 MgCl2, 2 CaCl2, 1 MgCl2, 10 HEPES, 10 glucose (all Sigma),
pH 7.4. Coverslips with cultures were positioned in a Perspex chamber
mounted on an inverted microscope (Eclipse TE-200, Nikon, Japan).
Data were collected by Multiclamp 700B patch ampliﬁer (Axon CNS,
Molecular Devices) and digitized at 10 kHz with the pClamp 10.2
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acquisition software (Molecular Devices LLC, USA). The spontaneous
synaptic activity was recorded by clamping the membrane voltage at
−56 mV holding potential (not corrected for liquid junction potential,
which was 14 mV). In paired recordings, the presynaptic neuron was
held under current clamp mode at −70 mV (≤0.02 nA negative
current injection), and action potentials were elicited by injecting short
(4 ms) square current pulses (1 nA). The postsynaptic cell was voltage
clamped usually at −56 mV holding potential. Monosynaptic
connections were recognized by their short latency (<5 ms62),
measured between the peak of the evoked action potential and the
onset of the postsynaptic current response. All recorded events were
analyzed oﬄine with the AxoGraph 1.4.4 (Axon Instrument) event
detection software (Axon CNS, Molecular Devices).
Calcium Imaging. Cultures were loaded for 1 h at RT with cell-
permeable Fura-2-AM (2 μM) in the extracellular recording solution
supplemented with 0.5% bovine serum albumin. The Fura-2-loaded
cultures were observed with a 40× objective (0.6 NA, Nikon, Japan),
and recordings were performed from visual ﬁelds (120 × 160 μm2)
containing on average 7 ± 2 neurons. Prior to recording Ca2+ signals,
we selected the cells by drawing regions of interest (ROI) around their
bodies to reduce any background.23 Samples were excited at
wavelengths of 340 and 380 nm generated by a monochromator
device equipped with integrated light source (Polychrome IV, Till
Photonics). Excitation light was separated from the light emitted from
the sample using a 395 nm dichroic mirror. Images of emitted
ﬂuorescence >510 nm were acquired continuously for a maximum of
2400 s (200 ms individual exposure time) by a cooled slow-scan
interline transfer camera (IMAGO CCD camera; Till Photonics). The
camera was operated on 8 × 8 pixel binning mode, and the imaging
system was controlled by an integrating imaging software package
(TILLvisION; Till Photonics). To induce rhythmic bursts, 20 μM
bicuculline methiodide was bath-applied after 15 min recording;23 at
the end of each experiment, tetrodotoxin (1 μM; Latoxan) was applied
to conﬁrm the neuronal nature of the recorded signals.23 Recorded
images were analyzed oﬄine by Clampﬁt software (pClamp suite, 10.2
version; Molecular Devices LLC, US) and Igor Pro software (6.32A
version; WaveMetrics, Lake Oswego, Oregon, USA). Intracellular Ca2+
transients were expressed as fractional amplitude increase (ΔF/F0,
where F0 is the baseline ﬂuorescence level and ΔF is the rise over the
baseline); elevations in calcium level were considered signiﬁcant if they
exceeded 5 times the standard deviation of the noise. We then
computed the diﬀerence between consecutive onset times to obtain
the IEI. Hence, after the IEI values were obtained from each active cell
in the ﬁeld, data were pooled for all ﬁelds recorded under the same
experimental conditions and averaged for further comparison.
FM1-43 Loading and Destaining. Depolarization-dependent
staining of synaptic terminals with the styryl dye N-(3-triethylammo-
niumpropyl)-4-(4-(dibutylamino)styryl)pyridinium dibromide (FM1-
43, Molecular Probes, Life Technology) was obtained by incubating
cultures (after 10 min saline buﬀer wash at RT) for 120 s with 50 mM
KCl and FM1-43 (15 μM). The buﬀer was replaced with 2 mL of
normal saline containing FM1-43, and cells were left to recover for 10
min to ensure complete recycling of the vesicles63 and then incubated
for 10 min with saline containing 6-cyano-7-nitroquinoxaline-2,3-dione
(10 μM) and 2-aminophosphonovaleric acid (50 μM) to prevent
network activity altering the rate of FM release. These antagonists
were present throughout the experiment. After incubation with FM1-
43 dye, cultures were transferred to the stage of a Nikon Eclipse Ti−U
inverted microscope equipped with a piezoelectric table (Nano-ZI
Series 500 μm range, Mad City Laboratories), HBO 103 W/2 mercury
short lamp (Osram, Munich, Germany), mirror unit (exciter ﬁlter BP
465−495 nm, dichroic 505 nm, emission ﬁlter BP 515−555), and
electron multiplier CCD camera C9100-13 (Hamamatsu Photonics,
Japan). Images were acquired with an oil-immersion Plan Apo 100×
(1.4 NA, Nikon, Japan) objective at a sampling of 2 Hz with a spatial
resolution of 256 × 256 pixels. All experiments were performed at RT.
Application of 50 mM KCl (5 s), followed by a 2 min washout, was
used to stimulate vesicle exocytosis from the dye-containing terminals,
measured as a ﬂuorescence loss. The imaging system was controlled by
an integrating imaging software package (NIS Element, Nikon, Japan).
Oﬄine analysis was performed on the image sequence with the image-
processing package Fiji.64 After background subtraction, images were
analyzed using rounded ROIs of 4 pixels in diameter drawn on neural
processes. Endocytosed vesicles during FM1-43 loading were
measured by estimating the brightness of the total vesicle pool puncta
(raw ﬂuorescence intensity) in GO-treated and untreated cultures
before the unloading stimulus. The decay time constant, τ, was
measured by pClamp 10.2 software (Molecular Devices LLC, USA).
To avoid imaging nonselective FM staining, only puncta that showed
stimulus-dependent destaining were included in the analyses.
Immunoﬂuorescence Labeling. Hippocampal neurons or glial
cells, treated and untreated, were ﬁxed in PBS containing 4% PFA for
20 min at RT. Cells were permeabilized with 1% Triton X-100 for 30
min, blocked with 5% FBS in PBS for 30 min at RT, and incubated
with primary antibodies for 30 min. The primary antibodies used were
rabbit polyclonal anti-β-tubulin III (Sigma T2200, 1:250 dilution),
mouse monoclonal anti-GFAP (Sigma-Aldrich, 1:500 dilution), and
guinea pig polyclonal antivesicular glutamate transporter (Millipore
AB5905, dilution 1:2000). After the primary incubation and PBS
washes, neurons were incubated for 30 min with the secondary
antibodies AlexaFluor 594 goat anti-rabbit (Invitrogen, dilution
1:500), AlexaFluor 488 goat anti-mouse (Invitrogen, dilution 1:500),
AlexaFluor 488 goat anti-guinea pig (Invitrogen, dilution 1:500), and
DAPI (Invitrogen, dilution 1:200) to stain the nuclei. Samples were
mounted in Vectashield (Vector Laboratories) on 1 mm thick
coverslips. Cell densities were quantiﬁed at 20× (0.5 NA)
magniﬁcation using a DM6000 Leica microscope (Leica Microsystems
GmbH, Wetzlar, Germany), with random sampling of seven to ten
ﬁelds (713 × 532 μm; control and treated, n = 3 culture series). For
VGLUT1-positive terminals, image acquisition was performed using a
confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany)
with 63× (1.4 NA) magniﬁcation (Z-stacks were acquired every 300
nm; 12 ﬁelds for control and untreated conditions). Oﬄine analysis
was performed using Volocity software (Volocity 3D image analysis
software, PerkinElmer, USA). For each set of experiments, the images
were acquired using identical exposure settings. The ROIs for the
quantiﬁcation were blindly chosen using the tubulin channel. For each
analyzed ﬁeld, we used the Z-stacks to quantify VGLUT1 puncta as 3D
objects. The resulting numbers were normalized to the relative cellular
volume calculated on the basis of β-tubulin III labeling.
Micovesicle Isolation and Characterization. Microvesicle
shedding was induced in 21 DIV conﬂuent glial cells (after washing
in PBS, 37 °C) upon exposure to benzoyl-ATP (bzATP; 100 μM) in
Krebs−Ringer solution with the following composition: 125 mM
NaCl, 5 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 2 mM CaCl2, 6
mM D-glucose, and 25 mM HEPES/NaOH (pH adjusted to 7.4), for
30 min at 37 °C and 5% CO2.
39 MVs were pelleted by centrifugation
as described in Bianco et al.39 Negative controls were incubated with
Krebs−Ringer solution without the presence of bzATP. MVs isolated
from conﬂuent mixed glial cells were resuspended in lysis buﬀer (50
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.1% SDS),
sonicated 3 × 10 s, and then boiled at 95 °C for 5 min. Samples were
run on a 10% polyacrylamide gel and were blotted onto nitrocellulose
ﬁlters (Millipore, Italy). Filters were then blocked in PBS-Tween-20
(0.1%) plus 5% nonfat dry milk and incubated with the primary
antibody antiﬂotillin-1 (dilution 1:1000) for 16 h at 4 °C. Speciﬁc MV
marker ﬂotillin-140,41 was detected with mouse monoclonal anti-
ﬂotillin-1 (dilution 1:1000). After three washes with PBS-Tween,
ﬁlters were incubated with peroxidase-conjugated anti-mouse secon-
dary antibody (dilution 1:1000). Optical density of immunolabeled
ECL-exposed protein bands was measured with UVI-1D software.
For the AFM characterization, MVs were diluted 1:10 in PBS buﬀer
solution and processed as described in Junker et al.65 Brieﬂy, a 15 μL
drop of sample solution was placed and left to adsorb (15 min) onto a
freshly peeled mica substrate, thereafter rinsed with PBS. In order to
reduce vesicle collapsing during AFM analysis, vesicles were ﬁxed with
1% formaldehyde for 1 h (RT). MVs were then washed with PBS and
dried under a gentle stream of nitrogen. AFM was used in semicontact
mode at RT in air using a commercial instrument (Solver Pro, NT-
MDT, RU). Silicon tips (NSC36/CR-AU, MikroMash, USA) with a
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typical force constant of 0.6 nN/nm and a resonance frequency of
about 65 kHz were employed. Topographic height and phase images
were recorded at 512 × 512 pixels at a scan rate of 0.5 Hz. Image
processing was performed using Gwyddion freeware AFM analysis
software, version 2.40.66 For statistical analysis, 107 individual MVs
were imaged in seven diﬀerent ﬁelds and measured. In particular,
width and height of each vesicle were evaluated from cross-line
proﬁles, and results were statistically analyzed using Igor Pro software
(Wavemetrics. USA).
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(17) Leoń, V.; Rodriguez, A. M.; Prieto, P.; Prato, M.; Vaźquez, E.
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Abstract 
Graphene-based nanomaterials represent potential tools in neuro-repair and are 
increasingly engineered as components of a variety of applications such as biosensors, 
interfaces or drug-delivery platforms. These developments necessitates addressing how this 
material affects biological systems and in particular, the interactions of 2D planar graphene 
with the neuronal tissue in physiological environment. In hippocampal cultures, we 
recently reported the ability of graphene oxide nano-sheets to interfere specifically with 
synapses, hampering excitatory neuro-transmission, and to alter glia reactivity, without 
affecting the viability of brain cells. Graphene oxide ability to specifically tune synapses 
might pose the basis for its exploitation in target applications in neuropharmacology. 
However, the potential neuroglia reactivity raises concerns from a toxicity point of view. 
To tailor graphene oxide nano-flakes safe developments, we need to model in vitro glial 
cell responses, and in particular the reactivity of microglia, a sub-population of neuroglia 
that acts as the first active immune response, when challenged by chronic graphene oxide 
nano-flakes delivery at high doses. Here, we investigated the tissue reactivity upon long-
term exposure to graphene oxide nano-sheets in 3D tissue models. We used the mouse 
organotypic spinal cord cultures, ideally suited for studying long-term interference with 
cues delivered at controlled times and concentrations. In cultured spinal segments, the 
normal presence, distribution and maturation of anatomically distinct classes of neurons 
and resident neuroglial cells are preserved. Organotypic explants were developed for two 
weeks embedded in fibrin glue alone or presenting graphene oxide nano-sheets at 10, 25 
and 50 µg/mL. We addressed the impact of such treatments on premotor synaptic activity 
monitored by patch clamp recordings of ventral interneurons. We investigated by 
immunofluorescence and confocal microscopy the accompanying glial responses upon 
graphene oxide exposure, focusing on resident microglia, tested in organotypic spinal slices 
and in isolated neuroglia cultures. In the latter condition, we further tested the role of 
microglial micro-vesicle release in mediating cell responses to graphene oxide nano-sheets.  
1. Introduction 
Graphene is a honeycomb lattice structure consisting of sp2 hybridized carbon atoms 
(Sanchez et al., 2012; Kostarelos and Novoselov, 2014), characterized by high mechanical 
strength and electrical conductivity, combined with optical transparency. In neurobiology, 
graphene has been used in surface engineering of regenerative scaffolds to control the 
neuro-induction of stem cells (Wang et al., 2012), and in that of neurological interfaces to 
improve the electrodes performance (Li et al., 2013; Kostarelos and Novoselov, 2014; Mao 
et al., 2013; Wang et al., 2011).  
Graphene oxide (GO) is the most common derivative of graphene. Recently, GO materials 
have been successfully designed for drug delivery applications (Baldrighi et al., 2016). 
However, their potential persistency in biological tissues requires investigating their safety. 
We have previously (Rauti et al., 2016) reported the ability of small GO (<100 nm; s-GO) 
nano-sheets to reduce synaptic activity at glutamatergic synapses without affecting cultured 
hippocampal neurons survival. To date, only few studies addressed the interaction between 
s-GO nanosheets and synapses (Rauti et al., 2016; Bramini et al., 2016), while there are 
scarcely any data on the interactions between neural circuit function, s-GO tissue 
accumulation and inflammation. Before any further exploitation of s-GO in synaptic 
targeting, a detailed analysis of tissue responses to s-GO exposure is needed. Mechanistic 
studies of the interplay between s-GOs, the activation of microglia and synaptic function, 
may require in vitro models to test central nervous system (CNS) responses at cellular 
resolution. Organotypic slices are explant cultures that preserve key, structural elements of 
the tissue of origin (Medelin et al., 2016; Furlan et al., 2007; Avossa et al., 2003, 2006; 
Schermer and Humpel, 2002; Tscherter et al., 2001; Fischer et al., 1998; Hailer et al., 1996) 
allowing detailed studies of cellular and subcellular responses, such as inflammatory 
reactivity and synaptic efficacy, upon chronic treatments, including the exposure to 
exogenous factors. In the CNS, the immune response is mediated by resident macrophages 
called microglia that are approximately 12 % of the total CNS cells originating from 
myeloid cells. This subpopulation of brain cells can switch between two different 
phenotypes: a ramified phenotype, typical of the resting/surveillant state, during which they 
“monitor” the surrounding environment (Nimmerjahn et al., 2005; Davalos et al., 2005; 
Cherry et al., 2014) and an amoeboid phenotype, which is induced by antigens-mediated 
stimulation. When activated, microglia rapidly changes its surface receptor expression and 
the production of molecules involved in the immune response, like cytokines and 
chemokines (Nimmerjahn et al., 2005; Fetler and Amigorena, 2005); activated microglia 
may represent an active player in neuron damage (Block et al., 2007). We used here mouse 
spinal organotypic cultures to mimic a chronic accumulation of s-GO in the spinal cord 
tissue. The s-GO nano-flakes were delivered to the spinal tissue upon dilution in the 
chicken plasma used to embed the explants for culturing, thus allowing s-GO to rapidly 
adsorb proteins (Bertrand et al., 2017), such a condition may mimic how nanosheets 
behave in a complex biological milieu. We patch-clamp ventral interneurons to monitor 
synaptic transmission. Contextually, by confocal microscopy we explored the effects of s-
GO on innate immunity, in both organotypic slices and primary isolated microglial 
cultures. We conclude that chronic accumulation of s-GOs, due to delivery of high doses of 
the materials, significantly affected synaptic activity with a clear involvement of the 
microglia cell population. Our experiments in isolated microglia cells in culture support the 
direct activation by s-GO of immune responses in these experimental conditions. 
 
2. Material and Methods 
2.1 Preparation of spinal tissue slices and primary glial cultures 
Organotypic cultures were obtained from spinal cords isolated from E12 embryonic mouse 
(C57Bl), as previously described (Avossa et al., 2003; Furlan et al., 2007; Furlan et al., 
2005; Usmani et al., 2016). Briefly, pregnant mice were sacrificed by CO2 overdose and 
decapitation and fetuses delivered by caesarean section. Isolated fetuses were decapitated 
and their backs were isolated from low thoracic and high lumbar regions and transversely 
sliced (275 µm) with a tissue chopper. Cultures were fixed on a glass coverslip (Kindler, 
EU) with fibrin glue, i.e. reconstituted chicken plasma (Rockland) clotted with thrombin 
(Merk). In graphene-treated cultures, s-GO (Rauti et al., 2016) nanosheets were embedded 
in the fibrin glue at 10, 25 and 50 µg/mL final concentration. Experiments were performed 
on control and s-GO treated cultures after 2 and 3 weeks in vitro.  
All experiments were performed in accordance with the EU guidelines (2010/63/UE) and 
Italian law (decree 26/14) and were approved by the local authority veterinary service and 
by our institution (SISSA-ISAS) ethical committee. All efforts were made to minimize 
animal suffering and to reduce the number of animal used. Animal use was approved by the 
Italian Ministry of Health, in agreement with the EU Recommendation 2007/526/CE.  
Primary brain glial cultures were obtained from P2−P3 rats (Wistar) cortices, as previously 
described (Calegari et al., 1999; Rauti et al., 2016). Dissociated cells were plated into 
plastic 75 cm2 flasks, incubated (37 °C; 5% CO2) in culture medium consisting of DMEM 
(Invitrogen), supplemented with 10% FBS, 100 IU/ mL penicillin, and 10 mg/mL 
streptomycin.  
Confluent mixed glial cultures from days in vitro (DIV) 21 to DIV 25 were treated with a 
trypsin solution (0.25% trypsin, 1 mM EDTA in HBSS) diluted 1:4 in PBS for 30 minutes 
at 37 °C and 5% CO2. The medium was then collected and diluted 1:4 in DMEM 
supplemented with 10% FBS and centrifuged for 5 minutes at 200 x g. The pellet was then 
re-suspended in DMEM supplemented with 10% FBS and mixed glial cultures conditioned 
medium (50:50) and plated on poly-L-lysine-coated glass coverslips. Twenty-four hours 
after trypsinization half of the cultures were incubated with s-GO at a concentration of 10 
µg/mL suspended in the culture medium for 1 or 5 days. 
 
 
2.2 Electrophysiological Recordings 
For patch-clamp recordings (whole-cell, voltage clamp mode), a coverslip with the spinal 
culture was positioned in a recording chamber, mounted on an inverted microscope 
(Eclipse TE-200, Nikon, Japan) and superfused with control physiological saline solution 
containing (in mM): 152 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and 10 Glucose. The 
pH was adjusted to 7.4 with NaOH (osmolarity 305 mosmol L-1). Cells were patched with 
glass pipettes (4-7 MΩ) filled with a solution of the following composition (in mM): 120 
Kgluconate, 20 KCl, 10 HEPES, 10 EGTA, 2 MgCl2 and Na2ATP. The pH was adjusted to 
7.3 with KOH (295 mosmol L-1). All electrophysiological recordings were performed at 
room temperature (RT; 20-22 °C) and the spontaneous synaptic activity was recorded by 
clamping the membrane voltage at –56 mV (not corrected for liquid junction potential, 
which was –14 mV). Recordings were performed from ventrally located spinal 
interneurons identified on the basis of previously reported criteria (Ballerini and Galante, 
1998; Ballerini et al., 1999; Galante et al., 2000). We detected no differences between 
controls (n = 45) and s-GO (n = 39) neurons in cell membrane capacitance (70 ± 8 pF 
controls, 68 ± 6 pF s-GO) and membrane input resistance (250 ± 28 MΩ controls, 242 ± 20 
MΩ s-GO). Spontaneous activity was also recorded in the presence of 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX, 10 µM), bicuculline (20 µM) and strychnine (10 µM) 
to pharmacologically discriminate between glutamatergic and GABAergic PSCs, 
respectively. To detect miniature post-synaptic currents (mPSCs), TTX (1 µM; Latoxan, 
Valence, France) was added. All reagents were purchased from Sigma-Aldrich, if not 
otherwise indicated. Data were collected by Multiclamp 700B patch amplifier (Axon CNS, 
Molecular Devices) and digitized at 10 kHz with the pClamp 10.2 software (Molecular 
Devices LLC, USA).  All recorded events were analyzed offline with the AxoGraph 1.4.4 
(Axon Instrument) event detection software (Axon CNS, Molecular Devices). 
2.3 Immunofluorescence Labeling of spinal-cord slices  
Organotypic cultures were fixed by 4% formaldehyde (prepared from fresh 
paraformaldehyde; Sigma) in PBS for 1 hour at RT and then washed in PBS. Free aldehyde 
groups were quenched in 0.1 M glycine in PBS for 5 min. The samples were blocked and 
permeabilized in 3 % fetal bovine serum (FBS), 3 % BSA and 0.3 % Triton-X 100 in PBS 
for 1 h at RT. Samples were incubated with primary antibodies (mouse anti-neurofilament 
H Smi 32, Biolegend, 1:250 dilution; mouse monoclonal anti-GFAP, Invitrogen, 1:500 
dilution; rabbit monoclonal anti-caspase 3, Euroclone, 1: 200 dilution; rabbit polyclonal 
anti-β-tubulin III, Sigma-Aldrich, 1:250 dilution; rabbit anti Iba1, Wako, 1:250 dilution) 
diluted in PBS with 5 % FBS at 4 °C, overnight. Samples were then incubated in secondary 
antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 goat anti-
rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to stain the 
nuclei, for 2 h at RT and finally mounted on 1 mm glass coverslips using Vectashield 
hardset mounting medium (Vector Laboratories). Images were acquired using a Nikon C2 
Confocal, equipped with Ar/Kr, He/Ne and UV lasers. Images were acquired with a 40× 
(1.4 NA) oil-objective (using oil mounting medium, 1.515 refractive index). Confocal 
sections were acquired every 500 nm and the total Z-stack thickness (50 µm) was set such 
that all emitted fluorescence was collected from the sample. Regions of interest were 
confined to the ventral part of slice. Offline analysis was performed using the open source 
image-processing package Fiji (Schindelin et al., 2012) and Volocity software (Volocity 
3D image analysis software, PerkinElmer, USA).  
2.4 Immunofluorescence Labeling of neuroglia primary cultures 
Primary glial and microglial cultures were fixed with by 4 % formaldehyde (prepared from 
fresh paraformaldehyde) in PBS for 20 min at RT and then washed in PBS. Free aldehyde 
groups were quenched in 0.1 M glycine in PBS for 5 min. The samples were blocked and 
permeabilized in 5 % fetal bovine serum (FBS), 0.3 % Triton-X 100 in PBS for 30 min at 
RT. Samples were incubated with primary antibodies (mouse monoclonal anti-GFAP, 
Invitrogen, 1:500 dilution; rabbit anti Iba1, Wako, 1:250 dilution; mouse monoclonal anti-
Brdu, Thermo Fisher, 1:200 dilution) diluted in PBS with 5 % FBS at 4 °C, overnight. 
Samples were then incubated in secondary antibodies (Alexa 488 goat anti-mouse, 
Invitrogen, 1:500 dilution; Alexa 594 goat anti-rabbit, Invitrogen, 1:500 dilution), and 
DAPI (Invitrogen, dilution 1:200) to stain the nuclei, for 45 minutes at RT and finally 
mounted on 1 mm thick glass coverslips using Vectashield mounting medium (Vector 
Laboratories). Cells densities were quantified at 20× (0.5 NA) magnification using a 
DM6000 Leica microscope (Leica Microsystems GmbH, Wetzlar, Germany). In order to 
investigate the internalization of s-GO in microglial cells, we used the reflection mode 
property during the confocal acquisition. Images were acquired using a Nikon C2 
Confocal, equipped with Ar/Kr, He/Ne and UV lasers. Images were acquired with a 40× 
(1.4 NA) oil-objective (using oil mounting medium, 1.515 refractive index). Confocal 
sections were acquired every 200 nm and the total Z-stack thickness 20µm. 
2.5 Bromodeoxyuridine (BrdU) Incorporation 
Microglial primary cultures were incubated with BrdU (Thermo Fisher) diluted in the 
culture medium at a final concentration of 10 µM for 24 hours. Cells were then washed 
with PBS and fixed by 4 % formaldehyde (prepared from fresh paraformaldehyde) for 20 
minutes at RT and then washed with PBS (3 times, 2 minutes each). Free aldehyde groups 
were quenched in 0.1 M glycine in PBS for 5 min. Cells were then incubated with HCl 1 M 
for 1 minutes on ice and with HCl 2 M for 15 minutes at 37 °C. Acid was then neutralized 
with boric acid 0.1 M for 10 minutes at RT. The samples were then blocked and 
permeabilized in 3 % fetal bovine serum (FBS) and 0.3 % Triton-X 100 in PBS for 1h at 
RT. Samples were incubated with primary antibodies at 4 °C overnight (mouse monoclonal 
anti-BrdU, 1:200 dilution; rabbit anti-Iba1, 1:200 dilution). Samples were then incubated in 
secondary antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 594 
goat anti-rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to stain 
the nuclei, for 45 minutes at RT and mounted on 1 mm thick glass coverslips using 
Vectashield mounting medium (Vector Laboratories). 
2.6 Microvesicles Isolation 
Microvesicles shedding and detection by western blotting were performed as previously 
described (Rauti et al., 2016).  The microvesicles release was induced in 21 DIV microglial 
cells by the stimulation with benzoyl-ATP (bzATP; 100 μM) in saline solution with the 
following composition: 125 mM NaCl, 5 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, 2 
mM CaCl2, 6 mM D-glucose, and 25 mM HEPES/NaOH (pH adjusted to 7.4), for 30 min 
at 37 °C and 5% CO2. Microvesicles were then pelleted by centrifugation (Bianco et al., 
2009). Negative controls were incubated with saline solution without the presence of 
bzATP. MVs were re-suspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 
% NP40, 0.1 % SDS), sonicated 3 × 10 s, and then boiled at 95 °C for 5 min. Samples were 
run on a 10 % polyacrylamide gel and were blotted onto nitrocellulose filters (Millipore, 
Italy). Filters were then blocked in PBS-Tween-20 (0.1 %) plus 5 % nonfat dry milk and 
incubated with the primary antibody antiflotillin-1 (dilution 1:1000) for 16 h at 4 °C. 
Specific MV marker flotillin-1 (Al-Nedawi et al., 2008; Del Conde et al., 2005) was 
detected with mouse monoclonal antiflotillin-1 (dilution 1:1000). After three washes with 
PBS-Tween, filters were incubated with peroxidase-conjugated anti-mouse secondary 
antibody (dilution 1:1000). Optical density of immunolabeled ECL-exposed protein bands 
was measured with UVI-1D software. 
2.7 Microglial morphological analysis 
For morphological analysis cells were fixed and immunostained for Iba1 and DAPI for 
nuclei, as described above and images were acquired with a 40 × oil objective. The 
quantitative analysis of cell morphology was performed with the particle analysis feature in 
Fiji (1.51v) to automatically measure the area, perimeter and Feret’s maximum diameter. In 
particular, Feret’s diameter is described as the greatest distance between any two points 
along cell perimeter and is considered as an index of cell length. A more ramified cell has a 
higher value for this parameter, while a more amoeboid shape is described by a lower 
value. 
2.8 Measurement of cytokines and chemokines 
Inflammatory reaction may be detected by cytokine and chemokine production. A panel of 
12 out of cytokines or chemokines was measured in organotypic culture supernatants after 
2 weeks culturing, by Luminex based technology, using a customized Procarta plex 
Immunoassy kit (Invitrogen), following the manufacturer’s protocol. The following soluble 
factors were simultaneously measured in 50 µl of supernatant: Il4, IL6, IL10, IL17, IL21, 
BAFF, IFNγ, TNFα, CXCL1, CXCL2, CXCL10, MCP1. 
2.9 Statistical Analysis 
The results are presented as the mean ± SD, if not otherwise indicated. A statistically 
significant difference between two data sets was assessed by Student’s t-test (after 
checking variances homogeneity by Leven’s test) for parametric data and by Mann-
Whitney’s test for non-parametric ones. P < 0.05 was considered at a statistically 
significant.  
 
3. Results 
3.1 Long Term Exposure to High Doses of s-GO Impaired Network Activity in Spinal-
Cord Organotypic Slices  
We first explored the long-term (2 weeks) exposure of neural tissue to s-GO in 3D tissue 
cultures. s-GO was delivered to the neural tissue via the plasma clot that constitutes the 
explant growth environment. Figure 1A shows a reconstruction at low confocal 
magnification of a spinal cord slice after 14 days of growth, labelled for neurofilament H 
(Smi-32; in green) and for the nuclei (DAPI, in blue). The entire area of tissue growth is 
visualized, and it includes the spinal slice, at the centre, and the outgrowing area 
comprising the co-cultured dorsal root ganglia (DRG) and the typical, dense mesh of 
neurites in the surrounding outgrowth belt (Fabbro et al., 2012).  
Spinal organotypic slices upon 2 weeks of culturing exhibit an intense spontaneous 
synaptic activity (Streit, 1993; Ballerini and Galante, 1998; Furlan et al., 2007). We patch-
clamped (sketched in Figure 1B) visually identified ventral interneurons (at holding 
potential, Vh of –56 mV) in control cultures (n = 45) and in s-GO treated ones (n = 52), and 
we recorded spontaneous, basal postsynaptic currents (PSCs). Figure 1C shows 
representative tracings in control (left) and after exposure to the higher dose (50 µg/mL) of 
s-GO (right). In all culture groups, PSCs appeared as heterogeneous inward currents of 
variable amplitudes, characterized by different kinetic properties (fast decaying, with decay 
time constant () of 6 ± 2 ms and slow decaying with  22 ± 6, n = 15, see sample in Figure 
1C insets; Medelin et al., 2018).  
The chronic (2 weeks) exposure to low (10 µg/mL) s-GO doses did not affect PSCs 
amplitude and frequency values (39 ± 7 pA and 23 ± 5 Hz, n = 13) when compared to 
control ones (42 ± 6 pA and 24 ± 4 Hz, n = 15; plots in Figure 1D).  
Conversely, higher s-GO doses significantly (25 and 50 µg/mL, P < 0.05 and P < 0.01, 
respectively; Student’s t test) reduced PSCs frequency (from 24 ± 6 Hz in control to 14 ± 3 
Hz, in s-GO 25 µg/mL, n = 15 and 13; from control 22 ± 8 Hz to 10 ± 2 Hz in s-GO 50 
µg/mL, n = 15 and 13). PSCs decay kinetics (fast decaying,  5 ± 2 ms and slow decaying  
26 ± 3, n = 13 at 50 µg/mL, see sample Figure 1C inset) and amplitudes were not altered by 
these treatments (Figure 1D). In 25 and 50 µg/mL s-GO treated cultures we investigated 
the amount of neuronal apoptosis in respect to aged-matched controls by measuring the 
expression of active caspase-3 (Cohen, 1997). Active caspase-3 positive cells were 
quantified in the ventral spinal horns (Figure 1E). We detected a comparative amount of 
apoptotic cells in all conditions (in control: 15 ± 3 Caspase-3 positive cells/mm2 namely 
3.7 % of the total amount of cells, n = 10 visual fields and in s-GO 50 µg/mL; 20 ± 3 
Caspase-3 positive cells/mm2, 4.3 % of the cells, n = 10 visual fields; plot in Figure 1E). 
Thus, s-GO only when delivered at higher concentrations altered synapse function, 
apparently without increasing neuronal cell death. 
Miniature synaptic currents (mPSCs; Figure 2) were recorded in a subset of control (n = 
12) and s-GO treated (n = 13) neurons by application of tetrodotoxin (TTX, 1 µM), to 
block voltage-gated sodium channels. As this treatment impairs the generation of action 
potentials, mPSCs reflect the stochastic release of vesicles from the presynaptic terminals 
at individual synapses impinging onto the recorded neuron: their frequency depends on the 
pre-synaptic release probability and on the number of synaptic contacts, while their 
amplitude depends on postsynaptic receptor sensitivity  
(Raastad et al., 1992). In neurons exposed to low (10 µg/mL) s-GO, mPSCs frequency was 
not affected (from 19 ± 3 Hz in control to 15 ± 3 Hz in s-GO treated slices; plot in Figure 
2). When investigating the impact of higher graphene doses (25 and 50 µg/mL), we 
detected a significant difference (P < 0.05 and P < 0.01, respectively; Student’s t test) in 
mPSCs frequency (from 20 ± 3 Hz to 13 ± 2 Hz in s-GO 25µg/mL and from 16 ± 3 Hz to 6 
± 1 Hz in s-GO 50 µg/mL). s-GO did not affect the amplitude of the recorded events (from 
27 ± 6 pA in controls to 32 ± 5 pA in s-GO 10 µg/mL; from 29 ± 5 pA in controls to 27 ± 4 
pA in s-GO 25 µg/mL; from 33 ± 8 pA in controls to 30 ± 6 pA in s-GO 50 µg/mL).  
In s-GO neurons (50 µg/mL) we pharmacologically (see Methods) isolated AMPA-
receptor mediated glutamatergic mEPSCs (n = 13) and GABAA- receptor mediated 
mIPSCs (n = 13), both detected as inward currents in our recording conditions (Medelin et 
al., 2016). mEPSCs and mIPSCs frequency values were similarly reduced by s-GO when 
compared to control slices (for mEPSPs in controls 14 ± 4 Hz, n = 12; in s-GO 7 ± 2 Hz, n 
= 13; P < 0.05, Student’s t test; histograms in Figure 2, bottom-left panel; for mIPSCs in 
controls 13 ± 4 Hz, n = 12; in s-GO 5 ± 2 Hz, n = 13; P < 0.05, Student’s t test; histograms 
in Figure 2, bottom-right panel).  
3.2 s-GO Exposure at High Doses Induced Microglial Proliferation 
To investigate tissue reactivity accompanying s-GO ability to alter synaptic signalling, 
we used the highest dose tested, namely the s-GO at 50 µg/mL. In organotypic slice 
cultures, neuroglia resident cells are mainly represented by astrocytes (GFAP positive 
cells) and microglia (Iba1 positive cells; Medelin et al., 2018).  
GFAP-positive astrocytes are not immune cells per se, but can, under certain conditions, 
contribute to the immune response (Farina et al., 2007). In organotypic cultures upon 2 
weeks of culturing, these cells are usually characterized by a stellate-like morphology 
(Figure 3A; Avossa et al., 2003) and their density was not significantly altered by s-GO 
treatment (Figure 3A, right histograms; 500 ± 70 GFAP-positive cells/mm2 in control 
and 650 ± 90 GFAP-positive cells in s-GO; n = 13 visual fields each).  
Iba1-positive microglia cells are known mediators of CNS inflammation. In contrast to 
astrocytes, the density of Iba1-positive cells was significantly (P < 0.01, Student’s t test) 
increased in slices exposed to s-GO (47 ± 17 Iba1-positive cells/mm2, n = 10 fields in 
control and 150 ± 30 Iba1-positive cells/mm2, n = 11 fields for s-GO; Figure 3B).  
To further investigate glia cell activation in reaction to s-GO treatment in complex systems, 
we measured from the spinal cord cultures supernatant (n = 6 for each condition) the 
presence of cytokine and chemokine, after 2 weeks in-vitro. s-GO induced an increased 
expression, when compared to controls, of CXCL2, and MCP1, T lymphocytes and 
monocytes recall factors, and IL6, IL10, BAFF and TNFα, cytokines responsible for pro-
inflammatory responses (IL6, TNF), regulatory function (IL10) and homeostatic B cell 
survival (BAFF), however the profiles of soluble factors production obtained from our 
analysis, did not reach statistical significance (Figure 3C). These observations are in line 
with a partial activation of microglial cells toward both polarized forms: M1 and M2, or 
most probably toward an intermediate one (Kabba et al., 2017).  
3.3 s-GO Exposure Induces Microglial Proliferation in Neuroglial Cultures 
The presence of several signatures of microglial cell activation after 2 weeks exposure to 
high s-GO dose, prompt us to directly investigate the effects of s-GO on microglial cell 
types in isolated glial preparations. Due to the relatively low-cell density typical of cultures 
comprising isolated Iba1-positive cells, as shown in Figure 4A (control), we exposed the 
cells for 5 days to a lower (10 µg/mL) dose of s-GO. s-GO readily increased Iba1-positive 
cell-density, as shown in Figure 4A, a response reminiscent of the one observed in 
organotypic slices (Figure 3B). In order to assess whether s-GO flakes induced microglia 
activation, we analysed the cellular shape, a traditionally accepted index of the phenotypes 
microglia acquires when entrained in cytotoxic responses. In particular, a highly ramified 
shape is linked to a quiescent state in which microglia actively monitors the surrounding 
environment. On the other hand, an amoeboid phenotype reveals the transition to the 
activated, pro-inflammatory state (Saijo and Glass, 2011). Consistent with a transformation 
from a ramified to an amoeboid phenotype, the Feret’s maximum diameter (plot in Figure 
4B) significantly decreased (P < 0.05, Student’s t test) after 6 days of s-GO exposure 
(meanGO = 47.03 ± 2.20; n = 42 cells), compared to control (meancontrol = 55.43 ± 2.25; n = 
46 cells) (n = 6 visual fields for both conditions; 3 different cultures series). This suggested 
that the exposure to s-GO caused an activation of microglial cells.  
Next we analysed the number of cycling cells present in each culture group (control and s-
GO). For this purpose, cells were pulsed at 24 h and at 5 days with 10 mM 
bromodeoxyuridine (BrdU) prior to fixation. The number of cells that had incorporated the 
nucleotide analogue was then assessed by immunofluorescence, using anti-BrdU-specific 
antibodies. In Figure 4C the box plot shows the BrdU+/Iba1+ ratio, an index of microglial 
cells that incorporated BrdU in the newly synthesized DNA during cell division, providing 
a quantitative measure of proliferative capacity of cells (Nowakowski et al., 1989). The 
higher BrdU+/Iba1+ ratio was already significant at 24 hours of s-GO exposure (medianGO= 
0.85; mediancontrol=0.08), suggesting an early interaction of microglia with small graphene 
flakes. The increased proliferation was more pronounced after five days of incubation with 
s-GO (medianGO= 0.2; mediancontrol=0.45; P < 0.001, Mann-Whitney test, for both time 
points; n=10 fields for each condition; 4 different cultures). 
Microvesicles (MVs), released from almost all cell brain types, are, in general, an emerging 
intercellular communication over long-range distance. In particular, MVs discharged by 
microglial cells represent a secretory pathway for inflammatory cytokine (Antonucci et al, 
2012) potentially promoting propagation of neuroinflammatory responses in the brain. We 
measured the release of MVs from isolated microglial cultures in control or exposed to s-
GO by western blot analysis for the protein flotillin-1, a marker of lipid rafts that are 
specific plasma membrane regions were the probability of MVs release is higher (Figure 
4D; Rauti et al., 2016). Pharmacological stimulation by bzATP induces only a slight 
release of MVs in isolated microglial cells, as depicted by the particularly weak signal in 
the specific band (Figure 4D).  Interestingly, bzATP stimulation in the presence of s-GO 
triggers a massive microglia shedding of MVs, shown by the high intensity of the band 
(Figure 4D).  
3.4 Localization of s-GO in microglial cells 
By confocal microscopy reconstructions, we directly investigated the fate of s-GO in 
isolated microglia cultures. Iba1-positive cells (2 different culture series) were exposed for 
3 days to s-GO (10 µg/mL). We tested the presence of s-GO flakes within Iba1 positive 
cells by operating the confocal microscopy under reflection mode. Figure 5A shows 
confocal reconstructions of control and treated Iba1 positive cells. In s-GO-treated cells, 
graphene flakes aggregates (in yellow, reflection mode) were detected inside microglial 
cells (in grey, Iba1+) by z-stack reconstruction (Figure 5, top panels: 40 ; 100  100 µm2 
visualized area). In Figure 5, high magnification confocal micrographs (control and s-GO 
treated, bottom panels) are shown (60 ; 50  50 µm2 visualized area) depicting a single 
microglia (grey) cell that co-localize with the reflected signal of graphene (yellow). The 
orthogonal view of the z-projection shows the XZ and YZ planes (bottom side and right 
side of the z-stack reconstructed image, respectively) of the acquired fields. As expected 
from cells that work as macrophages, the material were internalized and stocked inside the 
cell, forming small aggregates, appreciable by the orthogonal reconstruction. The signal of 
s-GO was not present in control cells, either in the z-stack reconstruction or in the 
orthogonal planes (Figure 5, left panels). 
 
4. Discussion  
We used here organotypic spinal cord cultures to test tissue responses to s-GO prolonged 
delivery. In particular, we were interested in assessing microglia reactivity in cultured 
neural explants, where immune resident cells are present, but not supported by the 
peripheral ones.  
The major result of the present investigation is that the long-term accumulation of s-GO 
(when delivered at high doses) activates resident microglia and, in the absence of an 
effective clearance, may induce a subtle, although chronic, reactive state, ultimately 
trimming down synaptic activity.  
In our experiments, both GABAR- and AMPAR-mediated mPSCs were reduced in 
frequency upon s-GO exposure at high concentrations. The reduction in miniatures’ 
frequency, but not in their amplitude, strongly suggests a reduction in the number of 
synapses or of release sites (Rauti et al., 2016). This down-regulation of synapses is 
apparently not due to a general cell membrane disruption or to neuronal apoptosis. In fact, 
we never detected alterations in basic electrophysiological parameters, reflecting neuronal 
health and membrane integrity (Carp, 1992; Djuric et al., 2015), indicating, together with 
the absence of up-regulated apoptosis, that the synaptic events diminished not as a 
consequence of direct neuronal damage brought about by s-GO. These findings are in 
accordance with our previous report, where s-GO sized down release sites in hippocampal 
cultures (Rauti et al., 2016). However, in organotypic slices, both glutamate- and GABA-
mediated synapses were down regulated by s-GO, excluding the presence of s-GO 
glutamate synapse-specificity as previously described. The lack of specific synaptic 
targeting may be related to the diverse CNS regions tested, i.e. ventral spinal cord vs 
hippocampus, to the more immature stage of network formation (embryonic vs postnatal) 
or to the s-GO high concentrations and delivery modality used here: in fact, s-GO 
accumulated in the fibrin glue embedding the spinal culture and, presumably, was from 
here released along 2 weeks of culturing. Although we cannot exclude the diverse CNS 
synapse geometries, allowing s-GO to interact with heterogeneous synapses in the spinal 
cord, we favour the hypothesis that the potential formation of a protein corona might have 
affected the nanoparticle biological fate (Bertrand et al., Nat Comm 2017). In addition, the 
presence in the spinal explants of microglia resident cells may result in a tissue reactivity 
that regulates synapses (Kettenmann et al., 2011), an effect that could not be observed 
within the previous experimental settings (Rauti et al., 2016). In fact, active phagocytosis 
restricted to intrinsic microglia, without the involvement of blood cells such as 
macrophages, could have activated these resident cells leading to a generic microglia 
response, known as synaptic stripping, ultimately leading to indiscriminate synapse 
reduction (Kettenmann et al., 2013).  
In spinal organotypic slices exposed to s-GO, the presence of mild tissue reactivity is 
supported by the observed increase in microglia cell-density, in the absence of astrocyte 
reactivity (Olson, 2010; Okada et al., 2018). In addition, although not significantly, the 
cytokines and chemokines profiles measured in organotypic cultures supernatant, were 
found altered after 2 weeks of s-GO exposure. Therefore, in this model, we may 
hypothesize that microglial activation, accompanied by proliferative response and variation 
of CKs production, does not involve a significant shift into the M1 phenotype.  
In support of a direct activation of microglial cells, in response to active s-GO 
phagocytosis, are our results obtained with isolated Iba1+ cells. s-GO boosted microglia 
proliferation leading to a significantly higher cell density in pure neuroglia cultures, 
accompanied by the typical morphological switch from a ramified to an amoeboid 
phenotype (Nimmerjahn et al., 2005; Saijo and Glass, 2011; Cherry et al., 2014), 
suggestive of an active role of Iba1-positive cells in the tissue reaction to graphene, even in 
the virtual absence of other cell types. The direct activation of microglia was apparently 
related to fast internalization of s-GO flake aggregates that occurs during the first 24h after 
the exposure.  
We thus suggest that s-GO, accumulated via the fibrin glue, activates resident microglia 
and phagocytosis. This hypothesis is also supported by the observation that pure microglial 
cultures grown and exposed to s-GO in a serum-free medium did not show a proliferation 
boost comparable to that found in the presence of FBS (Figure S1). As already discussed 
above, the interaction of nanoparticles such as s-GO with biological fluids may affect their 
fate and effectiveness. In fact, the corona formation takes place not only in the presence of 
plasma proteins like fibrinogen but also with proteins present in the serum (Gräfe et al., 
2016). Therefore, activation and proliferation response found in both pure microglial 
cultures and organotypic slices exposed to s-GO, despite their different origin and 
architecture, may be explained by an increase of the efficacy in the uptake of the material 
(Walkey et al., 2012) by microglia and mediated by s-GO interactions with the proteins 
pool of plasma and serum.  
An additional indication of microglia reactivity in s-GO was provided by the increased 
release of shed vesicles induced by bzATP. MVs released by microglia have been reported 
to affect synaptic activity, mainly acting at the presynaptic site of the excitatory synapses, 
but increasing synaptic activity and release in primary cultures (Antonucci et al., 2012) 
thus it seems unfeasible that the down regulation in synapses is due to MVs release.  
We favour the possibility that, in the current experimental conditions, the global reduction 
in synaptic activity accompanies tissue reactivity in general, more than being a specific 
targeting of synapses by s-GO (Rauti et al., 2016). However, we have to ask ourselves 
whether these data indicate a potential in vivo inflammatory response due to s-GO flakes. 
There are several relevant aspects that limit reporting it as an inflammatory response. First 
of all, the conditions we tested involved the delivering of s-GO to a “closed” biological 
system, allowing only resident macrophages to interact with it and limiting the contribution 
of neighbour tissues in the interaction with this material, how it would happen in an in vivo 
model. The lack of significance in the chemokines and cytokines concentration, that 
showed only a trend, suggest a mild immune response that may not necessary lead to a 
pathological inflammatory state or alternatively indicates a return to a physiological 
condition, from an intermediate immune activation. Last, astrocytes, which depend on 
microglia activation to be polarized to  pro-inflammatory cells (Liddelow et al., 2017) did 
not show, in this context, reactive gliosis.   
Microglia produces immune mediators secondary to neuronal stimulation, (i.e. tissue 
injury), or following a direct stimulus to microglia itself. Here we report an increased 
proliferation rate of Iba1-positive cells, suggestive of microglia activation, and consistent 
with morphological observations. However, the detected cell activation seems to involve a 
group of cells, not all of them, and this may explain the fact that we observed only a trend 
toward increased production of immune factors, without significant variations. We may 
hypothesize that the fraction of activated microglia includes cells in direct contact to s-GO. 
Indeed, microglia is often reported to function similarly to other myeloid cells, the 
macrophages, able to scavenge the environment, perform phagocytosis, antigen 
presentation and to react to contact with nano materials (Jin and Yamashita, 2016; 
Aldinucci et al., 2013) in order to maintain CNS homeostasis, with both detrimental and 
beneficial effects. It is important to underline that the pro-inflammatory molecules, 
increased after s-GO contact, were not enhancing astrogliosis. Therefore, as a side effect, 
our in vitro model not only allows the direct observation and study of material/neuron 
interactions in the presence of glial cells, but simulates accumulation of material in CNS 
and the possible consequences.   
 
6. Figures 
Figure 1. In (A) confocal micrograph of a spinal slice culture (14 DIV) immune-labelled 
for the neurofilament H (SMI-32; in green) and the nuclei (DAPI; in blue; scale bar 500 
μm). In (B) sketch of the experimental setting for ventral interneuron recordings. In (C) 
spontaneous synaptic activity recorded from ventral interneurons in Control and s-GO 
treated slices (50 µg/mL). In the inset: isolated fast and slow events are shown 
superimposed (in white averaged tracings). In (D) the plots represent pooled data of 
average PSCs frequency and amplitude values; note the reduction in PSC frequency upon 
s-GO treatments (25 and 50 µg/mL) (* = P < 0.05 and ** = P < 0.01, respectively; 
Student’s t test). In (E) confocal micrographs visualize caspase-3 positive cells (in red), 
counter-stained for β-tubulin III (in green, to visualize neurons) in Control (left) and s-GO 
(50 µg/mL; right) treated slices. Nuclei are visualized by DAPI (blue; scale bar: 50 μm). 
The histograms summarize the density of caspase and β-tubulin double positive cells; note 
the absence of statistical significant differences between the two conditions.       
Figure 2. Sample tracings of mPSCs recorded in Control and s-GO (50 µg/mL) treated 
cultures (left panel). Right panel: plot reporting mPSCs frequency values in control and in 
the three different s-GO concentrations tested. s-GO treatment (25 and 50 µg/mL) 
significantly decreased the frequency of mPSCs (* = P < 0.05 and ** = P < 0.01, 
respectively; Student’s t test). Bottom: histograms summarize the average values of 
AMPA-glutamate (left panel) and GABAA (right panel) receptor mediated mPSCs 
pharmacologically isolated. In s-GO treatments (50 µg/mL) a significant decrease in the 
frequency of both mPSCs was detecetd (* = P < 0.05 and ** = P < 0.01, respectively; 
Student’s t test). 
Figure 3. In (A) immune-labelling of astrocytes in Control and s-GO treated slices (50 
µg/mL). Both cultures were labelled for GFAP (in green) and nuclei (visualized by DAPI; 
in blue; scale bar 100 μm). GFAP+ cell density did not differ between the two conditions 
(right plot). In (B) immunofluorescence images are shown to visualize glial and microglial 
cells in the two different conditions, Control and s-GO (50 µg/mL) treated slices (anti-Iba1, 
in red; anti-GFAP in green; nuclei are visualized by DAPI in blue; scale bar 50 μm). Note 
that Iba1+ cell density was significantly (P < 0.01, Student’s t test) increased by s-GO (50 
µg/mL; right histograms). In (C) In organotypic culture supernatant we detected by 
Milliplex assay the production of the following cytokines: IL6, IL10, TNF and BAFF and 
chemokines: CXCL1, CXCL2, CXCL10 and MCP1 in the presence or absence of s-GO, 
after 2 weeks in vitro. Column graphs report mean values ± SEM of 6 independent 
experiments. We observed a trend toward IL-6, IL10. TNF and BAFF increase in s-GO 
supernatant. 
Figure 4. Cell density analysis (A) of microglial cells in control and s-GO treated 
microglial cultures (10 µg/mL). Both cultures were immunostained for Iba1 (red) to 
visualize microglia. The microglial density is significantly higher in cultures treated with s-
GO (right plot) (P < 0.001, Student’s t test). In (B) high magnification of Iba1+ cells 
highlight the different morphology detected in s-GO treated cultures, the right plot 
summarizes the Ferret’s maximum diameter, an index of cellular ramification, that is 
significantly decreased (P < 0.05, Student’s t-test) after s-GO exposure. 
In (C) box plots show the brdU+/Iba1+ ratio measured in isolated microglial cultures 24h 
and 5 days after s-GO exposure (10 µg/mL) (P < 0.001, Mann-Whitney test, for both 
timepoints) Note the statistical significant differences (P<0.001). In (D) western blot 
analysis for the MVs marker flotillin-1 of each condition. Microvesicles were isolated from 
glial cultures incubated with s-GO (10 µg/mL) for 6 days and then treated or not with 
bzATP.  
Figure 5. Representative confocal reconstructions of microglial cells in Control or treated 
with s-GO (10 µg/mL), scale bar 20 µm. In the bottom panel, for both conditions a 60  
zoom (50  50 µm field) of a single microglial cell (scale bar 20 µm) is shown. Cultures 
are immunostained for Iba1 (in grey), and DAPI (in blue), s-GO is visualized by the 
reflection mode of the confocal system (in yellow). s-GO flakes are visible as aggregates 
coloured in yellow inside the cell. 
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ABSTRACT  
Natural microvesicles (MVs) derived from astrocytes are increasingly considered crucial in 
contributing to intercellular communication, able to actively transfer biological materials 
between neuroglia and neurons. To investigate the features of such glio-signalling requires 
the applications of new tools in generating MVs and in measuring their properties. Here, 
we used small graphene nanoflakes (s-GO) to artificially generate MVs from astrocytes in 
cultures and we compared s-GO generated MVs with those generated by ATP stimulation. 
We used atomic force microscopy, light scattering and spectroscopy to investigated the 
morphological and structural features of MVs produced by means of different stimuli. 
Finally, we set up a functional test to compare the impact of mvG delivery with that of 
mvA on synaptic activity, when neuronal networks are acutely and transiently exposed to 
MVs. Our results indicate a substantial similarity between MVs generated by the two 
different stressors, however by AFM a difference in MV dimensions when vesicles are 
induced by s-GO is detected. Regardless the smaller dimension, acute exposure to MVs of 
both groups alters spontaneous synaptic current frequency, inducing a stable increase in 
network activity. 
 
 
 
 MAIN TEXT 
In biology, newly described forms of intercellular communication 1,2 comprise the release 
of vesicles, named exosomes, from specific cell types, including neuroglia phenotypes such 
as astrocytes. These vesicles store signalling molecules within their cargo or embed them in 
the plasma membrane 3 to modulate relevant processes in the development, physiology and 
pathology of the central nervous system (CNS). Extracellular vesicles comprise shedding 
microvesicles (MVs), exosome and apoptotic bodies, characterized by different size, 
membrane composition, cargo and origin 4,5. 
MVs are nanovesicles able to interact specifically with cells at local or distant sites 6. In 
maintaining CNS functions, glial cells intensely communicate with neurons, also via the 
release of extracellular vesicles, which represents a highly versatile tool to functionally 
impact the CNS 7–9. MVs are considered a mighty “vectorized” signalling system 10 able to 
bind to target cells to transmit their information.  
Graphene oxide (GO) is the most common derivative of graphene. GO properties can be 
tailored to adapt to new physical and biological applications 11 and, more recently, GO 
flakes have been successfully designed for drug delivery applications in biomedicine 12. In 
the CNS, small GO nano-flakes (s-GO) were shown to induce constitutive MVs release 
from cultured astrocytes and to potentiate evoked MVs release induced by bzATP 
applications 13.  
Unarguably, to elucidate MVs properties and in particular to characterize whether the 
ambient conditions used to release and harvest MVs from the same cell type, i.e. astrocytes, 
influence their signalling ability, will impact our understanding of MVs physiology and the 
design of MV-based biomedical applications in the CNS 14,15. Here, we exploited the 
ability of s-GO to substantially increase the production of MVs from astrocytes to provide, 
for the first time, a robust and comparative vesicle characterization by means of ultra 
microscopy and infra-red spectroscopy combined to electrophysiology.  
Astrocytes were isolated from postnatal (2-3 days) rats (Wistar) cortices, as previously 
described 13,16.  We used visually homogenous s-GO dispersions containing s-GO 
nanosheets with lateral dimensions predominantly between 50 – 500 nm 13,17. We treated 
pure glial cell cultures with s-GO (10 μg/mL) for 6−8 days 13. Immunofluorescence 
labelling by antigen against glial-fibrillary acidic protein (GFAP), an intermediate filament 
 protein that is highly specific for cells of the astroglial lineage 18, was used to visualize 
control and s-GO-treated neuroglial cultures (GFAP, in green; Figure 1A). s-GO treatment 
did not impair astrocyte morphology and density when compared with matched control 
cultures (box-plot in Figure 1A; ref). MVs are released into the extracellular space by 
direct budding from the plasma membrane of astrocytes 19. To determine the dynamic of 
MVs release, we measured the presence of changes in membrane trafficking by briefly 
incubating cultures with the fluorescent styryl dye FM1-43 and then quantifying the 
membrane-fluorescence decay to provide a cumulative measure of exocytosis 19.   
FM dyes are fluorescent probes that reversibly stain membranes, and are largely used for 
optical real-time measurements of secretory dynamics 20–22. Incubation with the FM dye (2 
μM, 2 min) resulted in clear surface membrane staining of control and s-GO treated 
cultures, highlighted in Figure 1 B (left panels). Both bright and weak FM-stained plasma 
membrane domains were present along the whole cytoplasmic surface and became visible 
within 2 min treatment (Figure 1B), due to this initial intensity variability all FM de-
staining measures were normalized to the relative time 0 (see Supplementary Methods). 
Once astrocytes’ membranes were labelled by the fluorescent dye FM1-43 we measured 
the plasma membrane de-staining over a fixed time (10 min) in control, in s-GO treated 
cultures or during acute exposure to bzATP (100 μM, 10 min), an agent known to evoke 
massive MVs release 19, also in our culturing conditions 13. Representative fluorescence 
intensity traces are shown in Figure 1C; the dynamic of the fluorescence decay showed a 
faster rate in s-GO and bzATP groups, in respect to controls. This is also visualized by the 
time-lapse images framed at time 0, 300 s and 600 s of the recordings (Figure 1B middle 
and right panels). We quantified the fluorescence decay time constant () values (box plot 
of Figure 1C) and detected shorter decay values in both bzATP and s-GO groups 
(mediancontrol= 219 sec; medianbzATP= 184.2 sec; medians-GO= 163.9 sec). This result 
suggested that the membrane de-staining was actually related to MVs release, as expected 
in bzATP treated cells, more than to other membrane turnover activities. Such a release 
was comparable between bzATP and s-GO, both significantly faster than controls.  
The release of MVs suggested by FM1-43 measures was confirmed by immunoblot 
analysis for the biomarker flotillin-1 23 of the supernatant collected from control and 
treated cultures. As expected 13,19, bzATP stimulation (100 µM, 30 min) and s-GO induced 
 the appearance of a thick band corresponding to flottillin-1 (Figure 1D), a signature of 
MVs release by neuroglia, with a clear synergy between s-GO exposure and 
pharmacological stimulation with bzATP, compared with the other two conditions. In 
control conditions only a weak band was perceived, indicating a poorly detectable MVs 
constitutive release in culture. Atomic force microscopy (AFM) topographic reconstruction 
of re-suspended MVs pellet (Figure 1E) confirmed the presence of MVs detected by the 
immunoblot in both bzATP and s-GO groups. 
We systematically investigated and compared the MVs size distribution. When analyzed by 
AFM (Figure 2A, right), s-GO-derived MVs (mvG) were significantly smaller (n = 72, 
medianmvG= 244 nm) than bzATP-derived ones (mvA; n = 107, medianmvA= 479 nm). 
Conversely, we detected no differences in MVs height values (medianmvG= 19 nm; 
medianmvA= 22 nm). Within each group, the distribution of size values detected was not 
negatively correlated to the height, shown in Figure 2A (left; rmvG= 0.8808 and rmvA= 
0.4039). However, AFM experiments were performed in air, thus a not specific flattening 
of MVs caused by vesicle collapsing might have influenced their measurements. In 
addition, AFM representativeness could have been affected by the reduced size of the 
analyzed samples, given the limited number of MVs collected by this procedure, 
potentially not reflecting the entire population. We enforced large-scale measurement in the 
next set of experiments, by adopting dynamic light scattering (DLS) and nanoparticle 
tracking analysis (NTA) to analyze the entire population of MVs in aqueous suspension. 
NTA tracks single particle Brownian motion, within a dark field microscope, derives mean 
square vesicles velocity and translates them into size distribution 24. DLS analysis showed a 
similar diameter profile for both the populations of MVs (Figure 2B) with a single peak 
located around 140 nm. However, NTA revealed a more complex pattern of size 
distribution (Figure 2C): in the case of mvA we observed three subpopulations of vesicles 
at 115 nm, 235 nm and 400 nm respectively while in the case of mvG we found two 
partially overlapping peaks at 135 nm and 168 nm, plus two distinct peaks at 275 nm and 
385 nm (Figure 2C, left). The diameter analysis revealed a slight, but not significant, 
difference between the two populations with the diameter of mvG smaller and less 
distributed, compared to those of mvA (medianmvA = 235.4; medianmvG = 183.6).  These 
results convincingly suggested a comparable size distribution in both MVs populations and 
 subpopulations, however, we detected a significant difference in the number of vesicles 
released within the same time window (Figure 2C, right), with cultures treated with s-GO 
that produced more MVs when compared to cultures stimulated with bzATP (mvA= 3.32 x 
108 vesicle/mL; mvG= 8.19 x 108 vesicles/mL), consistently with our results obtained by 
MVs release analysis and immunoblot. Regardless the size of the global MVs population, 
s-GO is more efficient in generating MVs from astrocytes. 
Finally, in order to analyse the macromolecular composition of MVs we performed an 
infrared-ATR measurement of the two pools of vesicles isolated with the same protocol of 
differential centrifugation used before. However, to avoid the absorption contribution of 
phosphate groups and sugars, we removed glucose from the buffer solutions and used a 
solution of NaCl (150 mM) for the washing and dilution of MVs. We have not found any 
significant difference between the two condition of release suggesting a similar structural 
composition and cargoes content. Both the absorbance spectra revealed a clear contribution 
of the amide I located at 1650 cm-1 and then of proteins.  Lipids signatures are present in 
traces: the methyl and methylene stretching modes are quite suppress and the carbonyl 
ester of phospholipids is visible at about 1740 cm-1. There are contributions from poly-
sugars as visible from the bands related to C-O-C (1045 cm-1) and C-OH (1178 cm-1), 
probably related to the presence of genetic material. Because of the low concentration of 
sample and the consequent low signal-noise ratio, we were not able to perform second 
derivative analysis of the spectra to better elucidate the nature of protein material present. 
 
In summary, we compared, for the first time, the morphological and structural features of 
MVs produced by means of different stimuli and we documented a substantial similarity 
between mvA and mvG, with the only exception of AFM measures. Yet, besides the bias 
introduced by the small size of the AFM samples, we cannot exclude the influence of 
differences in MVs elastic properties, potentially related to diverse membrane components, 
leading to a variable collapsing of MVs when measured in air.  
 
Finally, we set up a functional test to compare the impact of mvG delivery with that of 
mvA on synaptic activity, when neuronal networks are acutely and transiently exposed to 
MVs. To this aim we isolated cortical neurons and glial cells from postnatal rat cortices and 
 cultured them for 10 days. Figure 3A shows confocal high magnification micrograph of 
cortical cultures where neurons are visualised by labelling Class III β-tubulin (in red), a 
microtubule component expressed exclusively in neurons 25, and astrocytes are visualised 
by GFAP labelling (in green). We patch-clamped visually identified cortical neurons (in 
voltage clamp configuration, holding potential – 70 mV) while a second pipette for the 
local delivery of saline solution was positioned at a distance of 200 μm (under microscopy 
visual control) from the recorded cell (sketched in Figure 3B). We estimated that, at this 
distance, the application of a brief (500 ms) pulse of pressure should result in a local (i.e. 
on the recorded neuron) and transient delivery of standard saline solution alone or 
containing mvG or mvA (re-suspended in saline; see Supporting Information). A typical 
feature of these cultures is the prominent expression of spontaneous synaptic activity, 
represented by heterogeneous postsynaptic currents (PSCs) of variable frequency and 
amplitude (box plots in Figure 3C). Baseline PSCs were recorded before (10 min) and after 
(15 min) the local saline or mvG or mvA ejection. Figure 3D shows representative current 
tracings where standard saline was ejected (light grey, top), or where mvA solution 
(orange, middle) and mvG (black, bottom) were administered. Since spontaneous 
fluctuations in PSCs frequency ≤ 15 % of baseline were frequently detected, we took this 
as threshold value to estimate changes when comparing PSCs before and after pressure 
ejections of saline. In the large majority (n= 16/18; histograms in Figure 3E, left) of 
neurons exposed to saline solution alone, spontaneous PSCs frequency did not change. On 
the contrary, within 5-8 min from the acute mvA and mvG ejections, PSCs frequency was 
stably increased in 64 % (n= 16/25, mvA) and 54 % (13/24, mvG; summarized in the 
histograms of Figure 3E, left) of neurons. The plot in Figure 3E (right) shows the increases 
in PSCs frequency in individual experiments and highlights the variability of such changes 
when administering MVs, with increased frequencies ranging from 20 % to 200 %. Since 
we could not experimentally control the amount of MVs collected by primary astrocytes 
and delivered by pressure ejection (see Methods in Supporting Information), neurons were 
exposed to different amounts of MVs and this can in part explain the detected variability. 
PSCs frequency increases due to MVs exposures were not reversible upon 20 min washout.  
From our functional investigation, gliosignalling generated by ATP or s-GO affected 
similarly neuronal synapses upon transient, direct exposure. This is the first attempt to 
 investigate the effects of MVs generated by astrocytes when locally delivered to neurons. 
Neuroglia extracellular vesicles have been described to provide support on synaptic activity 
26,27, with the majority of studies focused on microglia and inflammation, apparently 
regulating neural transmission at the pre-synaptic level 28,29. Besides inflammatory or 
degenerative contests 30, astrocytes MVs have been proposed to exert neuroprotective 
effects and to support neuronal energy metabolism, however the role of astrocytes or of 
discrete astrocyte populations in delivering different messages via MVs release has yet to 
be elucidated 31.  
 
 
FIGURE CAPTION 
Figure 1. Cultured astrocytes release microvesicles (MVs) upon ATP or s-GO stimulation. 
A. Confocal images are shown to visualize cultured astrocytes in control and after s-GO 
(10 μg/mL; 6 days) treatment; anti-GFAP, in green, and DAPI (to visualize nuclei), in blue; 
scale bar 50 μm. Box plot summarizes the cell density measures, note the similar values in 
both groups. B. Surface membrane staining and activity dependent de-staining of FM1-43 
in cultured astrocytes; scale bar 25 μm. Brighter spots are adherent debris and were 
excluded form the analysis. C. Plot of normalized FM1-43 de-staining traces in control 
astrocytes (light grey), in bzATP treated once (orange) and in s-GO treated once (black). 
Box plot summarizes the decay time constant τ of FM1-43 de-staining in the three 
conditions (mediancontrol = 219.2; medianbzATP = 184.2; medians-GO = 163.9. Thick 
horizontal bars in the box plots indicate median value; boxed area extends from the 25th to 
75th percentiles, whiskers from 2.5th to the 97.5th percentiles. Significance: ** P<0.01 
***P<0.001, Kruskal-Wallis test, Dunn’s post hoc test) D. Western blotting of the pellets 
(top row) and cell lysates (bottom row) for the MV marker flotillin-1. Pellets were obtained 
from the medium of glial cultures treated or untreated with s-GO under two different 
conditions: stimulated and not stimulated (saline) by 100 μM bzATP.  E. AFM topographic 
reconstruction of MVs isolated from cultured primary astrocytes treated with bzATP (100 
μM) and s-GO (10μg/mL) and performed in air (semi-contact mode). Scale bar 500 nm. 
Figure 2. Microvesicle produced by glial cells by bzATP or s-GO exposure characterized 
by ultra-resolution approaches. A. AFM measures of lateral size is plotted against AFM 
 measures of height of MVs isolated from glial cells treated with bzATP (100 μM; mvA; 
orange) or with s-GO (10μg/mL; mvG; black). Right plot illustrate lateral size values 
distribution and median values for both groups, note that mvG lateral size is significantly 
smaller than that of mvA (medianmvA = 479; medianmvA =  244.1. Significance: P>0.001, 
Mann-Whitney test. B. Size distribution of MVs measured by Dynamic Light Scattering 
(DLS). C. Size distribution of MVs measured by nanoparticle tracking analysis (NTA). 
Values of the peaks are expressed in nm. D. Representative ATR-FTIR spectra of MV. 
Values of the peaks are expressed in arbitrary unit of infrared light absorbance.  
Figure 3. Potentiation of PSCs frequency upon local applications of MVs in cortical 
cultures. A. Confocal micrograph visualizing cortical primary cultures at 8 days in vitro; 
anti-class III β-tubulin is used to visualize neurons (in red), anti-GFAP for astrocytes (in 
green) and DAPI (in blue) to visualize neurons. Scale bar 50 μm. B. (A) Sketch of the 
experimental setting for the simultaneous MVs pressure-release (puff) and cell recording 
from cultured neurons. C. Box plot summarizes the PSCs frequency and amplitude values. 
D. Top: diagram of the experimental protocol; bottom: representative tracings of the 
spontaneous synaptic activity detected prior and after puff applications of control saline 
(light grey) or mvA (orange) or mvG (black). E. Histograms of pooled data summarize the 
% of cells displaying PSCs frequency increase in the three conditions. The plot summarizes 
the distribution of the % of increase in PCSs frequency detected within the three groups. 
 
METHODS 
Cell Cultures.  
Primary glial cultures were obtained from cortices isolated from neonatal rats (Wistar) at 
postnatal day 2-3 (P2−P3), as previously described (Calegari et al., 1999; Rauti et al., 
2016). Dissociated cells were plated into plastic 150 cm2 flasks and incubated at 37 °C; 5 
% CO2 in culture medium composed of DMEM (Invitrogen), supplemented with 10 % fetal 
bovine serum (FBS; Thermo Fisher), 100 IU/ mL penicillin, and 10 mg/mL streptomycin.  
Cortical neurons were isolated from from neonatal rats cortices (Wistar) at postnatal day 0-
1 (P0−P1). Dissociated cells were then plated on poly-L-ornithine (Sigma) coated 
coverslips (Kindler, EU) at a concentration of 150000 cells in a volume of 200 μL and 
incubated at 37 °C; 5 % CO2 in a culture medium composed of Neurobasal-A (Thermo 
 Fischer) containing 2% B27 (Gibco), 10 mM Glutamax and 0.5 μM  Gentamycin (Gibco) 
for 8-10 DIV before performing electrophysiological experiments. 
MVs Isolation 
MVs shedding and isolation was performed as previously described (Rauti et al., 2016).  
MVs were collected from 21-24 DIV glial cultures previously treated with graphene oxide 
nanoflakes (s-GO) for 6 days at a concentration of 10 µg/mL or with benzoyl-ATP 
(bzATP; 100 μM) diluited in physiological saline solution with the following composition: 
152 mM NaCl, 4 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES and 10 mM 
Glucose (pH adjusted to 7.4), and left for 30 min at 37 °C and 5 % CO2 before the harvest. 
Negative controls were incubated with physiological solution without the presence of 
bzATP or s-GO. After the incubation period, cell medium was collected and centrifuged 
for 15 min at a speed of 300 x g in order to remove cell debris. Supernatant was then 
collected MVs were pelleted by centrifugation at 300 x g for 15 min and at 20000 x g for 2 
hours. 
Western blot analysis  
MVs were prepared as previously reported , briefly they were re-suspended in lysis buffer 
(50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 % NP40, 0.1 % SDS), sonicated for 30 s, and 
then boiled at 95 °C for 5 min. Samples were run on a 10 % polyacrylamide gel and blotted 
onto nitrocellulose membranes (Millipore, Italy). Membranes were then blocked in PBS-
Tween-20 (0.1 %) plus 5 % nonfat dry milk and incubated with the primary antibody 
antiflotillin-1 (dilution 1:1000) for 16 h at 4 °C. Membranes were then washed with PBS-
Tween and incubated with peroxidase-conjugated anti-mouse secondary antibody (dilution 
1:1000). Detection of immunolabeled ECL-exposed protein bands was measured with 
UVI-1D software. 
Immunofluorescence and confocal microscopy 
Primary glial and cortical neurons cultures were fixed in 4 % formaldehyde (prepared from 
fresh paraformaldehyde) in PBS for 60 min at room temperature (RT) and then washed in 
PBS. Free aldehyde groups were quenched in 0.1 M glycine solution for 5 min. The 
samples were permeabilized in 5 % FBS, 0.3 % Triton-X 100 in PBS for 30 min at RT. 
Samples were then incubated with primary antibodies (mouse monoclonal anti-GFAP, 
Invitrogen, 1:500 dilution; rabbit polyclonal anti-β-tubulin III, Sigma-Aldrich, 1:500 
 dilution) diluted in PBS with 5 % FBS at 4 °C for 1 hours. Samples were then incubated 
with secondary antibodies (Alexa 488 goat anti-mouse, Invitrogen, 1:500 dilution; Alexa 
594 goat anti-rabbit, Invitrogen, 1:500 dilution), and DAPI (Invitrogen, dilution 1:200) to 
stain the nuclei, for 45 minutes at RT and finally mounted on 1 mm thick glass coverslips 
using Fluoromount mounting medium (Sigma-Andrich). Images were acquired using a 
Nikon C2 Confocal, equipped with Ar/Kr, He/Ne and UV lasers with a 40 × (1.4 NA) oil-
objective (using oil mounting medium, 1.515 refractive index). 
FM1-43 staining 
Glial cells were incubated with the fluorescent styryl dye FM1-43 (2 μM) for 2 minutes in 
order to completely stain plasma membrane, then extensively washed with PBS and 
exposed for 10 minutes to bzATP (100 μM concentration) or to standard extracellular 
solution. Samples were placed in a recording chamber mounted on an inverted microscope 
(Nikon Eclipse Ti-U) and observed with a 40 × objective (0.6 NA, PlanFluor, Nikon). 
Images (512x512 px) were acquired for 10 min with an exposure time of 150 ms (6.6 Hz) 
by a Hamamatsu Orca-Flash 4.0 digital camera controlled by an integrating imaging 
software package (HCImage, Hamamatsu). Recorded images were analyzed offline with 
the Clampfit software (pClamp suite, 10.2 version; Axon Instruments). Image time 
stacks were analyzed in selected regions of interest (ROI) to measure the variations in 
FM1-43 fluorescence intensity over time. 
AFM Analysis  
AFM characterization was performed as previously described (Rauti et al., 2016). Briefly, 
the pellet of MVs was re-suspended in PBS solution after isolation from cell cultures and a 
15 μL drop of sample solution was placed and left to adsorb (30 min) onto a freshly peeled 
mica substrate. Vesicles were then fixed with 1% formaldehyde for 1 h (RT) in order to 
prevent their collapse during AFM acquisition. MVs were then washed with PBS and dried 
under a gentle stream of nitrogen. AFM analysis was performed in air at RT, using the 
semicontact mode of a commercial instrument (Solver Pro, NT-MDT, RU). Silicon tips 
(NSC36/CR-AU, MikroMash, USA) with a typical force constant of 0.6 nN/nm and a 
resonance frequency of about 65 kHz were employed. Topographic height and phase 
images were recorded at 512 × 512 pixels at a scan rate of 0.5 Hz. Image processing was 
performed using Gwyddion freeware AFM analysis software, version 2.40. Diameter and 
 height of each vesicle were evaluated from cross-line profiles, and results were statistically 
analysed using Prism (Graphpad software). 
Nanoparticle Tracking analysis (NTA) 
Measurement and analysis of MVs size distribution by NTA was performed on a 
NanoSight LM10 system (Malvern) using approximately 500 μL of MVs of both 
conditions (bzATP-derived and s-GO-derived) diluited 1:20 in MilliQ H2O. Individual 
videos of 60 seconds for each sample were acquired using the maximum camera gain and 
analyzed by the NanoSight particle tracking software to calculate size and vesicles 
concentration. 
Dynamic Light Scattering (DLS) 
DLS measurements were carried out on a Zetasizer Nano ZS (Malvern Panalytical Ltd, 
UK), working in back scattering mode at a fixed scattering angle of 173°. The 
concentration of the vesicle solution was adjusted with regard to the scattering intensity. 
With sufficient photocounts, the lowest concentration was used for experiments. The 
samples were prepared 1 day the measurements and the analysis was conducted at 25°C in 
folded capillary cells. Each sample was tested three times. 
FTIR-ATR Spectroscopy Measurements 
MVs were isolated from 21-24 DIV glial cultures by centrifugation as described above and 
MVs pellet was successively washed with NaCl solution (150mM) and finally resuspended 
in 50 μL of the same solution in order to avoid contribution of phosphate and sugar groups 
to the absorbance spectra. For each experiment, 10 μL of sample solution were spread over 
the whole area of a round germanium ATR plate and left to dry forming a thin film of 
sample. 30 repeated spectra were acquired for monitoring the complete drying of the 
sample. Every spectrum was collected at 2 cm-1, repeating 256 scans in the range 
3000÷700 cm-1. Measurements were performed at SISSI (Synchrotron Infrared Source for 
Spectroscopy and Imaging, Elettra-Sincrotrone Beamlines, Basovizza, Trieste, Italy). 
Electrophysiological Recordings 
Patch-clamp recordings (whole-cell, voltage clamp mode) were performed from visually 
identified (under DIC microscopy) cortical neurons (DIV 9-11) placed in a recording 
chamber, mounted on an inverted microscope (Eclipse Ti-U, Nikon, Japan) and superfused 
with control physiological saline solution of the following concentration: 152 mM NaCl, 4 
 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM HEPES and 10 mM Glucose (pH adjusted 
to 7.4). Cells were patched with glass pipettes (4-7 MΩ) containing: 120 mM potassium 
gluconate, 20 mM KCl, 10 mM HEPES, 10 mM EGTA, 2 mM MgCl2 and 2 mM Na2ATP,  
pH 7.35; osmolarity was adjusted to 300 mOsm. All electrophysiological recordings were 
performed at RT and the spontaneous synaptic activity was recorded by clamping the 
membrane voltage at –56 mV (not corrected for liquid junction potential, which was –14 
mV). To investigate the acute effect on cortical neurons of glia-derived MVs, an injection 
pipette (patch pipette with resistance of 1–4 MΩ) filled with MVs previously isolated glial 
cultures as described above and resuspended in 100 μL of physiological saline solution was 
positioned at 200μm from the cell soma and connected to a pico-spritzer (PDES-02DX, npi 
Electronics) with 0.3 psi in-line pressure. The concentration of MVs used was 
approximately 6.64 x 109 for MVs obtained by bzATP stimulation and  1.64 x 1010 for 
MVs isolated from s-GO treated cultures. Baseline spontaneous synaptic activity was 
recorded for the 10 minutes prior delivering the puff (500 ms) of MVs and followed up for 
20 minutes to verify changes in post synaptic current (PSC) frequency and amplitude 
induced by the fusion of MVs with neuronal membranes.  
Data were collected by Multiclamp 700B patch amplifier (Axon CNS, Molecular Devices) 
and digitized at 10 kHz with the pClamp 10.2 software (Molecular Devices LLC, USA).  
All recorded events were analysed offline with the AxoGraph 1.4.4 (Axon Instrument) 
event detection software (Axon CNS, Molecular Devices). 
Statistical Analysis 
Data sets found to follow a non-normal distribution, were represented as box plot. The 
central thick horizontal bar in the box plots indicates the median value, while the boxed 
area extends from the 25th to 75th percentiles with the whiskers ranging from the 2.5th to 
the 97.5th percentiles. Statistically significant differences between two non-parametric data 
sets was assessed by Mann-Whitney’s test, while to assess statistically significant 
differences among three data sets was used the Kruskal-Wallis test and Dunn’s post hoc 
test. P < 0.05 was considered at a statistically significant.  
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Abstract 
In the last decades we have witnessed an exponential increase in the engineering of carbon-based 
(nano)-materials towards biomedical applications in neurology. Carbon constitutes one of the most 
versatile elements, characterized by a variety of allotropes and structures expressing different 
properties due to sp, sp2 and sp3 hybridizations. Carbon nano-materials are naturally excellent 
electrical conductors and were shown to possess variable degrees of biocompatibility, which make 
them promising candidates for the development of neural devices such as neural interfaces. 
Successful interfacing of the nervous system with devices that record or modulate neuronal 
electrical activity requires stable device/neuronal electrical coupling, favored by tight interactions 
between the electrode surface and the cell membrane. Such interactions as well as the efficient 
electrical coupling might be improved significantly by the use of conductive, ad hoc designed, 
nano-materials. Here we review the diverse carbon-based nanomaterials currently used in basic and 
applied neuroscience, the recent discoveries in this research field, focusing in particular on in vitro 
and in vivo neural interfaces.  
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1. Introduction. 
In the past decades, increasing attention to nanotechnology has fostered the development of diverse 
nanomaterials and nanostructures, from quantum dots [1], to nanofibers, nanotubes [2] and 
nanowires [3,4]. These nanomaterials are particularly promising in neuroscience applications, due 
to their ability to promote electrical and chemical communication within the nervous system at 
micro- and nanoscale levels. Applications of nanostructures to neuroscience rapidly expanded from 
molecular imaging [5], to neuro-regenerative scaffolds [6] and neural interfaces [7-9]. 
In the framework of nanotechnologies, carbon-based nanomaterials (CBNs) deserve particular 
attention. These materials, composed of pure carbon with different hybridization or structures [10], 
were recently introduced and became instrumental to the development of nanotechnology based 
research in neuroscience. 
 
2. Carbon and carbon-based nanomaterials 
Carbon [11] is the most versatile element in the periodic table, owing to the large number of bonds 
of different type and strength that can form with itself and with many different elements. Within the 
periodic table, carbon constitutes a versatile element, because of the variety of its allotropes and 
structures, given by the ability of the carbon valence orbitals to hybridize in sp, sp2 and sp3 
configurations. To date, the three naturally occurring allotropes of carbon (diamond, amorphous 
carbon and graphite) have been joined by allotropes deriving from synthetic process (such as 
graphene, carbon nanotubes, fullerenes, nanodiamonds) [12; Figure 1].  
  
                                              Figure 1. Carbon allotropes derived from synthetic process.  
 
The interest in CBNs increased exponentially in the last decades, first with the discovery of 
fullerenes (1985), then with carbon nanotubes (1991) and finally with the synthesis of graphene 
(2004). Carbon nanomaterials are naturally good electrical conductor and have good 
biocompatibility, which make them excellent candidates for electrically conductive scaffolds [14]. 
The unique properties of CBNs make them widely used in many fields ranging within material 
science [15], energy [16], environment [17,18], biology [19-22], medicine [23,24], and so forth. 
Among all kinds of carbon nanomaterials, carbon nanotubes (CNTs) and graphene are the most 
popular that have been extensively studied, since both possess excellent mechanical strength, 
electrical and thermal conductivity, and optical properties. The Young's modulus and tensile 
strength of CNTs and graphene can reach 1 TPa and 130 GPa [25]. Electron mobility of graphene is 
more than 15000 cm2×V-1×s-1, and the current density of metallic CNTs is orders of magnitude 
higher than those of metals such as copper [26,27]. Thermal conductivities of CNTs and graphene 
are about 3000-3500 W/mK and 5000 W/mK respectively [28]. The light absorption ratio of single-
layer graphene is just 2.5% [29]. Lots of the research efforts have been focused on utilizing these 
advantageous properties for various applications including electronics, biological engineering, 
filtration, lightweight/strong composite materials, photovoltaic and energy storage [30-32]. 
 
 
 
3. Carbon nanotubes (CNTs) 
CNTs have been discovered by Ijima in 1991 [33] and exhibit outstanding mechanical, thermal, and 
conductive properties. They are unique nano-objects made of one-atom-thick sheets of carbon 
(graphene) rolled in a cylindrical shape.  
In their simplest geometry, they are generally constituted by a single side-wall, made of benzene 
rings, and two end caps, presenting fullerene-like structures. CNTs can be classified mainly into 
two categories: single walled CNTs (SWNTs) and multi walled CNTs (MWNTs). SWNTs are 
formed of a single layer of graphene and their diameter ranges from 0.7 to 1.4 nm depending on the 
temperature at which they have been synthesized, while their length can vary from few hundreds of 
nm up to some μm. MWNT consist of many rolled layers of graphite, leading to tubes with larger 
diameter, up to 100 nm. 
They possess high surface area, high mechanical strength but ultralight weight, rich electronic 
properties, and excellent chemical and thermal stability [34]. These properties make CNTs very 
promising in different fields: they have been used in conductive composites, for energy storage and 
energy conversion devices, sensors, field emission displays and radiation sources, hydrogen storage 
media and nanometer-sized semiconductor devices, probes, and interconnects [35]. Their poor 
solubility and their apparently high toxicity have been faced in the past decade via functionalization 
of the CNTs surface by means of many different approaches aimed at increasing their solubility and 
lowering their toxic effects to promote biomedical applications [36]. CNTs have been proposed as 
biosensors [37], ion channel blockers [38], biocatalysts [39] tools in cancer diagnosis and therapy 
[40] and nanovectors [41].  
Among the number of possible biological applications of carbon nanotubes, tissue engineering has 
emerged as one of the more promising [42]. In particular, due to their peculiar features, CNTs 
appear to be suitable for the interaction with electrically active tissues, like neuronal and cardiac 
tissues. For example, many studies have demonstrated that CNT substrates are able to sustain 
neuronal survival and to promote neuronal process outgrowth [43-47]. 
An emerging application of CNTs to the nervous system is related to the issue of brain machine 
interfaces. These devices are designed to provide a direct communication pathway between Central 
Nervous System (CNS) structures and an external effector in order to restore abilities to patients 
who have lost sensory or motor function because of disease or injury. 
In this context, electrical recording or stimulation of nerve cells is widely employed in neural 
prostheses (for hearing, vision, and limb-movement recovery), in clinical therapies (treating 
Parkinson’s disease, dystonia, and chronic pain), as well as in basic neuroscience studies. In all 
these applications, individual electrodes or microelectrode arrays (MEA), characterized by various 
shapes and dimensions, stimulate neurons and/or record their activity to modulate their behavior. 
Ideally, an implanted stimulation electrode should maintain stability over time with a high spatio-
temporal resolution of signals, being safe for the patient. Often these requirements are conflicting, 
because small electrodes, useful to reduce brain damage in the site of implantation, need high 
current density to be efficacious and this can cause abnormalities in neural functions and cell 
structures [48]. CNTs, thanks of their nanometer size and their conductive properties, might be 
advantageous for designing novel brain machine interfaces. 
A first series of studies have addressed the ability of CNTs to deliver electrical stimuli to nerve 
cells. The first example of neuronal electrical stimulation through CNTs is reported by Liopo and 
colleagues [49]. CNTs were deposited onto polyethylene terephthalate films and a separated 
stimulation chamber was created by putting a ring in the middle of the film to contain dorsal root 
ganglion neurons, while the stimulating electrodes were attached to the CNTs substrate outside of 
the ring. It has been found that a current step of 1 μA amplitude, applied directly to the CNTs 
substrate, elicited a neuronal response, monitored as inward trans-membrane current by whole-cell 
patch recordings; such an inward current was indistinguishable from those induced by direct patch-
clamp electrode-mediated depolarizing voltage steps. 
Similarly, Gheith and coworkers [50] showed that neurons were activated by steps of electrical 
stimulation delivered through SWNT films, made by the layer- by-layer method, which consists in 
alternate layering with a negatively charged polyacrylic acid polymer and positive charged SWNTs. 
Although these were the pieces of evidence of successful stimulation of neurons via CNTs 
substrates, the nature of the interaction between neurons and nanotubes was still poorly understood. 
New insights about this issue were obtained by the work of Mazzatenta and coauthors [51]: by 
using an experimental setting similar to that reported by Liopo, these authors found that neuronal 
circuits, chronically grown on SWNT substrates, could be effectively stimulated via the SWNT-
layers. In fact, they observed that the delivery of voltage steps via Ag wire-SWNT layer induced the 
appearance of fast inward currents in hippocampal cultured neurons, monitored in voltage-clamp 
mode, which were abolished by tetrodotoxin (TTX), a selective blocker of voltage gated fast 
sodium channels. When recording in current clamp, supra-threshold stimulations elicited repetitive 
action potentials (APs). However the effective stimulation of neural network via SWNT was proved 
by monitoring the emergence of monosynaptic responses in neurons connected with ones in which 
presumably CNT mediated stimulation induced APs. 
In addition, the presence of tight contacts between neuronal membranes and CNTs were imaged by 
means of SEM [51], indicating, together with electrophysiological experiments, the presence of an 
electrical coupling between CNTs and neural membranes. 
The next advance in CNT-based neuronal interfaces was reported by Wang and collaborators [52]. 
These authors designed a prototype of neural interface, using vertically aligned MWNTs pillars as 
microelectrodes (VACNF), which offered a high charge injection limit (1-1.6 mC/cm2) without 
faradic reactions. Then, they cultured rat hippocampal primary cultures on the device and, while 
neurons were stimulated via CNTs electrodes, neuronal activity was optically monitored by 
observing intracellular Ca2+ level changes using a fluorescent calcium indicator. This study outlined 
that CNTs could be applied to provide safer and more efficient solutions for neural prostheses than 
previous metal electrode approaches [52]. 
In addition, CNTs forming the neuronal interfaces can be layered by electrically conductive 
polymers, such as polypyrrole, in order to improve the mechanical properties of the substrate and 
the efficacy of the electrical stimulation, together with their biocompatibility [53]; potentially, this 
might provide also a method for controlled drug release into the local environments [54]. Carbon 
nanofibers electrode architectures have been further employed to provide long-term, neuron-electro-
analytical measurements of the dynamic processes of intercellular communication between 
excitable cells. Multi-element electrode arrays composed of individually addressed VACNF were 
used as substrates for culturing of both neuronal-like derived cell lines (PC12) and primary cells (rat 
hippocampus) over extended periods (days to weeks) [55]. Neuronal activity was monitored at the 
electrode site in terms of detection of easily oxidized species generated by the cultured cells, i.e. 
neurotransmitters. Preliminary data also suggested that quantal release (in vesicular quanta) of 
easily oxidized transmitters could be observed at nanofiber electrodes following direct culture and 
differentiation on the arrays for periods of at least 16 days [55]. 
Recently, researchers are focusing on the optimization of production process in order to obtain 
CNT-based MEA systems more easily and with a high degree of reproducibility. Shein and 
collaborators [56] prepared CNTs-MEA systems by means of a conventional micro-fabrication 
technique, where CNTs were deposited through a chemical vapor deposition growth procedure 
utilizing metal electrodes as catalyst. These authors tested chips by culturing rat cortical neurons on 
them: they observed that, after several days in culture, neurons and glial cells aggregated and 
accumulated on CNT covered regions allowing the detection of neuronal activity via CNT 
electrodes up to 60 days in-vitro with high stability. Electrical stimulations were delivered by an 
electrode and the evoked neuronal responses recorded by adjacent ones. This work showed how 
CNTs can be exploited to design biocompatible, long lasting stimulation/recording systems, where 
micro-fabrication technique allows the design of patterned network. 
Shoval and coauthors [57] employed a similar procedure to develop CNT-MEA devices, which 
were exploited to record the activity of whole-mount neonatal mouse retinas. After minutes from 
the placement of retinas on electrodes, the authors could monitor neural spontaneous activity as 
typical bursting and propagating waves with a higher signal-to-noise ratio in comparison with 
commercially available electrodes. Interestingly, the recorded signals underwent over a period of 
minutes to hours to a gradual increase in APs amplitude, suggesting a dynamic interaction between 
CNTs and neurons, which resulted in an improvement in cell electrode coupling. 
Recently, another fascinating view is emerging in the field of CNT-based neuronal interfaces, 
namely that they provide not only a better quality in spatio- temporal resolution of recorded signals, 
but that CNTs might influence the fate of cells, thanks to the CNT intrinsic properties. 
In fact, it has been observed that the electrical activity of rat hippocampal neuronal network 
developed on CNTs immobilized microelectrodes is characterized by an earlier onset (4 days after 
seeding) in comparison to the ones of cultures grown on control electrodes. The authors suggested 
that the increase in surface roughness in CNT immobilized microelectrodes provides cells with a 
larger surface area to adhere leading to an increase in the activation of adhesion integrins, which 
might promote a faster neuronal differentiation [58]. 
Much of the understanding of neural interfaces has been gained by studying 2D structures/devices, 
however more recently biologists have come to understand the dissimilarity between the flat 
surfaces and the 3D topographical complexes i.e. the extracellular environment in which cells 
routinely operate in vivo [59]. Ghibaudo and team in 2009 [60] reported differences in cellular 
interactions between 2D and 3D substrates. They assessed cellular adhesion and migration of 
fibroblasts in both conditions. Cells interfaced to 3D microenvironment showed more elongated and 
branched shapes. Thus, 3D offers more control on size and shape of the substrate and cellular 
morphology than traditional 2D substrates [60]. 
CNTs fortunately present tunable properties that can lead to modification of their dimensions. Gui 
et al., [61] have molded CNTs into a porous sponge of 3D with a very high porosity while retaining 
desired mechanical properties. The sponge structure obtained was very stable and in fact allowed 
excellent compressibility and ability to recover volume by free expansion. 3D scaffold discussed in 
the literature maintained good contact and percolation and polymer infiltration [61]. 
Moreover, CNTs as implantable materials can also easily be tagged with biomolecules or polymers. 
Using a polymer incorporated with CNTs can provide the desired mechanical and physical 
properties as well as offer favorable electrical environment elicited by CNTs. Due to their 
biological applications, and resistance to biodegradation, CNTs have proved to be one of the 
promising choices for brain or spinal implantable materials or devices e.g scaffold, electrodes, other 
neural interfaces. In order to further enhance neuronal performance or detect existing neuronal 
connections, optimized electrical stimulations can be delivered to CNTs or CNTs-entrapped-
polymer. These strategies can be exploited all together to build scaffolds that can trigger 
improvements in neuronal network formations and functional tissues. 
CNTs have also been used to enhance the functional reconnections of separated spinal explants [62; 
Figure 2] and reconstruct 3D hippocampal network in vitro [63, Figure 3]. Bosi and collaborators 
were able to fabricate 3D PDMS scaffolds with pores layered by an irregular carbon nanotube 
carpet stably entrapped in the PDMS matrix. These mixed 3D scaffolds were applied not only to 
study the activity of primary hippocampal neurons in vitro [63], but also as scaffolds for the growth 
and functional reconnection of separated spinal cord organotypic slices and in vivo implant in the 
adult rats visual cortex, where they show a limited tissue reaction [64].  
 
 
Figure 2. Spinal organotypic slices cocultured in Control and in 3D CNF after 14 days of growth. Immunofluorescence 
is for neuron-specific microtubules (β-tubulin III; red), neurofilament H (SMI-32; green), and nuclei (DAPI; blue). 
(Modified with permission from Usmani et al. 2016 [62]) 
 
 
 
 Figure 3. Confocal micrographs show hippocampal cultures grown (9 DIV) on 2D-PDMS (left) and 3D-MWCNTS 
(right) immune-stained for β-tubulin III (in red), GFAP (green) and DAPI (blue). Scale bar: 100 μm. Repetitive Ca2+ 
activities spontaneously (middle) or bicuculline induced (right) recorded in 2D- and 3D-MWCNT. (Modified with the 
permission from Bosi et al. 2015 [63]). 
 
4. Graphene 
The CBN that is nowadays taking the stage is graphene (GR): this carbon allotrope consists of a 
single layer of carbon atoms arranged in a hexagonal honeycomb lattice and can be considered the 
founder of many other allotropes of carbon, such as graphite, diamond, charcoal, carbon nanotubes 
and fullerenes. Graphene is the thinnest compound known to man at one atom thick, the lightest 
material known (with 1 square meter coming in at around 0.77 milligrams), the strongest compound 
discovered (between 100-300 times stronger than steel and with a tensile stiffness of 150,000,000 
psi), the best conductor of heat at room temperature (around 5000 W/mK) and also the best 
conductor of electricity known (studies have shown electron mobility at values of more than 15,000 
cm2×V−1×s−1 [25]). Being able to create super-capacitors out of graphene will possibly be the big 
step in electronic engineering in a very long time, when the development of electronic components 
has been progressing at a very high rate over the last 20 years. However, the excellent electrical and 
chemical properties of graphene combined with its biocompatibility provide exciting opportunities 
for new biomedical applications. After the groundbreaking experiments of Geim and Novoselov 
[65] on graphene, research on this carbon allotrope has grown exponentially with more than 30000 
publications in the last ten years. Its simple molecular architecture and the ability to combine with 
other existing nano- and biomaterials make graphene suitable for a variety of purposes. The 
different applications for which graphene has been proposed, lead to the engineering of not only 
graphene monolayers, but a wide variety of graphene-based materials. Single layer graphene, bi-
layer graphene, multilayer graphene, graphene oxide (GO), reduced graphene oxide (rGO) and 
chemically modified graphene are the members of the graphene-based nanomaterial family: each 
member of this family possesses its own features in terms of oxygen content, number of layers, 
surface chemistry, purity, lateral dimensions, defect density and composition. Due to its highly 
reactive surface, single layer defect-free graphene production is challenging and it is also difficult to 
suspend in solution. These are the main reasons why GO and rGO are often preferred for biological 
applications. 
However, graphene has already been engineered for a variety of biomedical applications, including 
cellular imaging and drug delivery [66], bio-analysis [67], stem cell research [68,69] and even 
photothermal therapy for tumor [70]. 
It has been demonstrated that graphene films have excellent biocompatibility for primary cultures of 
mouse hippocampal neurons and are even capable of promoting neurite sprouting and outgrowth, 
especially during the early developmental phase [71]. Fabbro et al. observed that graphene-based 
materials are inert neuron-interfacing materials, able to preserve the basal physiological level of 
neuronal activity [72]. They noticed uncommon ability of Graphene-based substrates (GBSs) to 
support neuronal development (in terms of neuronal passive properties, spontaneous synaptic 
activity, synaptogenesis, and short-term synaptic plasticity) without pre-coating with adhesion-
promoting peptides (e.g., polylysine or polyornithine). More recently, graphene was reported to 
tune the extracellular ion distribution at the interface with hippocampal neurons, key regulator of 
neuronal excitability. The ability to trap ions by graphene is maximized when a single layer 
graphene is deposited on substrates electrically insulated. These biophysical changes caused a 
significant shift in neuronal firing phenotypes and affected network activity [73]. 
One of the first observations related to the possible use of GR in the brain environment was that the 
biocompatibility and broad-spectrum transparency, flexibility and mass-producibility makes GR an 
ideal candidate for replacement of ITO in neural interfacing devices. Indeed, there are several 
examples of effective graphene-based electrode devices in the recent literature.  A graphene-based, 
carbon-layered electrode array device was implanted on the brain surface in rodents for high-
resolution neurophysiological recording. The optical transparency of the device at >90% 
transmission over the ultraviolet to infrared spectrum demonstrated its utility through optical 
interface experiments that use this broad spectrum transparency. These experiments included 
optogenetic activation of focal cortical areas directly beneath electrodes, in vivo imaging of the 
cortical vasculature via fluorescence microscopy and 3D optical coherence tomography [74; Figure 
4].  
 
  
Figure 4. Left panel: diagram of CLEAR device construction showing the layered structures; middle panel: schematic 
drawing of opto-experimental setup, showing the CLEAR device implanted on the cerebral cortex of a mouse, with an 
optical fibre delivering blue light stimuli to the neural cells; right panel: optical evoked potentials recorded by the 
CLEAR device. X-scale bars represent 50 ms, y-scale bars represent 100 mV (Modified with the permission from Park 
et al. 2014 [74]). 
Graphene and related materials (GRMs) offer several benefits as novel components for the 
engineering of neural interfaces, including multifunctionality and biocompatibility. Kostarelos et 
al., [75] have reported flexible neural implants with very low noise levels. Using a flexible array of 
graphene field-effect transistors, the implants successfully detected slow-wave activity, 
synchronous epileptic activity and audio-visual responses in rats, matching the performance of 
state-of-the-art platinum electrode implants [76].  
GR is also explored as a novel platform for the local delivery of therapeutic molecules with 
encouraging preliminary results. Functionalization of GR and GO can tailor their properties and 
enable their use as carriers of therapeutic molecules, while their biosensing, optical and 
photothermal properties are also being exploited for combinatory interventions [77]. As an 
electroactive material, graphene is considered emerging as a next-generation neuronal tissue 
engineering scaffolds to enhance neuronal regeneration and functional recovery after brain injury. 
Electrospun microfiber scaffolds coated with self-assembled colloidal graphene were implanted into 
the striatum or into the subventricular zone of adult rats [78], while microglia and astrocytes 
activation levels were suppressed with graphene functionalization. In addition, self-assembled 
graphene implants prevented glial scarring in the brain 7 weeks following implantation. Astrocytes 
guidance within the scaffold and redirection of neuroblasts from the subventricular zone along the 
implants was also demonstrated. Song et al. observed [79] that 3D graphene supported the growth 
of microglia and showed good biocompatibility. Microglia is a macrophage like phagocytic cell 
normally inactive unless provoked by damaging xenobiotics. These cells are derived from myeloid 
cells and constitute 12% of brain cells [80]. The observations indicated that 3D graphene offered 
milder neuroinflammation on microglial cells compared to 2D graphene, which further suggested 
that the topographical features could affect inflammatory behaviors. Additionally, the 3D graphene 
foams facilitated the growth of neural stem cells and PC-12 cells (originated from neural crest) and 
proved that they can be used for neural repairing and neurogenesis. 
Several other studies demonstrated the ability of GR substrates to promote neurites sprouting and 
outgrowth [71], to enhance neuron electrical signaling [81] and to reduce the inflammatory 
response [79]. In neurology, GR represents a promising tool for neuronal implants or bio-devices, 
with potential applications that range from neurooncology to neuroregeneration [82,83]. It was also 
reported recently the ability of small graphene oxide nanosheets (s-GO) to interfere specifically 
with neuronal synapses, without affecting cell viability. In particular, in cultured neuronal networks, 
upon chronic s-GO exposure, glutamatergic release sites were sized down [84]. Different studies 
reported the use of GBMs at the CNS for cell labeling and real-time live-cell monitoring [85,86]; 
delivery to the brain of molecules that are usually rejected by the Blood Brain Barrier (BBB) 
[87,88], and cell analysis based on G-electrodes [89,90]. In addition, interfacing graphene with 
neural cells was also proposed to be extremely advantageous for exploring their electrical behavior 
or facilitating neuronal regeneration by promoting controlled elongation of neuronal processes 
[71,72,91,92, Figure 5].  
 
 
Figure 5. SEM images showing large number of graphene oxide flakes (white arrowheads) in contact with the neuronal 
cortical cell membrane, exposed to GO flakes for 14 days. On the right panel, representative spontaneous (left panels) 
or bicuculline-evoked (right panels) Ca2+ oscillations recorded in 14 DIV cortical cultures in control or GO conditions. 
(Reprinted with the permission from Bramini et al. 2016 [92], American Chemical Society). 
 
Among the different possible implementations of GBMs, building of graphene-based scaffolds for 
cell growth and differentiation is one of the most promising. 3D graphene foams (3D-GF) can be 
obtained using nickel foam template for chemical vapor deposition of graphene. Growing neural 
stem cells on these substrates allows not only a more physiological condition but also a substrate 
that can be electrically stimulated [93; Figure 6].  
 
 
 
Figure 6. Top panel: low- (a) and high- (b) magnified SEM images of NSCs cultured on 3D-GFs. The inset illustrates 
the interaction between the cell filopodia and 3D-GF surface. Bottom panel: Representative fluorescence images of 
differentiated NSCs under differentiation conditions, the cells were immunostained with Tuj-1 for neuron (green, a), 
GFAP for astrocyte (red, a&b), O4 for oligodendrocyte (green, b) and DAPI for nuclei (blue, a&b) (Modified from Li 
et al., 2013 [93])  
 
Neuronal dissociated hippocampal cultures, grown on 3D-GFs built as previously described, were 
also able to recapitulate two basic properties of the complexity of the brain: firstly, the coexistence 
of local and global electrical activity, and secondly, the existence of neuronal assembly with a 
degree of correlated electrical activity varying in space and time [94]. In a different strategy Martìn 
et al. built hybrid hydrogels with polyacrylamide and graphene. This study demonstrates that 
graphene improves the biocompatibility of 3D scaffold [95].  
 
5. Diamond 
Diamond, a natural as well as a synthetic material, has captured researchers’ attention more than 10 
years ago. From any list summarizing the specific material properties, diamond is often at the 
extreme [96]: crystalline diamond shows the highest atomic density of any bulk crystal, the highest 
bulk modulus and high thermal conductivity. Diamond, a wide band gap semiconductor, is optically 
transparent from the far infrared to the ultraviolet, making it an ideal candidate for optical 
applications [97]. The attractiveness of diamond is that different morphologies and forms can be 
obtained from this sp3-hybridized material. Indeed, modulation of the growth parameters results in 
microcrystalline to ultra-nanocrystalline CVD diamond films. Ultra-nanocrystalline films have the 
advantage of possessing smooth surfaces, lower strain and improved fracture resistance. Such films 
are characterized by diamond domains that are ≈10 nm or less in size, with thin sp2 boundaries. 
Nanoscale diamond particles (also termed nanodiamonds, NDs) represent another interesting form 
of diamond, largely explored for applications in drug delivery or medical diagnostics.  
Due to its chemical and biochemical inertness, diamond is generally considered as a biocompatible 
material, meaning that it is chemically non-cytotoxic when in contact with biological cells [98]. 
This makes diamond a material of interest for coating medical devices, building artificial organs, 
and as a growth support for biological cells. ND particles and thin film have been used as substrates 
for cultivation of different cell phenotypes including neurons [99], fibroblasts [100], osteoblasts 
[101] and many other cell lines [102].  Guarina and collaborators [103] used fluorescent 
nanodiamonds (FND) to evaluate their functional implications on hippocampal neurons, using 
MEA recordings. The firing frequency of neurons was differently affected depending on the 
developmental stage of incubation with FNDs (7 versus 14). When FNDs were applied at 14 days in 
vitro they drastically reduced the neuronal frequency (Figure 7).  
In all cases diamond exhibited no measurable cytotoxicity and, in some cases, appeared to promote 
cell adhesion and proliferation over conventional materials such as glass or tissue culture 
polystyrene.  
 
 
Figure 7. Confocal fluorescence micrograph of cultured hippocampal neurons (14 DIV), exposed to 40 μg/ml FND for 
2 days, and stained in green with the cytoplasmic labelling dye (CellTracker™ Green CMFDA). Red emission is from 
FNDs. The entire field and cross-sections (XZ and YZ) were shown. Representative traces of spontaneous firing at 18 
DIV (data from 3 representative MEA channels) under control conditions (CTRL), without FNDs, with FNDs seeded at 
7 DIV and at 14 DIV. Insets: higher magnification of single spikes and bursts. (Modified with the permission from 
Guarina et al. 2018 [103]). 
 
In neuroscience, in addition to the employment as growing substrate, NDs were applied in the 
development of biosensors for recording neuronal activity, thanks to their peculiar electrical and 
chemical properties and stability [104,105]. Its high biocompatibility and low cytotoxicity make 
ND an excellent candidate for the development of neural interfaces in biological systems with 
different levels of complexity.  
The increasing interest and the recent development of new techniques for constructing 
micro/nanodevices [106-110] has rapidly broadened the number of diamond-based MEAs (DBMs) 
employed for electrical recording and stimulation and for detecting neurotransmitter release [111]. 
DBMs can now be used to either resolve the electrical activity in complex neuronal networks (low-
density MEAs) [112,113], to identify the extension of cell microdomains (active zones) where 
neurosecretion occurs (high-density MEAs) [114] or to assay the protein content of the 
physiological liquids that condition the growth, formation, and maturation of complex neuronal 
networks [115,116].  
Ariano and colleagues fabricated a device to record extracellular activity of cultured neurons, based 
on hydrogen terminated (H-terminated) conductive diamonds. The device allows to record the 
entire activity of the network in a way similar to conventional microelectrode array (MEA) and with 
comparable neuronal activity signals [104]. 2D and 3D MEA systems based on diamond and 
consisting of 256 electrodes on a surface of 28.8 mm2 have also been developed with the purpose of 
studying ex-vivo models, in order to obtain more information from a more complex neuronal 
network [117]. Finally, Halpern and colleagues successfully implanted diamond electrodes in 
Aplysia californica attaching it on the buccal nerve 2, a primary nerve involved in the feeding 
behavior of Aplysia and recording extracellular electrical activity for up to 9 days after the 
implantation [118].  
Diamond in the form of nanowires should also be considered. The use of diamond nanowires is 
believed to address positively issues related to improving the overall performance of sensors, 
including sensitivity and selectivity [119-122].  
In the field of cellular sensing, diamond-based substrates offer unique advantages in comparison to 
conventional materials (silicon, glass, metals, and polymers), [123] which directly derive from the 
extreme physical properties of this material, i.e., mechanical robustness, wide optical transparency 
and thermal conductivity [124]. 
In-vitro tests demonstrated that diamond-based substrates are non-cytotoxic and display a 
significantly better cell adhesion and growth in comparison with standard substrates [125,126].  
Furthermore, the chemical inertness of the pristine diamond surface does not prevent its efficient 
chemical functionalization upon the termination with specific covalent bonds that allows the 
attachment of a broad variety of molecules, including DNA strands [127-129].  
The H-termination of the diamond surface favors the formation of an electrically conductive two-
dimensional layer in contrast with the insulating O-terminated surface [130]. These transparent 
electrodes have been exploited to record the activity of cultured neuronal cells with a single 
macroelectrode [104] and subsequently to record the activity of cultured cardiomyocyte-like and 
human embryonic kidney cells using arrays of solution-gated field-effect transistors. 
 
6. Carbon nanofibers  
The typical lengths and diameters of carbon nanofibers are in the ranges of 5–100 mm and 5–500 
nm, respectively [131]. Compared to the conventional technologies, carbon nanofibers (CNFs) have 
great potential as neural interfaces, for their superior electrical, chemical, and physical properties 
[1]: chemically stable and inert in physiological environment [2], biocompatible for long-term 
implantation due to their solid carbon skeleton [3], electrically robust and conductive for signal 
detection [4], 3D structures that allow intra-tissue and intracellular penetration [132], with high 
surface-to-volume ratio, which reduces contacting electrical impedance greatly, and [5] high spatial 
resolution due to their ultra-micro scale sizes. 
In addition, carbon nanofiber materials have been developed as electroconductive scaffolds for 
neural tissues to facilitate communication through neural interfaces. Electrical fields are able to 
enhance and direct nerve growth [133], therefore electroconductive scaffolds have been applied to 
enhance the nerve regeneration process, not only providing physical support for cell growth but also 
delivering the functional stimulus. Moreover, CNFs have great potential as multiplexing and 
intracellular neural interfaces, capable of dual-mode detecting electrophysiological and 
neurochemical signals, not only at the extracellular level with high spatial resolution, but also at the 
intracellular level by penetrating into single neurons [9].  
 
7. Fullerenes 
The first fullerene C60 came to life in 1985 [134] but the family of fullerenes includes a wide range 
of carbon-based molecules with different number of carbon atoms and symmetries. The most 
common fullerene is also called buckyball and consists of 60 carbon atoms arranged into 12 
pentagons and 20 hexagons to create a structure with the geometry of a hollow sphere [134-136]. 
C60 attracted great attention because of its very stable and symmetric structure [137].  
Fullerenes are considered zero-dimensional materials which possess very interesting physical and 
chemical properties [138-142] for medicine and technology. 
The main issue the biomedical field faced was the natural water repulsion of C60 and its resulting 
hydrophobicity. This insolubility in aqueous media induces fullerenes to aggregate [143] and this 
led to develop several strategies to overcome the problem. Hydroxyl and malonic acid 
functionalized fullerenes found important applications in neuroprotection against free radicals 
generated by fatty acid aerobic metabolism, which neurons are rich of [144], after brain injury or 
inflammatory response to diseases. These derivatives of fullerene can interrupt chain reactions 
generating the radicals by removing intermediate peroxyl radicals and showing robust 
neuroprotection activity in several in vitro models of CNS injury and neurological disease including 
Parkinson’s disease [145]. This ability has also important clinical applications, in fact, it can 
prevent excitotoxicity produced by the leak of neurotransmitters and excitatory ions following the 
free radical damage even present after neuroprosthetic surgery and this effect is probably due in part 
by its ability to inhibit glutamate channels [146]. 
 
8.   Other carbon nanomaterials 
Single wall carbon nanohorns (SWCNHs), reported by Ijima in 1999, are tiny graphene sheets, 
wrapped up to form horn-shaped cones with a half fullerene cap, having 30-50 nm length and 2-5 
nm diameter. They have the tendency to group together and form aggregates (spherical clusters or 
bundles) like "dahlia" flowers or buds, with an overall diameter of 80-100 nanometers. 
Being their structure similar to tiny carbon nanotubes, SWCNHs maintain most of the typical 
properties of nanotubes: high electrical conductivity, high thermal conductivity and possibility of 
functionalization. SWCNHs peapods (functionalized with CdSe/ZnSe QDs), encapsulating 
Gd3N@C80 fullerenes and delivered to U87 tumor bearing mice by convection-enhanced delivery 
intratumoral infusion [147], enabled tumor imaging either in vivo by MRI (thanks to Gd3+) and ex 
vivo by confocal microscopy (owing to the presence of QDs). SWCNHs showed to be retained 
inside the tumor for at least 3 days. Although this study indicates SWCNHs as a possible brain drug 
delivery nanoplatform, other reports on the in vivo bio-distribution of SWCNHs have demonstrated 
that they could not cross the BBB [148,149]. This precludes the SWCNHs to be delivered i.v. to the 
brain, leaving the more dangerous and complicated intracranial administration as the only feasible 
option available at the moment. Carbon dots (CDs) are a recently discovered class of discrete, 
quasi-spherical CBNs [150], which essentially combine the presence of an amorphous core and a 
graphitic shell. CDs are expected to have a huge impact in biotechnological and environmental 
applications, based on their high potential as a nontoxic, fluorescent alternative to the popular 
semiconductor-based QDs. Their peculiar properties have been exploited in photocatalysis [151], 
electrocatalysis [152], as sensitizers for solar cells [153], as well as for sensing applications [154]. 
Due to their high intrinsic fluorescence that can span from the VIS to the NIR [155,156], CDs were 
considered particularly appealing for bioimaging applications (for a review see Peng Z. et al. 2017 
[157]). Depending on the synthetic strategy adopted, they might expose functional groups on their 
surface, allowing surface passivation with biocompatible polymers or grafting additional 
biomolecules [158,159]. Finally, molecules like anticancer drugs and nucleic acids can be non-
covalently loaded on their surface, allowing the use of these nanomaterials for delivery purposes 
[160,161]. Among all the carbon nanomaterials described so far, CDs seem to display the highest 
biocompatibility [162]. One important contribution to this effect seems to be the high density of 
charged groups on their surface, which provides high stability of their suspensions in water and 
biological fluids. Several authors have reported that carbon dots penetrate cell lines in vitro [163-
167;]. No toxicity was observed in various studies conducted on cell lines [162,165] and on animals 
[168]. However, Borisova et al. reported that these nanoparticles could interfere with exocytotic 
mechanisms, and therefore hamper the normal neuronal and brain functions [169]. However, the 
effect of CDs on cellular biochemistry has not been completely explored. 
Given their recent discovery, only a few studies have applied CDs to the CNS with the aim of 
diagnosis and therapy. Interestingly, the CDs used in in vivo biodistribution studies exhibited very 
good BBB crossing capabilities and a strong tendency to accumulate in the brain even if they were 
not specifically functionalized: 100 nm fluorescent CDs, prepared via the inexpensive and efficient 
pyrolysis of a glucose and glutamic acid mixture, were uptaken by cerebral tissues after i.v. 
administration in mice [170]. Epifluorescence imaging, made possible thanks to the CDs bright 
fluorescence emission, revealed that they crossed readily the BBB after systemic injection and 
diffused in the brain tissues, where they reached the highest concentration within 1 h. Ex vivo 
imaging of brain slices indicated that CDs were predominantly accumulated at the cortex surface, in 
the hippocampus and in the ventricles. The authors hypothesized that the presence of still intact 
glucose and glutamine molecules on the CDs surface endowed the nanoparticles of “CNS-
targeting” capabilities. From the available epifluorescence images, the nanomaterial did not show 
diffusion in other specific body regions apart from the brain and the blood. Interestingly, the 
nanomaterial was also rapidly cleared from the CNS. In vitro studies [171,172] have demonstrated 
that CDs dispersions in plasma had high stability, and good hemocompatibility with moderate 
cytotoxicity for brain endothelial cells, detected only at very high concentrations. In summary they 
provided in vivo data, although referring only to early time-points, suggested that the nanomaterial 
had an adequate safety profile for biomedical applications in the CNS. 
Also 3–4 nm glycine-derived CDs were able to cross very efficiently the BBB and accumulate in 
the brain. Moreover, they were able to target a human glioma tumor xenographted in mice brain 
[173]. Epifluorescence imaging indicated that they displayed a maximum brain uptake just 5 min 
after tail vein injection, and strongly localized inside the tumor mass to be then rapidly cleared. 
Systemically, CDs distributed in the liver, kidneys and hearth. In vitro hemolysis, plasma stability 
and cytotoxicity studies indicated a high biocompatibility of this nanomaterials [168,174]. Although 
these CDs displayed fast and consistent accumulation inside the tumor, their potential use as vectors 
for delivering antitumor drugs in the CNS is not suggested at the moment because of their fast 
excretion from the tumor lesion and their accumulation in the heart, which is a known target of 
anticancer drugs toxicity. 
These nanomaterials are in the very early stages of development for biomedical applications: 
suitable chemical modification with molecules able to increase their plasma circulation time and/or 
with targeting moieties might improve their retention in the brain allowing future applications in 
tumor therapy. A deep toxicological evaluation of their effects in the CNS in particular but also in 
the whole body is needed since current available data, albeit very promising, are not sufficient to 
draw clear conclusions. 
 
9.    Conclusions 
In the past few years, CBNs have been studied in a wide range of technological fields, including 
biomedical applications. Many CBNs have demonstrated to possess unexpected and outstanding 
properties towards electrically active systems, such as the neuronal and the cardiac tissues. In 
particular, CNTs are in the spotlight for having a powerful influence on the physiological activity of 
neuronal tissue. The precise biophysical mechanisms of these special interactions are not 
completely understood, but the features and the remarkable applications of such materials, together 
with their ability to manipulate neural activity, hold strong promise in manufacturing interfaces 
enriched by artificial cues that can guide tissue reconstruction. The ability of CNT-based 3D 
structures to dictate neurite web morphology toward successful reconnection of segregated spinal 
explants has been explored in vitro [62] and the same material has been implanted in vivo in the rat 
brain with a limited tissue reaction surrounding the implants [64]. The new protagonist among 
CBNs, graphene, has also displayed interesting features that can be exploited at the interface with 
neurons and other CBNs are under investigation for their own peculiar properties.  
We strongly believe that a great future awaits CBNs in machine-brain interfaces and in tissue 
engineering. For this reason, in this review, we have reported some of the more recent CBN 
applications related to engineer brain interfaces. We have discussed their properties and their 
performances in improving and boosting neuronal growth, in developing new research lines in 
neurophysiology and neurobiology and in providing novel methods to explore brain function. 
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DISCUSSION 
 
EVs discovery represents a breakthrough in the understanding of signaling among cells, 
unveiling an alternative and complementary way every cell phenotype may adopt to 
communicate either with neighbor or distant targets, not only circumscribed to a single tissue. 
EVs structure allows the organisms to deliver complex signals mediated by macromolecules 
in a stable environment and avoiding potential interactions with external agents. Their 
conservation over the evolution suggests a fundamental role in many aspects of functioning 
of biological systems, at different levels of complexity (Lawson et al., 2017). 
However one of the main issue in the study of these particles is their isolation, detection and 
measurement (Witwer et al., 2013). The recent increasing studies on EVs coincides in fact 
with the rising of technologies and tools for the investigation of the nanoscale and synthesis 
of nanosized materials, the so-called “nanotechnologies” (Wong et al., 2013). In the vast 
panorama of nanomaterials, an extraordinary scientific interest is growing up on carbon-
based materials, driven by the immense variety of possibilities that these materials can 
provide to the development of biomedical interfaces, especially in the field of neuroscience 
(Baldrighi et al., 2016a; John et al., 2015). 
What we have done was to study the interfacing of nanomaterials with glial cells, focusing 
on s-GO flakes. s-GO flakes are nanosized fragments of graphene oxide which directly 
interact with cellular plasma membrane by adsorbing on it or being internalized by the cell. 
This interaction is known to alter the equilibrium of the membrane and in some conditions, 
mostly correlated with concentration and exposure-time, also its integrity (Zhang et al., 
2016).  
We already know from literature that glial cells, both astrocytes and microglia, are able to 
release MVs under pharmacological stimulation with bzATP (Bianco et al., 2005, 2009) and 
as first step we confirmed this data (Rauti et al., 2016b). However the massive release of 
MVs evoked by bzATP represents a stressful condition for cells that could not be maintained 
over time, due to the long-term cytotoxic effects of bzATP. On the other hand, MVs basal 
release has been known to be very weak in resting condition, as also shown by the western 
blot analysis. Therefore, starting from the fact that s-GO flakes interacts with plasma 
membrane and considering the biogenesis and origin of MVs, we tested the capacity of those 
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flakes to modulate the release of vesicles by simply exposing glial cell to it for a short-term 
period. The treatment did not visibly affect glia viability, as demonstrated by the cell density 
analysis, however significantly affected basal MVs release. s-GO flakes indeed boosted MVs 
basal release to a level totally comparable to that of bzATP and significantly higher than the 
basal release measured in the untreated cultures, as demonstrated by western blot. Since this 
way of inducing MVs release by this specific kind of cell was not reported before, we 
investigated the nature of those MVs by comparing them with MVs released by a well-known 
model of release, represented by bzATP stimulation. We investigated similarities and 
differences to better understand the nature of this alternative pool of MVs by characterizing 
them for structure, composition and physiological effects exerted. Once we identified MVs 
by AFM measurement and verified that MVs released from s-GO-treated cultures were 
completely similar to those isolated after bzATP stimulation, proving that s-GO effectively 
induced release of MVs from glial cells we investigated the dynamic of the release by 
staining plasma membranes with FM1-43 styryl dye in both the condition of release. The 
plasma membrane de-staining revealed a faster decay of fluorescence equivalent in both the 
treated cultures when compared with controls, suggesting that this was actually related to 
MVs budding from the cell surface and not the result of lipid membrane physiological 
turnover and finally verifying the flotillin-1 positive signals obtained from treated cultures 
culture media. Once the hypothesis of the enhanced MVs basal release induced by s-GO was 
confirmed, we investigated the nature of MVs obtained by comparing the two populations. 
Size measurement revealed a comparable size distribution with the exception of AFM 
measurements, where s-GO-derived MVs were significantly smaller than the bzATP-derived 
ones. This result could be related to the small number of vesicles analysed, if compared with 
the large scale measurement of DLS and NTA. However, the smaller diameter reported for 
s-GO-derived MVs may also suggest a difference in the elastic properties between the two 
population of vesicles, in fact the AFM measures performed in air may cause MVs to collapse 
under the atmospheric pressure; the different size observed could then represent a higher 
resistance of s-GO-derived MVs to this pressure. Also the analysis of macromolecular 
composition performed with infrared-ATR measurement revealed an equivalent nature for 
MVs isolated from the two conditions of release. The absorption peaks highlighted the 
presence of nucleic acids, mostly represented by RNAs, proteins and lipids, even if the low 
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signal-noise ratio did not allow a deeper analysis of the spectrum aimed to identify which 
specific class of nucleic acids and proteins they carry. These data together suggest that even 
if the stimulus that triggers the production of vesicles is different, the product of release is 
similar and reinforce the hypothesis that s-GO potentiate the MVs pathway of release, 
without affecting the vesicles makeup. 
Finally, the role of MVs and EVs in general is to deliver complex messages that are stored 
in their cargo as macromolecules like nucleic acids, proteins and bioactive lipids which, once 
uptaken by target cells, may affect their physiology at different level and with different 
timings. In literature there are several studies on different cellular models which investigate 
the biological effects mediated by EVs on other cells and only few of them focuses on 
nervous system. The effects reported, studied both in physiological and pathological 
conditions, are usually the result of a long-time exposure to EVs (Antonucci et al., 2012; 
Emmanouilidou et al., 2010; Simeoli et al., 2017) but almost nothing is known about the 
short-time effects that take place few minutes after the interaction of EVs with the target. In 
the last part of the work we investigated how an acute administration of MVs to cortical 
neurons affects their synaptic activity. We found that over 50% of the neurons exposed to 
MVs, isolated from both conditions, showed an increase in PSCs frequencies 15 minutes 
after the puff of MVs, revealing however a large variability. The cause of this variability may 
be attributed to at least three factors: the concentration of MVs really delivered is variable 
by definition because we cannot actually control the number of vesicles released by a single 
culture of glial cell, even if MVs density is localized in a fixed range, the intrinsic variability 
could affect the response of cells targeted; the number of MVs that actually reach and fuse 
with the plasma membrane may also variate and finally the mechanism of signaling itself 
involves the synergy of several pathways that cooperate all together to generate a biological 
output (Rhoads, 1999). One of those is RNA translation and protein synthesis, which require 
a variable time span of the order of minutes, significantly slower and less precise than the 
response mediated by the activation of receptors by their ligands. 
 
In conclusion, MVs and more in general EVs are a field of research that has to be explored 
more in depth since the comprehension of underlying mechanisms is still at an embryonic 
stage. They represent a great opportunity to better understand the physiology of intercellular 
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communication even in a pathological environment, and provide a powerful tool to modulate 
and possibly control the signaling among cells. On the other hand, in the field of cellular 
engineering, gene therapy and drug delivery, EVs constitute a promising strategy for the 
development of applications in biomedicine and bioengineering. However, the fulfillment of 
these goals cannot be reached without the integration of biological sciences with 
nanotechnologies. High throughput instruments and nanosized substrates are essential to 
create efficient interfaces able to control those processes that were uncontrollable until few 
years ago. In this context we cannot overlook the capacity of such nanomaterials to be 
integrated in biological systems without affecting their physiology. For this reason, studies 
of biocompatibility must be conducted in parallel, in order to minimize possible adverse 
reaction and maximize the outputs.  
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